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Stephen John Walters 
The use of bootstrap methods for estimating sample size and analysing health- 
related quality of life outcomes (particularly the SF-36) 
Summary of PhD thesis 
Health-Related Quality of Life (HRQoL) measures are becoming increasingly used in 
clinical trials and health services research, both as primary and secondary outcome 
measures. Investigators are now asking statisticians for advice on how to plan (e. g. 
sample size) and analyse studies using HRQoI_ outcomes. 
HRQoL outcomes like the SF-36 are usually measured on an ordinal scale. However, 
most investigators assume that there exists an underlying continuous latent variable 
that measures HRQoL, and that the actual measured outcomes (the ordered 
categories), reflect contiguous intervals along this continuum. 
The ordinal scaling of HRQoL measures means they tend to generate data that have 
discrete, bounded and skewed distributions. Thus, standard methods of analysis 
such as the t-test and linear regression that assume Normality and constant variance 
may not be appropriate. For this reason, non-parametric methods are often used to 
analyse HRQoL data. The bootstrap is one such computer intensive non-parametric 
method for estimating sample sizes and analysing data. 
From a review of the literature, I found five methods of estimating sample sizes for 
two-group cross-sectional comparisons of HRQoL outcomes. All five methods 
(amongst other factors) require the specification of an effect size, which varies 
according to the method of sample size estimation. The empirical effect sizes 
calculated from the various datasets suggested that large differences in HRQoL (as 
measured by the SF-36) between groups are unlikely, particularly from the RCT 
comparisons. Most of the observed effect sizes were mainly in the 'small' to 
'moderate' range (0.2 to 0.5) using Cohen's (1988) criteria. 
I compared the power of various methods of sample size estimation for two-group 
cross-sectional study designs via bootstrap simulation. The results showed that 
under the location shift alternative hypothesis, conventional methods of sample size 
estimation performed well, particularly Whitehead's (1993) method. Whitehead's 
method is recommended if the HRQoL outcome has a limited number of discrete 
values (< 7) and/or the expected proportion of cases at either of the bounds is high. If 
a pilot dataset is readily available (to estimate the shape of the distribution) then 
bootstrap simulation may provide a more accurate and reliable estimate, than 
conventional methods. 
Finally, I used the bootstrap for hypothesis testing and the estimation of standard 
errors and confidence intervals for parameters, in four datasets (which illustrate the 
different aspects of study design). I then compared and contrasted the bootstrap with 
standard methods of analysing HRQoL outcomes as described in Fayers and Machin 
(2000). 
Overall, in the datasets studied with the SF-36 outcome the use of the bootstrap for 
estimating sample sizes and analysing HRQoL data appears to produce results 
similar to conventional statistical methods. Therefore, the results of this thesis 
suggest that bootstrap methods are not more appropriate for analysing HRQoL 
outcome data than standard methods. This result requires confirmation with other 
HRQoL outcome measures, interventions and populations. V 
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Chapter 1: Introduction 
Health Related Quality of Life (HRQoL) measures are becoming more 
frequently used in clinical trials and health services research (HSR), as both 
primary and secondary endpoints. Investigators are now asking statisticians 
for advice on how to plan (e. g. sample size) and analyse studies using 
HRQoL measures. 
The analysis of data from quality of life (QoL) measurements requires some 
basic assumptions. We will assume that (01schewski and Schumacher, 1990): 
(1) QoL is a subjective construct which is not directly observable and 
measurable; 
(2) QoL is a multi-dimensional construct consisting of different aspects of 
physical and psychological well being; 
(3) QoL is a time-dependent construct reflecting a person's experiences 
and perceptions over their life history. 
HRQoL measures such as the Short Form (SF)-36, Nottingham Health Profile 
(NHP) and EORTC QLQ-C30 are described in Bowling (1995,1997) and are 
usually measured on an ordered categorical (ordinal) scale. This means that 
responses to individual questions are usually classified into a small number of 
response categories, which can be ordered, for example, poor, moderate and 
good. The question responses are often analysed by assigning equally 
spaced numerical scores to the ordinal categories (e. g. 0= 'poor, 1= 
'moderate' and 2= 'good') and the scores across similar questions are then 
summed to generate a HRQoL measurement. These 'summated scores' are 
treated as if they were from a continuous distribution and were Normally 
distributed. We will also assume that there exists an underlying continuous 
latent variable that measures HRQoL (although not necessarily Normally 
distributed), and that the actual measured outcomes are ordered categories 
that reflect contiguous intervals along this continuum. 
However, this scaling of HRQoL measures may lead to several problems in 
determining sample size and analysing the data (Walters et al 2001 a, 2001 b). 
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(1) The apparent continuum hides the fact that only a few discrete values 
are possible. 
(2) The scale may not be linear. 
(3) The scales are bounded and have range-limited values. 
(4) Methods based on the Normal distribution (such as linear regression) 
assume that the outcome variable has a constant variance. The 
variance of HRQoL may not be constant. 
(5) Normal approximations may not apply. 
(6) Missing values are likely. 
(7) It is difficult to quantify an effect size in advance. 
The advantages in being able to treat HRQoL scales as continuous and 
Normally distributed are simplicity in sample size estimation and statistical 
analysis. Therefore, it is important to examine such simplifying assumptions 
for different instruments and their scales. Since HRQoL outcome measures 
may not meet the distributional requirements (usually that the data have a 
Normal distribution) of parametric methods of sample size estimation and 
analysis, non-parametric methods are often used to analyse HRQoL data. 
The bootstrap is an important non-parametric method for estimating sample 
size and analysing data (including hypothesis testing, standard error and 
confidence interval estimation). The bootstrap is a data based simulation 
method for statistical inference, which involves repeatedly drawing random 
samples from the original data, with replacement. It seeks to mimic, in an 
appropriate manner, the way the sample is collected from the population in 
the bootstrap samples from the observed data. The 'with replacement' means 
that any observation can be sampled more than once. HRQoL outcome 
measures actually generate data with discrete, bounded and non-standard 
distributions. So, in theory, computer intensive methods such as the bootstrap 
that make no distributional assumptions may therefore be more appropriate 
for estimating sample size and analysing HRQoL data than conventional 
statistical methods. 
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Conventional methods of analysis of HRQoL outcomes are extensively 
discussed in Fayers and Machin (2000) and Fairclough (2002). However, 
neither of these texts used the bootstrap to analyse HRQoL outcomes. As a 
consequence of this omission, the aim of this thesis is to compare bootstrap 
computer simulation methods with standard methods of sample size 
determination and analysis of HRQoL measures (particularly the SF-36). 
The SF-36 is the most commonly used health status measure in the world 
today and has many of the problems with HRQoL measures described above. 
To compare and contrast the bootstrap methods with standard methods, we 
use SF-36 HRQoL data from a variety of cross-sectional and longitudinal 
studies including randomised controlled trials (RCTs). 
The remainder of this thesis is structured into the following chapters. Chapter 
2 describes the SF-36 HRQoL measure and the potential problems in 
calculating sample sizes and analysing such an outcome. Chapter 2 also 
describes the various datasets that are going to be used throughout the rest of 
the thesis to illustrate the methods. Chapter 3 briefly describes the bootstrap 
method of computer simulation. The results of a literature review of methods 
of sample size estimation and analysis of HRQoL measures are summarised 
in Chapter 4. The observed effects and summary statistics from the example 
datasets are shown in Chapter 5. Chapter 6 compares the power of various 
methods of sample size estimation and test statistics for some simple two 
group cross-sectional comparisons via bootstrap simulation. Methods of 
analysing cross-sectional HRQoL data and HRQoL measured at two time- 
points (say baseline and a single follow-up) are discussed in Chapter 7. 
Chapter 8 discusses summary measures, such as the area under the curve 
(AUC) and the modelling of longitudinal data, for repeated HRQoL (three or 
more) measurements over time. The final two chapters (9 and 10) end with a 
discussion and conclusions. 
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The SF-36 Health Survey 
The Medical Outcomes Study (MOS) Short Form (SF)-36 is the most commonly 
used health status measure in the world today (Kaplan, 1998). It originated in the 
USA (Ware et al 1992), but it has been validated for use in the UK (Brazier et al 
1992). It contains 36 questions measuring health across eight dimensions: 
physical functioning (PF) 10 items; role limitation because of physical health (RP) 
4 items; social functioning (SF) 2 items, vitality (VT) 4 items; bodily pain (BP) 2 
items; mental health (MH) 5 items; role limitation because of emotional problems 
(RE) 3 items and general health (GH) 5 items. (The full version of the SF-36 is 
shown in Appendix 1). 
The responses to the 36 individual questions are classified into a mixture of 
binary (yes/no) and three, five and six point ordered response categories. In 
planning and analysis, the question responses are often analysed by assigning 
equally spaced numerical scores to the ordinal categories (e. g. 0= 'poor', 1= 
'moderate' and 2= 'good'). The raw scores across similar questions are 
combined to generate a raw dimension score. Finally, these raw dimension 
scores are then transformed to generate a HRQoL score from 0 to 100, where 
100 indicates "good health". Figure 2.1 shows the distribution of the eight main 
dimensions of the SF-36 from a general population survey of Sheffield residents 
(Brazier et al 1992). 
Two further summary components, the Mental Component Summary (MCS) and 
Physical Component Summary (PCS) have also been derived from the eight 
dimensions using factor analysis (Ware et al 1994). The PCS and MCS scales of 
the SF-36 are standardized such that a mean score of 50 (standard deviation 10) 
reflects the mean score of a standard population. Thus, the SF-36 generates a 
profile of HRQoL outcomes (on up to 10 dimensions), which makes statistical 
analysis and interpretation difficult (Fayers and Machin, 2000). We will 
concentrate on the analysis of the eight main dimensions of the SF-36 rather 
than the two summary components. 
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The ordinal scaling of HRQoL measures such as the SF-36 may lead to several 
problems in determining sample size and analysing the data. 
(1) The apparent continuum hides the fact that only a few discrete values are 
possible. For example, the Role Physical (RP) dimension of the SF-36 is 
scored on a0 to 100 scale but there are only five possible categories/scores 
e. g. 0,25,50,75 and 100 (see Figure 2.1c). 
(2) The scale may not be linear. For example, using the SF-36 RP dimension, Is 
a change of score from 0 to 25 the same as a change from 75 to 100? 
(3) There is often a floor or ceiling effect. Patients cannot be worse than the worst 
category or better than the best category. (In the case of the SF-36 score 
either 0 or 100). For some populations the level is wrong and most people 
score on either the best category or the worst category. Floor and ceiling 
effects are more likely to be a problem in longitudinal studies because they 
limit the ability of the instrument to detect an improvement or deterioration in a 
patient's HRQoL over time. Figure 2.1c shows that for the RIP dimension of 
the SF-36 over 72% (1000/1372) of the general population sample had 
scored 100 and were at the ceiling of the distribution. 
(4) Methods based on the Normal distribution (such as linear regression) assume 
that the outcome variable has a constant variance. The variances of changes 
may depend on initial values. This is a common problem with range-limited 
values. Patients may enter the study with a wide variety of scores, but tend 
always to increase their scores. Thus patients who score lower at the start of 
the study have more range to improve than those who are already close to 
the maximum. 
(5) Normal approximations may not apply. Since the data are in fact categorical, 
they may require different techniques of analysis. By definition, no ordinal 
variable can be Normally distributed, although in some cases a Normal 
approximation will suffice. 
(6) Missing values are likely, for example in questionnaires that ask 'how far can 
you walk? 'when the patient is in a wheel chair. 
(7) It is difficult to quantify an effect size (e. g. a desirable difference in mean 
score between groups) in advance. 
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Figure 2.1: Distribution of the eight SF-36 Dimensions from a general 
population survey (n=1372) 
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There are advantages in being able to treat HRQoL scales as continuous (e. g. for 
statistical analysis and economic evaluations) and, therefore, it is important to 
examine such discrepancies for different instruments and populations. To 
illustrate the various statistical techniques, throughout this thesis we will use data 
from a variety of cross-sectional and longitudinal studies, Including randomised 
controlled trials and observational studies that have used the SF-36. 
The datasets 
There now follows a brief description of the datasets which are used throughout 
the rest of this thesis. These datasets illustrate the use of HRQoL outcomes 
across a variety of study designs. There are three types of study: observational 
(both cross-sectional and with baseline and a single follow-up assessment, two 
group RCT and longitudinal RCT (with several follow-ups). 
SF-36 general population data (Brazier et at 1992) 
The aim of this study was to test the acceptability, validity, and reliability of the 
SF-36 and compare it with the Nottingham Health Profile (NHP). The design was 
a postal survey using a questionnaire booklet together with a letter from the 
general practitioner. Non-respondents received two reminders at two-week 
intervals. The questionnaire booklet was sent to 1980 people aged 16-74 years, 
randomly selected from two general practice lists in Sheffield. The main 
outcomes were the scores on the eight dimensions on the SF-36. Completed 
questionnaires were received from 1582 of the 1980 patients surveyed. Our 
analysis is based on the 1372 responders who completed all 36 items of the SF- 
36. This sample consisted of 45% (616/1372) men and 55% (756/1372) women 
with an average age of 40.3 years (range 16 to 74 years). 
We will use this clataset to illustrate the non-standard distributions of HRQoL and 
to calculate some simple effect sizes. We will also use these data as a pilot data 
set for the bootstrap sample size simulations. 
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CPSW Data: Costs & effectiveness of community postnatal support 
workers (CPSK9: randomised controlled trial (Morrell et al 2000) 
This randomised controlled trial aimed to establish the relative cost-effectiveness 
of postnatal support in the community compared to the usual care provided by 
community midwives. Six hundred and twenty-three postnatal women were 
allocated at random to Intervention (n = 311) or Control (n = 312) groups. The 
intervention consisted of up to 10 home visits in the first postnatal month of up to 
three hours duration by a community postnatal support worker (CPSW). The 
main outcomes were HRQoL as measured by the SF-36 at six weeks postnatally. 
This study is unusual since no baseline HRQoL assessment was made. It was 
felt that it was inappropriate to assess HRQoL just prior to or immediately after 
childbirth. 
Our analysis is based on the 495 responders to the six-week postnatal 
questionnaire who completed all 36 items of the SF-36. This sample consisted of 
241 women in the Control group and 254 women in the Intervention group. We 
will use this data set to illustrate various methods for two group cross-sectional 
comparisons of HRQoL ranging from a simple comparison of mean scores (using 
conventional and bootstrap hypothesis tests) through to more complex 
regression analysis including ordinal regression. 
OA Knee Data (Brazier et at 1999) 
The aim of this longitudinal observational study was to evaluate two condition 
specific and two generic health status questionnaires for measuring HRQoL in 
patients with Osteoarthritis (OA) of the Knee, and offer guidance to clinicians and 
researchers in choosing between them. Patients were recruited from two 
settings, knee surgery waiting listings and rheumatology clinics. Four self- 
completion questionnaires including the SF-36 were sent to the subjects on two 
occasions 6 months apart. Two hundred and thirty patients returned the 
questionnaire at initial assessment, consisting of 118 patients awaiting total knee 
replacement (TKR) Surgery and 112 patients attending Rheumatology 
outpatient Clinics. At the six-month follow-up assessment, 211 patients returned 
8 
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the questionnaire (109 and 102 in the Surgery and Rheumatology groups 
respectively). The data used here are based on the 211 patients returning both 
assessments. The mean age of Rheumatology clinic respondents, 64.2 (SID 11.3) 
years, was significantly younger (p = 0.001) than the sample of patients 
undergoing TKR Surgery (71.1 (SID 8.5)), with more than twice as many women 
as men. Overall 69.6% (71/102) of the sample were females in the 
Rheumatology outpatient Clinics group compared to 54.1% (59/109) in TKR 
Surgery group (p = 0.03). 
Since there was a difference in the baseline HRQoL and sociodemographic 
characteristics (age and gender) of the Clinic and Surgery groups, we use this 
dataset to illustrate multiple regression/analysis of covariance (ANCOVA) 
methods with follow-up HRQoL as the outcome variable and baseline HRQoL, 
age, gender and group as covariates. We compare the conventional ordinary 
least squares (OLS) estimates of standard error (SE) and Confidence Interval 
(CI) for the group regression coefficient with their bootstrap counterparts. 
Leg Ulcer data (Morrell et al 1998) 
The aim of this randomised controlled trial with one year of follow-up was to 
establish the relative cost-effectiveness of community leg ulcer clinics that use 
four layer compression bandaging versus usual care provided by district nurses. 
Two hundred and thirty-three patients with venous leg ulcers were allocated at 
random to intervention (120) or control group (113). The intervention consisted of 
weekly treatment with four layer bandaging in leg ulcer clinic (Clinic group) or 
usual care at home by the district nursing service (Home group). The primary 
outcome was time to complete ulcer healing over the one-year follow-up. 
Secondary outcomes included HRQoL as measured by the SF-36 at baseline, 
three months and 12 months follow-up. 
We use these data to illustrate various methods for analysing longitudinal data, 
including ANCOVA, with follow-up HRQoL as the dependent variable and 
baseline HRQOL and treatment group as covariates, and summary measures 
9 
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such as the (AUC). We compare OLS estimates of SE and Cl for the group 
regression coefficient with their bootstrap counterparts. 
NAMEIT data (Allard et at 2000) 
The NAMEIT trial (NEO-BSL-08) was a 48-week, randomised, double blind study 
to compare Neoral with methotrexate (Neoral) versus placebo plus methotrexate 
(Placebo) in patients with early severe rheumatoid arthritis (RA). The primary 
efficacy variable in this study was the attainment of American College of 
Rheurnatology (ACR) criteria for improvement of rheumatoid arthritis. Secondary 
efficacy variables included patient assessment of health related quality of life 
(HRQoL). 
In order to assess the impact of the treatments on patients' health related quality 
of life, the SF-36 was completed by subjects at seven time-points, Week 0 
(baseline), Weeks 8,16,24,32,40, and Week 48 at the end of the study or at 
the time of premature withdrawal from the trial. 
Three hundred and six subjects at 48 centres were actually entered into the 
study. One hundred and fifty-two subjects receiving methotrexate were 
randomised to the Neoral treatment group and 154 subjects receiving 
methotrexate were randomised to the Placebo group. Of the 306 subjects 
randomised, 227 completed the study. Seventy-nine randomised subjects 
discontinued from the study prior to completion. 
We use these data to illustrate various methods for analysing longitudinal data, 
including ANCOVA, summary measures using (e. g. AUC) and generalised 
estimating equations (GEE) and compare bootstrap SEs and Cls for the 
parameters with their conventionally estimated counterparts. 
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Introduction 
Permutation tests and Monte Carlo tests, described in Armitage et al 2002, 
make extensive use of random samples and lack of computational power may 
have lead to their relative neglect in the past. Now that good computational 
facilities are widely available, permutation and Monte Carlo tests are taking 
their place in an increasingly important group of techniques known as 
computationally intensive methods. The bootstrap, which will be the main 
subject of this thesis, is another member of this class of techniques and plays 
an important role in estimation. The jackknife is a rather older technique, 
which still has its uses and is related to the bootstrap. 
According to Everitt's (1995) Dictionary of Statistics in the Medical Sciences: 
"The bootstrap is a data-based simulation method for statistical inference, 
which can be used to study the variability of estimated characteristics of the 
probability distribution of a set of observations, and provide confidence 
intervals for parameters in situations where these are difficult or impossible to 
derive in the usual way. " 
The term bootstrap derives from the phrase 'to pull oneself up by one's 
bootstraps'. Efron and Tibshirani (1993) mention that the phrase is thought to 
be based on one of the eighteenth century Adventures of Baron Munchausen 
by Rudolph Erich Raspe. (The Baron had fallen to the bottom of a deep lake. 
Just when it looked like all was lost, he thought to pick himself up by his own 
bootstraps! ) 
The basic idea of the bootstrap involves repeated random sampling with 
replacement from the original data, X "*2 (XI* X2v. -., xn) to produce random 
samples of the same size n of the original sample, each of which is known as 
a bootstrap sample, x* and each provides an estimate ý* of the parameter of 
interest, 0. We seek to mimic in an appropriate manner the way the sample is 
collected from the population in the bootstrap samples from the observed 
11 
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data. The "with replacement" means that any observation can be sampled 
more than once in each bootstrap sample. It is important because sampling 
without replacement would simply give a random permutation of the original 
data, with many statistics such as the mean being exactly the same 
(Campbell, 2001). 
Repeating the process a larger number of times provides the required 
information on the variability of the estimator, since the standard error is 
estimated from the standard deviation of the statistics derived from the 
bootstrap samples. The point about the bootstrap is that it produces a variety 
of values, whose variability reflects the standard error that would be obtained 
if samples were repeatedly taken from the whole population. 
Confidence Interval estimation 
Suppose we wish to calculate a 95% confidence interval for a mean from a 
sample x *ý (Xlt X29 ... 1Xn)- 
We take a random sample x*, with replacement from 
data, of the same size as the original sample, and calculate the mean of the 
data, d* in this bootstrap random sample. We do this repeatedly, say B times. 
So we now have B bootstrap samples x*,, X*2,..., x*j3, and B estimates of the 
sample mean, one from each bootstrap sample 
(tý, *, &2 dB *). If these are 
I 
ordered in increasing value, ^' -0 Oý B)), a bootstrap 95% confidence K) ý 0ý2) 
interval for the mean would be from the 0.025Býh to the 0.975Býh largest 
values. For a 100(1-cc)% interval the limits would the (al2)Bth and (I - cd2)Bth 
largest values. This is known as the percentile method and although it is an 
obvious choice, it is not the best method for bootstrapping confidence 
intervals, because it can have a bias, which one can estimate and correct for. 
This leads to methods such as the bias corrected method and the bias 
corrected and accelerated (BCa) method, the latter being the preferred option 
(Davison and Hinckley, 1997; Efron and Tibshirani, 1993). The paper in 
Statistics in Medicine by Carpenter and Bithell (2000) provides a useful 
practical guide for medical statisticians on bootstrap confidence intervals. 
(Further details of how to estimate BC,, Confidence Intervals are given in 
Appendix 2. ) 
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The bootstrap can be applied to data with a more complex structure than the 
simple single sample example considered above. For comparing two groups, 
one with distribution F and the other with an independent distribution G, then a 
bootstrap approach would proceed from separate estimates P and G^ , with 
bootstrap samples chosen independently from each estimated distribution. 
Using the bootstrap method, valid bootstrap confidence intervals can be 
constructed for all common estimators such as the sample mean, median, 
proportion, difference in means, and difference in proportions. 
Linear regression: Model (residual) and case resampling 
Standard errors for regression coefficients can also be obtained using 
bootstrap methods. However, two different approaches are possible, case and 
model (residual) resampling. 
For example with the simple linear model yj = Po + Pix, + ej; with E(cj) = 0, if the 
data are w= (xj, yj), (X2v Y2)o---, (X,, Yn), then case-based resampling involves 
drawing a bootstrap sample of size n, with replacement from these n pairs. 
The bootstrap data set is of the form 
(I **. 
w*= lYi1 Xii ) 'eY! 2 12 
where ij, i2,..., in is a random sample of integers 1 through n. Ordinary least 
squares is then used to estimate the regression coefficients 0 and 
ý, *, for 
this bootstrap sample of paired cases. We do this repeatedly, say B times, so 
we now have B bootstrap samples and B estimates of the regression 
coefficients, one from each bootstrap sample 
" -, ý, *), 
91. 
)V-91 ^'I )BI* wo- Vo- 9K Wo K 
The standard error of these estimated coefficients se VO) and se V, ) is simply 
the standard deviation of these B estimates. As before if these estimates are 
ordered in increasing value, 
IVI* )(I 
)I 
VI* )( 
2) 9** *') 
V. * )(B)I, 
a simple 95% bootstrap 
percentile confidence interval for the coefficient would be from the 0.025Býh to 
the 0.975Býh largest values. 
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Case-based resampling may be entirely natural for situations where it is 
plausible that the (x, y) pairs have been drawn from a bivariate distribution 
function F(x, y) of the pairs. However, case based resampling is less 
appealing if the x values were controlled for in some way, perhaps by the 
design of the study. In this situation the alternative model or residual based 
procedures could be used. 
For model based resampling the simple linear regression model [Yj = P0 + Pix, 
+ ej, with E(ej) = 01, the conventional fitted values yir't and residuals e, are first 
data i. e. Y1 A0 +. obtained from the observed fit X, and 
obs fit 
e, = yj yj yj - 
ý0 
-. 
ýIxj, A bootstrap sample of the residuals is drawn e* 
(e, * 
. 'ej, '... 'ej, 
where ii, i2,... jn is a random sample of integers 1 through n. 
The bootstrap sample for the regression z* = ý, *, x, *) comprises the x values 
(x, * = xi) from the original data and y values computed by adding the fitted 
values to the bootstrap residuals i. e. y, * = ý() + x, + e, * . (Note and 
P, are 19,19. 
the estimates from the original sample). The bootstrap data set is of the form 
V z+ AX, + e, * ej 
jI, 
. IXI 
) VO 
+AIX2 + 
;, 9X2 
) 
.... 
Vo 
+ AX. + e'. ' X 
where il, i2,... jn is a random sample of integers I through n. Ordinary least 
squares is then used to estimate the regression coefficients 0* and 
ft, *, for A 
this bootstrap sample. As before the process (resampling of the residuals, 
adding them to the fitted values and estimating the regression coefficients) is 
repeated B times to estimate standard errors and confidence intervals for the 
B regression coefficients from the bootstrap samples. 
Thus model based resampling is an example of the "parametric bootstrap" 
when the residuals from a parametric model are bootstrapped to give 
estimates of the standard error of the parameters. 
Hypothesis testing with the bootstrap 
Bootstrap methods have also been used for hypothesis testing. These 
bootstrap tests give similar results to the much older statistical technique of 
14 
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permutation tests. The bootstrap tests give similar results to permutation tests 
when both are available. The bootstrap tests are more widely applicable 
though less accurate (Efron and Tibshirani, 1993). Unlike the permutation test, 
the p-value from bootstrap hypothesis test has no interpretation as an exact 
probability, and like all bootstrap estimates is only guaranteed to be accurate 
as the sample size goes to infinity. 
The two quantities that we must choose when carrying out a bootstrap 
hypothesis test are a test statistic t(x) and a null distribution AO for the data 
under the null hypothesis (Ho). Given these, we generate B bootstrap values 
of the test statistic t(x*) under the null distribution for the data FO and estimate 
the achieved significance level (ASL) by calculating the proportion of the 
bootstrap values of the B test statistics t(x*), which are greater than or equal 
to the observed value of the test statistic t(x) from the original data. Full details 
of permutation tests and hypothesis testing with the bootstrap can be found in 
Efron and Tibshirani (1993, Chapters 15 and 16). 
Sample size estimation with the bootstrap 
The choice of the test statistic will determine the power of the test. That is the 
chance that we reject HO when it is false. Again bootstrap methods are well 
suited to answering power and sample size questions, as we will see later on 
in Chapter 6. 
Suppose we have two independent random samples x =(X1 i X29 .... x,,, ) and y= 
(YI, Y29 .... y,, 
). The x's and y's are random samples from continuous 
distributions having cumulative distribution functions (cdfs), Fx and Fy 
respectively. We consider the simple situation where the distributions have the 
same shape, but the locations may differ. Thus if 8 denotes the location 
difference (i. e. mean (y) - mean (x) 8), then Fy(y) = Fx(y - 8), for every y. We 
focus on the null hypothesis HO: 50 against the alternative HA: 8# 0. Then 
we can test this hypothesis using an appropriate significance test (e. g. Mann- 
Whitney or Mest), and will let n (F, 8, a, n) denote the power function of the 
test. 
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The bootstrap strategy (Collings and Hamilton, 1988) is to use pilot data to 
provide a non-parametric estimate, P of F and to use a simulation method for 
finding the power of the test associated with any specified sample size n if the 
data follow the estimated distribution function. If we denote the distribution 
function estimate by G, under the alternative hypothesis 9, we can estimate 
the approximate power, ;ý (G, tF, a, n) by the following computer simulation 
procedure. 
(1) Draw a random sample with replacement of size 2n from P. The first n 
observations in the sample form a simulated sample of x's, denoted by 
Xi*,..., x, *, with estimated cdf P. Then Sis added to each of the other 
n observations in the sample to form the simulated sample of y's, 
denoted by yl*,..., y, *, with estimated cdf G (The y*'s and x*'s have 
been generated from the same distribution except that the distribution 
of the y*'s is shifted $units to the right. ) 
(2) The test statistic t(x, y), (Mann-Whitney or t-test) is calculated for the 
x's and y*'s, yielding t(x*, y*). If t(x*,, y*) ý: Tj_a/2, (where Tj_, r2 is the 
critical value of the test statistic) a success is recorded; otherwise a 
failure is recorded. 
(3) Steps 1 and 2 are repeated B times. The estimated power of the test, 
, -ý(Gj, a, n), is approximated by the proportion of successes among the 
B repetitions. 
The jackknife 
The jackknife is a technique for the estimation of the bias and standard error 
of an estimate and is described more comprehensively in Chapter 11 of Efron 
and Tibshirani (1993). The jackknife pre-dates the bootstrap and bears close 
similarities to it. Quenouille (1949) first proposed the idea of the jackknife for 
the estimation of bias. Tukey (1958) recognised the jackknife's potential for 
estimating standard errors, and gave it its name. 
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Suppose we have a sample x= (xi, X2, .... Q and an estimator 0= s(x). We 
wish to estimate the bias and standard error of d. The jackknife focuses on 
the samples that leave out one observation at a time: 
X(i) = (XI, X2o --- A-I i Xi+i , -, Xn) 
For i=1,2,... n, called jackknife samples. The Jh jackknife sample consists of 
the data set with the th observation removed. Let d(, ) =s(x(, )) be the 
th 
jackknife replication of d. The jackknife estimate of bias is defined by 
Siasjack 
=(n-1)(d(. )4) where 
d(. 
) n. 
The jackknife estimate of standard error is defined by 
1/2 
sej., k 
0 
Since it requires computation only of for n jackknife data sets, the jackknife 
will be easier to compute than the bootstrap. However by looking only at the n 
jackknife samples, the jackknife uses only limited information about the 
statistic d, and thus one might guess that the jackknife is less efficient than 
the bootstrap. In fact in turns out that the jackknife can be viewed as an 
approximation to the bootstrap, for the estimation of standard errors and bias, 
although the jackknife can fail miserably if the statistic d is not "smooth". A 
simple example of a non-smooth statistic is the median (Efron and Tibshirani, 
1993). 
Graphical representation of the bootstrap for general data structures 
The bootstrap method can readily be adapted to more complicated data 
structures. Figure 3.1 (taken from Efron and Tibshirani, 1993) is a simple 
schematic diagram as it applies to one-sample problems. On the left is the 
real world, where an unknown distribution F has given the observed data x= 
(X1 
, X2r .... xn) 
by random sampling. We have calculated a statistic of interest 
from x, 0= s(x), and wish to know something about O's statistical behaviour, 
perhaps its standard error seF(d). 
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Figure 3.1: Schematic diagram of the bootstrap as it applies to ones 
sample problems (taken from Efron and Tibshlrani, 1993). 
REAL WORLD 
Unknown 
Probability Observed Random 
Distribution Sample 
x= (XI, X2, ... xn) 
O=S(X) 
Statistic of interest 
BOOTSTRAP WORLD 
Bootstrap EmPirical Sample Distribution 
F 00 x (XII, X2, 
O. S(x*) 
IL Bootstrap Replication 
On the right side of the diagram is the bootstrap world. In the bootstrap world, 
the empirical distribution P gives bootstrap samples x* = (X*19 X*2t .... x*, ) by 
random sampling with replacement, from which we calculate bootstrap 
replications of the statistics of interest, d*=s(x). The big advantage of the 
bootstrap world is that we can calculate as many replications of do as we 
want, or at least as many as we can afford. This allows us to do the 
probabilistic calculations directly, for example using the observed variability of 
the Ps to estimate the unobservable quantity, seF(d). 
The double arrow "=>" in Figure 3.1 indicates the calculation of P from F. 
Conceptually, this is the crucial step in the bootstrap process, even though it 
is computationally simple. Every other part of the bootstrap picture is defined 
by analogy (Efron and Tibshirani 1993). F gives x by random sampling, so F 
gives x* by random sampling; ý is obtained from x via the function s(k), so 0^' 
is obtained from x* in the same way. Bootstrap calculations for more complex 
probability mechanisms turn out to be straightforward, once we know how to 
carry out the double arrow process - estimating the entire probability 
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mechanism from the data. Fortunately this is easy to do for all of the common 
data structures. 
To facilitate the study of more complicated data structures, we use the 
notation, P -ý x, to indicate that an unknown probability model P has yielded 
the observed data set x. 
Figure 3.2: Schematic diagram of the bootstrap applied to problems with 
a general data structure P -> x (taken from Efron and Tibshirani, 1993). 
REAL WORLD 
Unknown 
Probability 
Model Observed Data 
00 )c ý (xl, x2, --- xn) 
O=S(X) 
Statistic of interest 
BOOTSTRAP WORLD 
Estimated Bootstrap 
Probability Sample 
Model 
4-P 00 X"= (Xý. Xj, ... 
O=s(x 
Bootstrap Replic*ation 
Figure 3.2 (again taken from Efron and Tibshirani, 1993) is a version of Figure 
3.1 that applies to general data structures P -> x. There is not much 
conceptual difference between the two figures, except for the level of 
generality involved. In the real world, an unknown probability mechanism P 
gives an observed data set x, according to the rule of construction indicated 
by the arrow "-+ ". In specific applications we need to define the arrow more 
Carefully, for example if we have two samples. The data set x may no longer 
be a single vector. It has a form dependent on the data structure, for example 
X= (z, y) in the two-sample problem. Having observed x, we calculate a 
statistic of interest 0 from x according to the function so. 
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The bootstrap side of Figure 3.2 is defined by the analogous quantities in the 
real world: the arrow in P -4 x* is defined to mean the same thing as the 
arrow in P -> x. The function mapping x* to ýO is the same function so as 
from x to d. 
Two practical problems arise in actually carrying out a bootstrap analysis 
based on Figure 3.2. 
(1) We need to estimate the entire probability mechanism P from the 
observed data x. This is the step indicated by the double arrow, x =: > A 
It is surprisingly easy to do for most familiar data structures. No general 
prescription is possible, but quite natural ad hoc solutions are available 
in each case, for example P for the two-sample problem. 
(2) We need to simulate the bootstrap data from P according to the 
relevant data structure. This is the step P -4 x* in Figure 3.2. This step 
is conceptually straightforward, being the same as P -ý x, but can 
require some care in the programming if computational efficiency is 
necessary. Usually the generation of the bootstrap data P -> x* 
requires less time, often much less time, than the calculation of 
S(x*)- 
Notation (following Efron and Tibshirani, 1993) 
We have already introduced some notation for the bootstrap in this chapter. 
This section briefly summarizes some of the notation used in the rest of this 
thesis. Lower case bold letters such as x refer to vectors, that is, x= (xi, 
X2, ---, xn)- 
Matrices are denoted by upper case bold letters such X, while a 
plain upper case variable like X refers to a random variable. The transpose of 
a vector is written as XT .A superscript "*" indicates a bootstrap random 
variable: for example x* indicates a bootstrap data set generated from data 
set x. Parameters are denoted by Greek letters such as Oor fl, while a is used 
for error rates in connection with significance tests and confidence sets. A hat 
on a letter indicates an estimate, such as d. Thus the estimator t(x) has 
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observed value tWobso which may be an estimate of the unknown parameter 
0. 
We use pdf, cdf and edf as shorthand for probability density function, 
cumulative density function and empirical density function. The letters F and G 
are used for cdfs. Notation such as #0>1.961 means a count of the number 
of Os greater than 1.96. The letter B is reserved for the number of replicate 
simulations or bootstrap samples. Simulated quantities of a statistic t(x) are 
denoted by t(x*ý), b=1,..., B, whose ordered values are t(x*(, )) t(X*j2)) 
t(X*(B))- 
Summary 
More details of bootstrap confidence intervals are given in Appendix 2. The 
bootstrap has the potential for such wide applications in statistics, that the 
present discussion cannot do it justice. The specialist texts on the bootstrap, 
by Efron and Tibshirani (1993) and Davison and Hinckley (1997) provide 
details of many aspects of the technique. The power of the technique makes it 
one of the most important advances in statistical methodology in recent years 
(Armitage et al 2002). The main advantage of the bootstrap is that it frees the 
investigator from making inappropriate assumptions about the distribution of 
an estimator d in order to make inferences (Campbell, 2001). Therefore, in 
theory the bootstrap should prove a useful technique for sample size 
estimation, hypothesis testing, and confidence interval estimation for data with 
non-standard distributions. 
HRQoL outcomes with their discrete, bounded and skewed data distributions 
should be ideal candidates for the application of bootstrap methods. So it is 
somewhat surprising that two otherwise comprehensive textbooks on the 
design and analysis of studies with HRQoL outcomes (Fayers and Machin, 
2000; Fairclough, 2002) make no mention of the use of the bootstrap. 
Therefore subsequent chapters of this thesis will compare and contrast 
conventional methods of sample estimation and analysis of HRQoL outcomes 
with bootstrap methods. 
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Chapter 4: Review of methods of sample size estimation for 
HRQoL outcomes 
Introduction and background 
Sample size calculations are now mandatory for many research protocols and 
are required to justify the size of clinical trials in papers before they will be 
accepted by journals (Altman et al 2000). Thus, when an investigator is 
designing a study to compare the outcomes of an intervention, an essential 
step is the calculation of sample sizes that will allow a reasonable chance 
(power) of detecting a predetermined difference (effect size) in the outcome 
variable, at a given level of significance. Sample size is critically dependent on 
the summary measure, the proposed effect size and the method of calculating 
the test statistic. For example, for a given power and significance level, the 
sample size is inversely proportional to the square of the effect size, so 
halving the effect size will quadruple the sample size. 
Whatever type of study design is used the problem of sample size must be 
faced. Sometimes we may wish to show that a new treatment is clinically 
equivalent in efficacy to the standard treatment. Machin et al (1997) describe 
statistical methods for calculating the appropriate sample sizes for 
demonstrating equivalence between two treatments. For simplicity in this 
chapter we will assume that the primary outcome for the study is a HRQoL 
measure and that we are interested in comparing the effectiveness (or 
superiority) of a new treatment compared to a standard control treatment at a 
single point in time. 
Since HRQoL measures are being used more frequently in clinical trials and 
HSR, as both primary and secondary endpoints, investigators are now asking 
statisticians for advice on how to plan and analyse studies using HRQoL 
measures, and this includes questions on the sample size. 
However, as we have seen in Chapter 2 the ordinal scaling of HRQoL 
measures may lead to several problems in determining sample size and 
analysing the data. To illustrate this, we use some HRQoL data from a RCT 
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that aimed to compare the difference in health status in a group of women 
who were offered postnatal support (intervention) from a community midwifery 
support worker compared with a control group of women who were not offered 
support (Morrell et al 2000). This study is briefly described in Chapter 2. 
HRQoL outcome data may not meet the distributional requirements (usually 
that the data have a Normal distribution) of parametric methods of analysis. 
Therefore non-parametric methods are most often used to analyse HRQoL 
data. The main aim of this chapter is to review, describe and compare several 
methods of sample size estimation (parametric and non-parametric) when 
using HRQoL measures as outcome in comparative clinical trials. 
This chapter is based on two papers published in the Health Services and 
Outcomes Research Methodology journal (Walters et al 2001 b; Walters and 
Brazier, 2003b see Appendix 3) and two earlier departmental discussion 
papers (Walters et al 2000; Walters and Brazier 2002). 
The remainder of this chapter is structured into the following sections. Section 
2 summarises the methods and the sample size formulae. What researchers 
actually do in practice is discussed in Section 3. The consequences if different 
sample size formulae are applied are explored in Section 4. Section 5 
discusses multiple end-points. The final sections (6 and 7) talk about the 
choice of sample size method with HRQoL outcomes and conclusions. 
Which sample size formulae? 
In principle, there are no major differences in planning a study using HRQoL 
assessment to those using conventional clinical outcomes. Pocock (1983) 
outlines five key questions regarding sample size: 
1. What is the main purpose of the trial? 
2. What is the principal measure of patient outcome? 
3. How will the data be analysed to detect a treatment difference? 
4. What type of results does one anticipate with standard treatment? 
5. How small a treatment difference is it important to detect and with what 
dle, gree of certainty? 
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Therefore after deciding on the purpose of the study and the principle 
outcome measure, the investigator must decide how the data are to be 
summarised and analysed to detect a treatment difference. Thus, the 
investigator must choose an appropriate summary measure of this outcome 
and then calculate a sample size based on the smallest treatment difference 
in this summary measure that is of such clinical value that it would be very 
undesirable to fail to detect. Given answers to all of the five questions above, 
we can then calculate a sample size. 
An appropriate summary measure of the outcome data will usually be the 
sample mean, median, or a rate or proportion. When comparing two groups or 
a single group over time, appropriate comparative summary measures may 
include the difference between sample means, difference in medians, 
difference in rates or proportions, the relative risk (RR) or the odds ratio (OR). 
The mean is often chosen as a suitable summary measure, although there are 
several reasons against using it. One reason would be that the HRQoL 
outcome measure of interest is an ordinal not a continuous variable, and 
therefore means are hard to interpret (see points 1 to 7, in Chapter 2). Also 
the HRQoL outcome may have a skewed distribution and the median or the 
proportion of the sample in a given category (or less) may be a more useful 
summary of HRQoL outcome. 
For individual patients, the outcome of treatment is usually dichotomous (the 
treatment either works or the treatment does not work) or ordinal (the effect of 
treatment worsens the patients' HRQoL, has no effect, or improves HRQoL). 
In this case, given the probability of a successful outcome (improved HRQoL) 
from the control treatment (pc), and the OR that the new treatment is 
beneficial (compared to the control treatment), then the probability that the 
new treatment will work for an individual patient (pT) is: 
Pr =_ 
ORpc 
ORpc +I -pc 
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Therefore the OR may be a suitable comparative summary measure for the 
effect of treatment at an individual level. We can calculate the risk difference 
(PT - PC) or absolute risk reduction (ARR) as it is sometimes known, and 
hence the reciprocal of the risk difference, VARR or 11(pT - PC) which is the 
Number Needed to Treat (NNT), 
NNT =1 (4.2) PT - PC 
The NNT is the number of patients who need to be treated with the new 
treatment rather than the standard control treatment in order for one additional 
patient to benefit. Thus, the NNT is a useful summary measure for clinicians 
to compare two treatments, although it does require the HRQoL outcome to 
be dichotomised (Laupacis et al 1988). 
The mean (and mean difference) is a more suitable summary measure for the 
effect of treatment on average (i. e. at a hospital level). The mean indicates the 
effect of treatment on average in this group of patients. This summary 
measure is useful for health care providers (or hospitals) in deciding whether 
or not to offer a new treatment to its population. 
Campbell et al (1995) outline the ways of calculating sample sizes in two 
group studies for binary, ordered categorical and continuous outcomes. 
Further details, examples and tables are given in the book by Machin et al 
(1997). 
Method 1: Continuous Normally distributed HRQoL data - comparing 
two means 
If the HRQoL outcome is assumed to be continuous and plausibly sampled 
from a Normal distribution, then the best summary statistic for a location 
parameter is the mean, and the usual hypothesis test for a difference or shift 
in location parameters between two independent samples is the two-sample t 
test. 
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For two independent groups with continuous and Normally distributed data, 
the standardised effect size is the expected mean value of the intervention 
outcome minus the expected mean value of the control outcome divided by a 
standard deviation of the outcomes. That is 
A 
Normal = 
Pr - PC 
9 (4.3) c 
where ANormal is the standardised effect size index, pT and pc are the expected 
group means of outcome variable under the null and alternative hypotheses 
and a is the standard deviation of outcome variable (assumed to be the same 
under the null and alternative hypotheses). 
In a two-group study comparing mean HRQoL between the two groups, the 
number of subjects per group n for a two-sided significance level a and power 
1-p is given by equation (4.4), 
nNormal = 
2[ZI-a/2 + ZI-, 81 
2- 
(4.4) A2 Normal 
where, zl-,,, 12 and zj-p are the appropriate values from the standard Normal 
distribution for the 100 (1 - m/2) and 100 (1 - P) percentiles respectively. 
If the sample size is "sufficiently large", then the Central Limit Theorem (CLT) 
guarantees that the sample means will be approximately Normally distributed 
(Hogg and Tanis, 1988). Thus, if the investigator is planning a large study and 
the sample mean is an appropriate summary measure of the HRQoL 
outcome, then pragmatically there is no need to worry about the distribution of 
the HRQoL outcome and we can use equation (4.4) to calculate sample sizes. 
Although the Normal distribution is strictly only the limiting form of the 
sampling distribution of the sample mean as the sample size n increases to 
infinity, it provides a remarkably good approximation to the sampling 
distribution even when n is small and the distribution of the data is far from 
Normal (Armitage et al 2002). Generally, if n is greater than 30, these 
approximations will be good. However, if the underlying distribution is 
symmetric, unimodal and continuous, a value of n as small as 4 can yield a 
very adequate approximation (Hogg and Tanis, 1988). Figure 4.1 clearly 
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illustrates the bounded, discrete and skewed nature of HROoL data and 
shows that a large sample size may be required for the assumption of 
Normality to be valid. 
Figure 4.1: Distribution of SF-36 Role Limitations Physical outcome by 
group from the CPSW study (Morrell et al 2000). 
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The skewed distribution of the HRQoL (the RP dimension of the SF-36) data 
from the CPSW study in Figure 4.1 also implies that the sample mean and 
mean difference may not be suitable summary measures to compare the two 
groups. The mean score of the Control group was 73.5 (SD 38.4) compared 
with a mean score of 65.7 (SID 39.2) in the Intervention group at six weeks 
postnatally, a mean difference of 7.8 (95% Cl- 1.2 to 14.2; t=2.31 on 523 df, 
p=0.02). The median scores were 100 and 75 respectively, with over 62% of 
the control group and 49% of the intervention group scoring 100. 
Suppose we are planning a two-group study comparing HRQoL between the 
groups, using the RP dimension of the SF-36 as the primary outcome. We 
believe that the mean difference in HRQoL scores between the two groups is 
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an appropriate comparative summary measure. Assuming a standard 
deviation a of 38 and that a mean difference (PT - pc) of 8 or more points Is 
clinically and practically relevant gives a standardised effect size (from 
equation 4.3) of 0.21. Using this effect size in equation (4.4) with a two-sided 
5% significance level (z,, v2 = 1.96) and 80% power (zi-p = 0.84) gives the 
estimated number of subjects per group as 356. 
Transformations 
If the HRQoL outcome data is continuous but has a skewed distribution, it 
may be transformed using a logarithmic transformation. The transformed 
variable may have a more symmetric distribution that approximates better to 
the Normal form. The problem is that certain HRQoL measures, such as the 
SF-36 are scored on 0 to 100 scales and the natural logarithm of zero does 
not exist. 
If we recode the RP dimension so that a score of 0=1,25 = 2,50 = 3,75 =4 
and 100 = 5, then the mean RP score in the control group (on a1 to 5 scale) 
is now 3.94 (SID 1.54). If we take natural logarithms (109e) of the recoded RP 
score, then the mean log-transformed score is 1.24 (SID 0.59). Equation (4.4) 
can now be applied to the log-transformed scale once the standardised effect 
size ANOrmaj is specified. Unfortunately, there is no simple interpretation for the 
log-transformed RP scale, and so the inverse transformation is used to obtain 
scores corresponding to the recoded (I to 5) RP scale. The mean RP score 
(on the 1 to 5 scale) using the inverse transformation is now exp (1.24) = 3.46 
compared to the original value of 3.94. 
If one third of a category or unit change on the recoded RP scale is 
considered the minimum clinically important difference to detect, this is 
approximately equivalent to an eight-point difference on the original 0 to 100 
scale of the SF-36 RP dimension as a one category change corresponds to 
25 points. Then the untransformed effect size from (4.3) is: (4.27 - 3.94)/1.55 
= 0.21. Using equation (4.4), this leads to a sample size of 356 patients per 
group. 
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Using the log-transformed scale of the RP, a third of a unit increase is 
approximately from 3.46 to 3.79. This is then expressed as an anticipated 
effect on the log transformed scale as AN,,,,,,, = (pT- pc)/(: r = [log, (3.46 + 0.33) 
log,. (3.46)]/0.59 = 0.15. Using equation (4.4) with AN,,,,,,, = 0.15 gives nN,,,, n,, l 
697 patients per group. 
We have used a logarithmic transformation for non-Normal data and made the 
sample size calculations accordingly. Other possible transformations for this 
purpose are the reciprocal or square root. A difficulty with the use of 
transformations is that they distort HRQoL scales and make interpretation of 
treatment effects difficult (Fayers; and Machin, 2000). In fact, only the 
logarithmic transformation gives results interpretable on the original scale 
(Bland and Altman, 1996). The logarithmic transformation expresses the effect 
as a ratio of the geometric mean for patients in the treatment group to the 
geometric mean for patients in the control group. This is because the 
difference between two logarithms is the logarithm of the ratio: log (T) - log 
(C) = log (T/C). 
However, this ratio will vary in a way that depends on the geometric mean 
value of the control treatment (Fayers and Machin, 2000). For example, if the 
geometric mean for the control treatment C is 2, and treatment T induces a 
change in RIP of 1 unit compared to this level, then this implies an effect size 
Of loge (3/2) = 0.41. On the other hand, for geometric mean of 4 for the 
treatment C, the same numerical change of one unit implies an effect size of 
loge (5/4) = 0.22. Thus, although in this example the effect size is a one unit 
difference in HRQoL in both cases when expressed on the untransformed RP 
scale, the logarithmic transformation results in a second effect size which is 
almost half (0.22/0.41 = 0.54) the first. This makes interpretation difficult. 
Method 2: Continuous HRQoL data with no distributional assumptions 
If the HRQoL outcome is assumed to be continuous and plausibly not 
sampled from a Normal distribution then the most popular (not necessarily the 
most efficient) non-parametric test for comparing two independent samples is 
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the two-sample Mann-Whitney U, also known as the Wilcoxon rank sum test 
(Lehman, 1975). 
Suppose we have two independent random samples X1, X2P .... X,,, and Y1, 
Y2,..., Y,, and we want to test the hypothesis that the two samples have come 
from the same population against the alternative that the Y observations tend 
to be larger than the X observations. As a test statistic we can use the Mann- 
Whitney (MK9 statistic U, i. e., U= #(Yj > XI), i=1,.., m; j=1,..., n, which is a 
count of the number of times the Yjs are greater than the Xs. The magnitude 
of U has a meaning, because Ulnm is an estimate of the probability that an 
observation drawn at random from population Y would exceed an observation 
drawn at random from population X. 
Noether (1987) derived a sample size formula for the MIN test (see equation 
4.6 below), using an effect size pN,, ýth,, (see equation 4.5) which is probability 
that an observation drawn at random from population Y would exceed an 
observation drawn at random from population X, 
PNoether «ý Pr(Y > X), (4.5) 
that makes no assumptions about the distribution of the data (except that it is 
continuous), and can be used whenever the sampling distribution of the test 
statistic U can be closely approximated by the Normal distribution, an 
approximation that is usually quite good except for very small n (Collins and 
Hamilton, 1991). 
= 
[ZI-a 
/2+ ZI-, 8 
I 
nNon 
-normal 6(pN,,,, 4, -0.5 
)2 (4.6) 
Thus to determine the sample size, we have to find the 'effect size' pNoether. 
There are several ways of estimating PNoether, (Simonoff et al 1986) under 
various assumptions, one possibility is PNoether --: Ulnm (Lesaffre et al 1993). 
Let pix, a2x, ýty, and cr 
2y be the mean and variance of the X and Y variables 
respectively. Then if X- N(px, cr 
2 
x) and Y- N(py, C; 
2Y) then Simonoff et al 
(1986) show that the maximum likelihood estimator of Pr(Y > X) using the 
, 4i. A2 sample estimates of the mean and variance (^r, 
p 
, 
&2 ) is: PX yy 
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P=P4Y>X)= -#X (4.7) k 
+&y2ý/2 p 
where (D is the Normal cumulative distribution function. 
If we assume the SF-36 RP dimension is Normally distributed (unlikely as we 
have seen) and crx = ay = cr then equation (4.7) allows the calculation of two 
comparable 'effect sizes'pN,,,, th,,,. and ANonnal thus enabling the two methods of 
sample size estimation (Equations 4.4 and 4.6) to be directly contrasted. If the 
SF-36 RP is not Normally distributed then we cannot use equation (4.7) to 
calculate comparable effect sizes and must rely on the empirical estimates 
calculated post hoc from the data. 
Suppose we are planning a two-group study comparing HRQoL (using the RP 
as the primary outcome) between the groups. We believe the RP outcome to 
be continuous, but not Normally distributed and are intending to compare RP 
scores in the two groups with a Mann-Whitney U test. Therefore Noether's 
method will be appropriate. As before if we assume a mean difference of 8 
and a standard deviation of 38 for the RP, then using equation (4.7) this leads 
to an effect size pN.,, th,,, = Pr(Y > X) of 0.56. Substituting PNoether = 0.56 in 
equation (4.6) with a two-sided 5% significance level and 80% power gives 
the estimated number of subjects per group as 363. 
The two methods have given similar sample size estimates (nNormal = 356 and 
n, on-Normal = 363). The two methods can be regarded as equivalent when the 
two distributions have the same shape and equal variances. When the two 
distributions are Normally distributed with equal variances, the MW test will 
require about 5% more observations than the two-sample Mest to provide the 
same power against the same alternative. For non-Normal populations, 
especially those with long tails, the MW test may not require as many 
observations as the two-sample Mest (Elashoff, 1999). 
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Method 3: Dichotomous categorical HRQoL data - comparing two 
proportions 
If the HRQoL outcomes are measured on a binary or dichotomous categorical 
scale, for example, "good health" and "poor health", then an appropriate 
summary measure of the outcome data will usually be the sample rate or 
proportion in the sample with "good" HRQoL. When comparing two groups or 
a single group over time, appropriate comparative summary measures may 
include the difference in rates or proportions, the relative risk or the odds ratio. 
The statistical hypothesis test used to compare two independent groups when 
the outcome is binary is the Pearson chi-squared test for a2x2 contingency 
table. In this situation, the anticipated effect size is 513inary `ý (nr- nc), where nr 
and 7rc are the proportions in the two treatment groups with 'good health'. In a 
two-group study comparing differences in rates or proportions between the 
groups, the number of subjects per group nBinary for a two-sided significance 
level a and power 1-P is given by equation (4.8). 
nB! 
napy 
:- 
(Z1-al2 
+ ZI-fl 
y k7. (1 
- Z, 
) + ; r, 
(1 
- Z)] 
. (4.8) (z7' 
-, Tc) 
2 
Alternatively, the same difference between treatments may be expressed 
through the odds ratio (OR), which is defined as: 
ORBinary (4.9) 
1 ZT -; rc ; rc('-; rr) 
This formulation leads to an alternative for equation (4.8) for the sample size. 
Thus, 
n., = 
2(zl-a/2 + z, 
-,, 
)2 /(log ORBi., 
y)2 (4.10) 
ýT(l -, W) 
where ýf = (; rr +; rc)12. 
Equations (4.8) and (4.10) are quite dissimilar, but Julious and Campbell 
(1996) show that for all practical purposes they give very similar sample sizes, 
with divergent results only occurring for relative large (or small) ORBinary. 
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Figure 4.1 indicates that approximately 60% of patients in the control group 
scored 100, i. e. "good health". Suppose it is anticipated that this may improve 
to 70% having good health with treatment T. The anticipated treatment effect 
is thus, 5Binary = (nT' 7CC)= 0.70 - 0.6 = 0.10. This equates to a sample size of 
nBi,,,,, y= 353 per group from equation (4.8). 
Alternatively, this anticipated treatment effect can be expressed (using 4.9) as 
ORBi,,,, y = (0.70/0.30)/(0.60/0.40) = 1.56. Using this in equation (4.10) with 
ýF = (0.70 + 0.60)/2 = 0.65 gives a sample size per group of nOR = 349 patients. 
As we indicated previously, there is usually only a small and inconsequential 
difference between the calculations from the alternative formulae. 
Method 4: Ordered categorical (Ordinal) HRQoL data 
If the HRQoL outcomes are measured on an ordinal scale, then the statistical 
hypothesis test used in this instance (to compare two independent groups) is 
the Mann-Whitney U test with allowance for ties or a Chi-squared test for 
trend (Altman, 1991). 
Whitehead (1993) presents the sample size formula for ordinal data in a key 
paper. To use Whitehead's formula we need to specify an effect size. For 
ordinal data Whitehead suggested the odds ratio (ORo,. di,,,,, ), which is the odds 
of a subject being in a given category or lower in one group compared with the 
odds in the other group. 
Suppose we have two groups, treatment (T) and control (C), and the HRQoL 
outcome measure of interest Y has k ordered categories yj denoted by i= 
I, Z..., k. Let M The the probability of being in category i in group T and YiT be 
the expected cumulative probability of being in category i or less in group T 
(i. e. 71 T= Pr(Y s- yi), wit hAT =Pr(Y.: 5yd = 1). For category i, where i takes 
values from 1 to k-1, the OROrdinai is given by 
OROrdinali oyiT 
Yic 
- YiT - Yic) 
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The assumption of proportional odds specifies that the ORordinall will be the 
same for all categories from 1=I to k-1, and is equal to ORordial. This is the 
proportional odds assumption which underlies the proportional odds model 
and hence the derivation of the formula 
Figure 4.1 illustrates that the HRQoL outcome has five categories, which 
implies four cut-offs (RLP scores = 0, :5 25, :! ý 50 and :5 75) and therefore four 
separate ORs. As the proportional odds model assumes a constant OR for all 
categories, Figure 4.2 shows the four observed ORs compared to the 
estimated common OR of 1.56 (95% Cl: 1.12 to 2.17) from the proportional 
odds model. All observed ORs are greater than 1 and seem similar to the 
model estimate. 
Figure 4.2: Odds Ratios for SF-36 Role Limitations Physical categories 
based on observed data and proportional odds model 
1.80 - 
1.60 - A ............. Ar ........ ... A ............. A 
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SF-36 Role-physical scorelcategory 
A chi-squared score test of proportional odds was X2 = 6.27 on 3 df, p=0.10. 
This suggests that the proportional odds assumption is plausible. Although in 
other cases the test may lack sufficient power to detect meaningful departures 
from proportional odds, (Peterson and Harrell, 1990; Brant, 1990). The model 
is robust to mild departures from the assumption of proportional odds. A crude 
test would be to examine the odds ratios and, if they are all greater than unity, 
or all less than unity, then assume a proportional odds model will suffice 
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(Walters et a/ 2001 a). With increasing numbers of categories it is less likely 
that proportional odds assumption remains true. 
The proportional odds model OR estimate implies that patients in the 
intervention group have 1.56 times the odds of being in a given category or 
below (i. e. have worse HRQoL) than patients in the control group. 
Whitehead's (1993) method can be regarded as a 'non-parametric' approach 
as the derivation of the sample size formula and analysis of data is based on 
the Mann-Whitney U test, although it still relies on the assumption of a 
constant odds ratio for the data. Whitehead's method also assumes a 
relatively small log odds ratio and a large sample size, which will often be the 
case in HRQoL studies where dramatic effects are unlikely. Equation (4.12) 
gives the number of subjects per group n for a two-sided significance level a 
and power 1-P. 
n 
6[(ZI-al2 + ZI-, 8 
Y /Oog OR Ordinal 
)2 
Ordinal [k (4.12) 
73 
i 
Here ýF, is the average proportion of subjects anticipated in category i, that is, 
+, Tic)/ 
(; 
riT 
Suppose (as before) we are planning a two-group study to compare HRQoL 
(using the RP as the primary outcome) between the groups. We believe that 
the mean difference in HRQoL scores between the two groups is not an 
appropriate comparative summary measure. However, the odds of patient in 
the intervention group having an HRQoL score in a given category or below 
compared to the odds for a patient in the control group is felt to be an 
appropriate comparative summary measure. Approximately 60% of patients in 
the control group scored 100 i. e. "good health", with 40% scoring less than 
good health. As before, suppose it is anticipated that this may improve to 70% 
having good health with treatment T, implying that 30% have less than good 
health. Using equation (4.8), 
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OROrdinali 0.3 /( 0.4 )=0.43 
= 0.64, (4.13) 
(1-0.3 
1-0.4 0.67 
leads to an OROdi,,,, = 0.64 Which is the reciprocal of ORBinary. 
If we assume proportions (, Tc) of patients of 0.15,0.09,0.06,0.08 and 0.62 
respectively in the five RP categories (0,25,50,75 and 100) in the control 
group, the cumulative proportions vic in category i for the control treatment C (i 
=1 to 5) are 0.15,0.24,0.30,0.38 and 1.0. Then, for a given constant 
OROrdinal = 0.64, the anticipated cumulative proportions ('VjT) for each category 
of treatment Tare given by: 
7iT :- 
OROrdinal7iC 
i=I to M. (4.14) OROrdinal YiC + (1 - YiC ) 
After calculating the cumulative proportions (yT), the anticipated proportions 
failing in each treatment category, ; r,, can be determined from the difference 
in successive YT. Finally, the combined mean (jFj) of the proportions of 
treatments C and Tfor each category is calculated. 
Using equation (4.12) with this OR and (if, ) with a two-sided 5% significance 
level and 80% power gives the estimated number of subjects per group as 
340. With a sample size of 340 and proportions of 0.10,0.06,0.05,0.07 and 
0.72 scoring 0,25,50,75 and 100 respectively in the treatment group, the 
mean RP score will be 81.1 in the treatment group compared to a mean RP 
score of 73.5 in the control group. This is a mean difference of 7.6 points, 
which is slightly smaller than the eight point mean difference used in equation 
(4) to calculate nN, ) ..... i. 
If the number of categories is large it is difficult to postulate the proportion of 
subjects who would fall in a given category. Both Whitehead (1993) and 
Julious et al (1997) point out that there is little increase in power (and hence 
saving in the number of subjects recruited) to be gained by increasing the 
number of categories beyond five. Categories that are equally likely to occur 
lead to the greatest efficiency. 
36 
Chapter 4: Review of methods of sample size estimation 
Julious and Campbell (1996) show that, with two categories only, the method 
given by Whitehead is approximately equivalent to one described by Machin 
et al (1997) for the binary case, even though at first sight the equations are 
very dissimilar. They state that the practical importance of this is to give the 
choice of two alternative measures of differences between groups: differences 
in proportions or odds ratios. 
Alternative approaches: exact methods and simulation 
Hilton and Mehta (1993) describe methods for sample size determinations 
based on either exact power or a very precise Monte Carlo estimate of it. This 
involves the use of an algorithm for computing the exact probabilities of each 
marginal table for a given fixed sample size. The conditional probability of a 
particular permutation of the data can be obtained by using the generalised 
hypergeometric distribution. Even with an efficient algorithm, processing the 
number of permutations is a considerable computational task and so its use is 
restricted to studies involving small sample sizes and a small number of 
ordered categories (Rabbee et al 2003). This is likely to be an unrealistic 
scenario with HRQoL outcomes such as the SF-36 where most dimensions 
have more than 11 ordered categories (the exceptions being the two Role 
dimensions, RE, and RE with four and five categories respectively). Large 
dramatic differences in HRQoL scores between groups (using the SF-36 
outcome) are unlikely (see Chapter 5). Therefore larger sample sizes will be 
required to detect such differences. 
Rabbee et al (2003) describe a method for computing power and sample size 
for linear rank tests of differences between two ordered multinomial 
populations. Again this method, like Whitehead's' (1993) is asymptotic, 
although it more closely approximates Hilton and Mehta's (1993) exact 
method. Rabbee's method overcomes some of the computational limitations 
of the exact methods, but it is still not a very practical way of sample size 
estimation and so will not be considered any further. 
Limitations of Whitehead's (1993) method when model assumptions (constant 
OR, relatively small log OR and a large sample size) are violated have been 
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pointed out by Kolassa (1995) and Hilton (1996) respectively. However, as we 
show in the next chapter dramatic effects are unlikely with HRQoL outcomes, 
so larger samples sizes are required to detect statistically significant 
differences. Therefore, the assumptions of a large sample size and relatively 
small effects are not unreasonable for H RQoL studies (Walters et al 2001 a). 
Julious and Campbell (11998) discuss the problem of calculating the number of 
subjects required in a matched or paired study in which the outcome variable 
is ordinal. In the two category (binary) case, the sample size is dependent on 
the expected number of discordant pairs. They suggest that, as a rule of 
thumb, the required discordant sample size for the binary/two category case 
can be used as an approximation to the total sample size when the number of 
categories is greater than two. 
Method 5 Bootstrap methods 
We have already mentioned briefly in Chapter 3, that bootstrap methods can 
be used to answer sample size and power questions. We will expand on this 
in more detail in Chapter 6. Briefly, the choice of the test statistic (t-test, MW 
test, Chi-squared test etc) will determine the power of the test. We can use 
bootstrap simulation to compare the power of Methods I to 4 of sample size 
estimation above for detecting differences in HRQoL between two groups. 
The bootstrap strategy is to use pilot HRQoL data to a provide a non- 
parametric estimate, P of F and to use a simulation method for finding the 
power of the test associated with any specified sample size n if the data follow 
the estimated distribution function. If we denote the distribution function 
estimate by G, under the alternative hypothesis F, we can estimate the 
approximate power using the algorithm described in Chapter 6 (Collings and 
Hamilton, 1988; Hamilton and Collings, 1991; Walters and Brazier, 2003b). 
Tsodikov et al (1998) and Troendle 0 999) also use the bootstrap and Collings 
and Hamilton's (1988) algorithm on bounded outcome data. Both assume that 
a historical or reliable pilot data set is available to use in estimating the shape 
of the distribution. Troendle shows that the bootstrap is a reasonably accurate 
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method of power estimation under the location shift alternative hypothesis. 
Conversely Tsodikov et al suggest some caution in using the bootstrap for 
power estimation if the pilot data set is small and the anticipated treatment 
effect is based on the results from the pilot sample. 
Lesaffre et al (1993) describe a method that involves the use of pilot data to 
estimate power and sample size for bounded outcome scores. They used a 
variety of computer simulations including Monte Carlo and bootstrap methods 
to estimate power for a fixed sample size. Again, the bootstrap methods are 
based on Collings and Hamilton's (1988) algorithm. The bootstrap methods 
perform reasonably well, and gave fairly unbiased estimates of power, though 
for small pilot samples with large variability. 
What sample size methods do investigators actually use? 
King (1996) mentions the importance of effect sizes in calculating sample 
sizes for clinical trials and also discusses the alternative parametric and non- 
parametric approaches, although she does not give a recommendation for 
either one. King notes that there can be quite marked differences between 
sample sizes calculated from parametric and non-parametric methods, 
particularly for HRQoL outcome measures that have a highly skewed 
distribution. 
A few papers (Julious et al 1995; Campbell et al 1995, Julious et al 1997 
Fayers and Machin, 2000) appear to have used Whitehead's (1993) non- 
parametric method for ordinal outcomes. Bolland et al (1998) applied 
Whitehead's method to a three category ordinal outcome (good recovery 
(GR), moderate disability (MD) severe disability/vegetative state/dead 
(SDN/D)) in a randomised trial of patients suffering from severe head injury. 
They assumed a common odds ratio (proportional odds) of 1.84; proportions 
of patients of 0.17,0.30 and 0.53 respectively in the three categories GR, MD 
and SDN/D in the control group; and no effect of prognostic factors on 
outcome. This led to an initial sample size of 400 patients. Due to the 
uncertainty about these assumptions, the authors planned a blinded sample 
size calculation after approximately 100 patients were recruited. The review 
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was performed on the first 93 patients to respond and led to an increase in 
sample size from 400 to 450. On completion of the study the authors note that 
the proportional odds assumption, "whilst not fully valid, was not misleading". 
Roset et al (1999) apply parametric and non-parametric sample size methods 
to two datasets comprising the EQ-51D. They recommend parametric methods 
when the outcome variables are thought to be reasonably symmetrical and 
non-parametric methods when the data are skewed. This conclusion is rather 
unexciting and follows conventional statistical thinking that non-parametric 
methods be used for data with non-Normal distributions. 
What happens when different sample size formulae are applied? 
The sample sizes per group with similar anticipated treatment effects 
calculated for our example using equations (4.4,4.6,4.8,4.10 and 4.12) 
respectively were nN,,, r,,,, = 356, nNon-normai = 363, nBinay = 353, nOR = 349 and 
nordinal = 340. The binary and ordinal calculations gave lower estimated 
sample sizes than for the continuous case, which may reflect the skewed 
nature of the RIP outcome data, although for practical purposes the sample 
size estimates are broadly similar. 
Three papers (Julious et al 1995; Julious et al 1997; Machin and Fayers, 
1998) have highlighted the discrepancies between sample sizes for 
intervention studies using HRQoL outcomes (HADS and SF-36) calculated 
using conventional parametric techniques and non-parametric approaches. In 
order to make the alternative hypotheses comparable, the authors used the 
distribution of the outcome for the control, and shifted it by one category for 
the intervention. The odds ratios between categories and groups formed by 
such a shift were calculated, so that the parametric and non-parametric 
methods are calculated using the same alternative hypothesis. 
Using the SF-36, Julious et al (1995) show that the results given by the 
parametric and non-parametric methods are similar in some dimensions of the 
SF-36 but are very different in dimensions where the scores are highly 
skewed. For such asymmetric distributions, the parametric methods give the 
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same sample sizes for effects that are one unit above and one unit below the 
population mean. This is because the parametric method assumes a 
symmetric (Normal) distribution, whereas the non-parametric method may 
give different sample sizes according to the expected direction of the effect. 
For example they show that the non-parametric estimate of the sample size to 
detect a change of one category for the GH dimension (which is quite 
symmetric) is similar for one category up or down, but for the MH dimension 
(which is asymmetric) the sample size required to detect a change of one 
category down is three times that to detect one category up. 
In all three articles the authors stress that (Julious et al 1995; Julious et al 
1997; Machin and Fayers, 1998). "In general, statistics such as means and 
standard deviations are not suitable summary measures for non-Normal 
distributions, and neither are standardised differences (effect sizes) a suitable 
basis for the calculation of sample sizes. " 
Julious et al (1997) recommend that the frequency distributions of HRQoL 
scores should always be given so that one can assess if non-parametric 
methods should be used for sample size calculations and analysis. Given the 
skewed/asym metric distribution of the majority of HRQoL outcomes in 
general, they recommend that ordered categorical methods be used for 
sample size calculations. 
Prieto et al (1996) in a letter to the editor about Julious et al's (1996) paper, 
strongly disagree with this recommendation. Firstly, Prieto and colleagues 
argue that between ordinal and continuous scales there are a number of 
instruments (such as the SF-36) that can be labelled 'summated scales', in 
which the total score is the sum of a set of ordinal rankings, and so these 
scales are 'between' ordinal and continuous. They do not claim that equal 
increments in the observed score along the summated scale represent equal 
increments in the underlying latent variable being measured, but the mode of 
construction of the instrument suggests that deviations from interval properties 
may not be extreme. Secondly, they argue that failure to meet the 
assumptions required for the use of parametric methods does not appear to 
41 
Chapter 4: Review of methods of sample size estimation 
have serious consequences in most instances. Therefore they suggest that 
parametric techniques should be used for SF-36 sample size calculations. 
They note, however, that the minimum clinically important difference (MCID) 
for the SF-36 scales is still unknown and further research is needed to clarify 
the clinical significance of score changes on the SF-36 scales. 
In reply, Campbell et al (1996) stated that the parametric method requires one 
to specify an effect size based on the standard deviation of the outcome. It is 
the distribution of the population not the estimate, that is important, and the 
standard deviation for data that are not Normally distributed is uninterpretable 
in terms of the distribution of the data. Thus one cannot expect 95% of the 
observations to be within plus or minus two standard deviations of the mean. 
The problems are exacerbated when there are a limited number of categories; 
for example, one dimension of the SF-36 (role limitations emotional (RE)) can 
take only four values (0,33,67,100), and in one study most of the population 
scored 100 (Brazier et al 1992). In practice, an apparent continuous scale is 
composed of several correlated binary responses and the final response scale 
is effectively binary (< 100 or = 100). In this case, Julious' methods (1995, 
1997) demonstrate that the required sample size approaches the size 
required for a binary variable. 
If the frequency distribution of the HRQoL outcome data is symmetric (or 
expected to be reasonably symmetric) then the mean and median will tend to 
coincide and either can be used as a suitable summary measure. If the 
HRQoL outcome has a discrete, skewed distribution and the proportion of the 
sample at the upper or lower bounds is large, then the relative frequency or 
cumulative probabilities may be a more appropriate summary measure for the 
data. In this case non-parametric methods and the proportional odds model 
would be more appropriate for analysis of the data. 
However, a limitation of the non-parametric and proportional odds model 
approaches is in their interpretation. The effect sizes pN,, ýthý, and OROdi,,,, l are 
more difficult to interpret than the simple mean difference 5 and its 
standardised effect size Secondly, it is more difficult to quantify the 
42 
Chapter 4: Review of methods of sample size estimation 
minimum important difference (MID) for the non-parametric and proportional 
odds model methods. 
We believe, if the main goal of the analysis is to assess the magnitude of the 
treatment effect on the HRQoL outcome (i. e. interest lies in comparing 
location between treatments), then it is more sensible and appealing to assign 
numerical scores to the ordered categories and to use statistical methods (for 
sample size estimation and analysis) appropriate for comparing means (e. g. t- 
tests and multiple linear regression). The mean is still a useful summary 
measure for ordinal scaled HRQoL data if we are prepared to assume an 
underlying continuous latent variable that quantifies the response of interest 
and that the actual measured HRQoL outcomes, the ordered categories 
reflect contiguous intervals along this continuum. If interest lies elsewhere, for 
example in comparing the relative frequencies or cumulative probabilities in 
the ordinal categories between treatments, then the proportional odds model 
would be more appropriate for sample size estimation and analysis. 
Multiple end points 
We have based the above calculations on the assumption that there is a 
single identifiable endpoint, or HRQoL outcome, upon which treatment 
comparisons are based. Sometimes there is more than one endpoint of 
interest; HRQoL outcomes are multi-dimensional (e. g. the SF-36 has eight 
dimensions including RP). If one of these dimensions is regarded as more 
important than the others, it can be named as the primary endpoint and the 
sample size estimates calculated accordingly. The remainder should be 
consigned to exploratory analyses or descriptions only. 
A problem arises when there are several outcome measures that are all 
regarded as equally important. One approach is to repeat the sample-size 
estimates for each outcome measure in turn and then select the largest 
number as the sample size required to answer all the questions of interest. 
Here, it is essential to note the relationship between significance tests and 
power: it is well recognised that p-values become distorted if many endpoints 
are each tested for significance, and adjustments should be made. 
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To guard against false statistical significance as a consequence of multiple 
hypothesis testing, it is a sensible precaution to examine the consequences of 
replacing the significance level a in the various equations by a significance 
level adjusted using the Bonferroni correction (Bland and Altman, 1995). The 
Bonferroni correction is: 
CtBonferroni 'ý CfJKP (4.15) 
where K is the number of endpoints or hypothesis tests to be performed. Such 
a correction will clearly lead to larger sample sizes. The Bonferroni approach 
to adjusting for multiple comparisons tends to be conservative as it assumes 
all the different endpoints are uncorrelated (Altman et al 2000). In the case of 
HRQoL outcomes there is likely to be a strong correlation between the 
different dimensions. This conservativeness implies that utilising criterion 
(4.15) will lead to failure to reject the null hypothesis on too many occasions. 
Fairclough (2002) gives a more comprehensive discussion of multiple 
endpoints and suggests several alternative methods to the Bonferroni 
approach when analysing HRQoL outcomes. 
Choice of sample size method with HRQoL outcomes 
it is important to make maximum use of the information available from other 
related studies or extrapolation from other unrelated studies. The more 
precise the information, the better we can design the trial. We would 
recommend that researchers planning a study with HRQoL as the primary 
outcome pay careful attention to any evidence on the validity and frequency 
distribution of the proposed HRQoL instrument. 
The frequency distribution of HRQoL scores from previous studies should be 
assessed to see if means, rates or proportions are appropriate summary 
measures for the data, and hence whether parametric or non-parametric 
methods should be used for sample size calculations and analysis. Given the 
skewed distribution of the majority HRQoL outcome measures, summary 
measures of central location such as means and summary measures of 
variability such as standard deviations may not be appropriate; and so 
standardised differences (effect sizes) and parametric methods may not be a 
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suitable basis for calculation of sample size. It is difficult to interpret an effect 
defined by equation (4.3) when the data are skewed. We would suggest that 
investigators consider clinically meaningful effect sizes, and do not rely on 
generic 'small', 'medium' or'large' ones as suggested by Cohen (1988). 
There may be considerable uncertainties in estimates of such quantities as 
the standard deviation and the treatment effect. Sample size calculations are 
sometimes based on estimates "pulled out of thin air". If an investigator is 
uncomfortable with the assumptions, then it is good practice to calculate 
sample sizes under a variety of scenarios so that the sensitivity to 
assumptions can be assessed (Julious et al 1997). We would recommend that 
various anticipated benefits be considered, ranging from the optimistic to the 
more realistic, with sample sizes being calculated for several scenarios within 
that range. It is a matter of judgement, rather than an exact science, as to 
which of the options is chosen for the final study size (Fayers and Machin, 
2000). 
If there is little prior knowledge of the full distribution of scores for the HRQoL 
outcome, sample size calculation may not be too problematical. Using the 
ordinal approach to sample size calculation, knowledge of the anticipated 
distribution within four or five broad categories is usually sufficient to 
determine the required number of subjects (Whitehead, 1993; Campbell et al 
1995; Julious et al 1997). 
The guidance presented here is not meant to imply that other more 
fundamental design factors such as whether a randomised controlled design 
can be used are not important or should not be considered. However, to date, 
the points made about calculating sample sizes for HRQoL measures have 
not been well recognised. Perhaps the adoption of some of the above 
recommendations by the developers of HRQoL instruments and in guidelines 
used by medical journals for refereeing HRQoL studies would help facilitate 
change. 
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Conclusions 
Given that the end goal of using HRQoL outcomes in research studies is to 
assess a patient's health and well being, using the right type of HRQoL 
outcome in the right setting with an appropriate sample size calculation is 
crucial. Much time and energy is devoted to developing and validating HRQoL 
measures. Developers and researchers need to complement this effort with 
clearer descriptions of the distribution of such outcomes and what is an 
appropriate summary measure, the mean or the proportion with a certain 
score. 
Finally we would stress the importance of a sample size calculation (with all its 
assumptions), and that any such estimate is better than no sample size 
calculation at all, particularly in a trial protocol (Williamson et al 2000). The 
mere fact of calculation of a sample size means that a number of fundamental 
issues have been thought about: what is the main outcome variable, what is a 
clinically important effect, and how is it measured? The investigator is also 
likely to have specified the method and frequency of data analysis. Thus 
protocols that are explicit about sample size are easier to evaluate in terms of 
scientific quality and the likelihood of achieving objectives. 
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Chapter 5: Summary statistics and observed effect sizes from 
the various HRQoL clatasets 
Introduction 
We have already seen from the previous chapter that amongst other factors 
sample size estimation is dependent on the "effect size" which is related to the 
smallest treatment difference that it is important to detect. 
This chapter calculates several effect sizes indices ANOrmah PNoether, 813inarys 
ORBinary, and OROrdinal (see equations 4.3,4.5,4.8,4.9 and 4.11) for the 
various data sets (described in Chapter 2). We will use a distribution-based 
approach, although other anchor-based ways of determining effect sizes are 
available, as are ways of determining the smallest important difference in a 
HRQoL measure that it is worthwhile detecting (Walters and Brazier, 2003a). 
Interpretation of HRQoL scores 
HRQoL outcome measures are being increasingly used in research trials, but 
less so in routine clinical practice. The interpretation of HRQoL scores raises 
many issues. The scales and instruments used may be unfamiliar to many 
clinicians and patients, and they may be uncertain of the meaning of the scale 
values and summary scores. 
Repeated experience and familiarity with a wide variety of physiological 
measures such as blood pressure or forced expiratory volume, has allowed 
clinicians to make meaningful interpretation of the results. In contrast, the 
meaning of a change in score of five points on a HRQoL instrument such as 
the SF-36 is less intuitively apparent, not only because the scale has 
unfamiliar units, but also because health professionals seldom use HRQoL 
measures in routine clinical practice. 
In clinical trials, where HRQoL instruments are being increasingly used as 
primary outcome measures, it is relatively simple to determine the statistical 
significance of a change in HRQoL (as I shall describe later on in Chapters 7 
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and 8), but placing the magnitude of these changes in a context that is 
meaningful for health professionals, patients and other stakeholders 
(Pharmaceutical and Medical Device Developers, Insurance Payers, 
Regulators, Governments) has not been so easy. Ascertaining the magnitude 
of change that corresponds to a minimal important difference would help 
address this problem (Juniper et al 1994). So when an investigator is 
determining an important change standard the perspective can influence the 
assessment approach and the way in which an important difference is 
determined (Frost et al 2002). The minimal important difference (MID), from 
the patient perspective, can be defined as uthe smallest difference in score in 
the domain of interest which patients perceive as beneficial and which would 
mandate, in the absence of troublesome side effects and excessive cost, a 
change in the patient's management". (Jaeschke et al 1989). 
Thus standards of individual change are needed to provide meaningful 
interpretation of HRQoL intervention and treatment effects and to classify 
patients based on this standard as improved, stable or declined. To date two 
broad strategies have been used to interpret differences or changes in 
HRQoL following treatment (Norman et al 2001): distribution based 
approaches - the effect size (ES); and anchor-based measures - the minimum 
clinically important difference (M CI D). 
Distribution based approaches rely on relating the difference between 
treatment and control groups to some measure of variability. The most 
popular approach uses Cohen's standardised effect size (Cohen, 1988), the 
mean change divided by the standard deviation to serve as an "effect size 
index", that is suitable for sample size estimation. Cohen suggested that 
standardised effect sizes of 0.2 to 0.5 should be regarded as "small", 0.5 to 
0.8 as "moderate" and those above 0.8 as "large". Cohen's effect size may be 
influenced by the degree of homogeneity or heterogeneity in the sample. 
Distribution-based methods rely on expressing an effect in terms of the 
underlying distribution of the results. Investigators may express effects in 
terms of between-person standard deviation units, within-person standard 
deviation units, and the standard error of measurement (Guyatt et al 2002). 
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Four statistics commonly used to index responsiveness are (Hays et al 1998): 
(1) effect size (Kazis et al 1989); 
(2) Mest comparisons (Liang et al 1995); 
(3) the standardised response mean (Liang et al 1990); 
(4) the responsiveness statistic (Guyatt et al 1987). 
The formulae for these statistics are as follows, where D= raw score change 
on measure; SE = standard error of the difference; SIDtim., standard 
deviation at time 1; SIDdifference = standard deviation of D; SIDStable standard 
deviation of D among stable subjects (those whose true status is constant 
over time): 
Paired t-statistics = D/SE (5-1) 
Effect size (ES) statistic = DISDtimel (5.2) 
Standardised response mean (SRM) = D/SDdifference (5.3) 
Responsiveness statistic = D/SDstable (5.4) 
The paired t-statistic is best suited to pre-post assessments of interventions of 
known efficacy. The effect size statistic relates change over time to the 
standard deviation of baseline scores. The standardised response mean 
compares change to the standard deviation of change. The responsiveness 
statistic looks at HRQoL change relative to variability for clinically stable 
respondents. The effect size statistic ignores variation in change entirely, the 
t-statistic ignores information about variation in scores for clinically stable 
respondents, and the responsiveness statistic ignores information about 
variation in scores for clinically unstable responders. We have already seen 
that similar effect size statistics to equation (5.2) can be used in the estimation 
of sample sizes. 
Therefore, we shall use the effect size statistic (5.2) which is analogous to 
equation (4.3) in Chapter 4 to determine ANormal. We shall use the pooled 
standard deviation of the two groups as our estimate of a rather than the 
standard deviation of baseline scores. For example, for the CPSW study 
where we were interested in comparing the HRQoL of new mothers six weeks 
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postnatal in the intervention and control groups, the effect size will be 
calculated as the mean HRQoL score in the Intervention group minus the 
mean HRQoL score in the Control group divided by the pooled standard 
deviation. The 'pooled' estimate of the standard deviation is given by, 
s= 
+(n2 
2 
v n, +n2-2 
where s, and S2 are the sample standard deviations and n, and n2 the sample 
sizes for the two groups respectively. 
We shall estimate, PNoether, which is the probability that an observation drawn 
at random from population X would exceed an observation drawn a random 
from population Y, by Ulnin2, where U is the value of the Mann-Whitney test 
statistic and nj and n2 are the sample sizes in the two groups. QXY is the 
number of pairs for which xi > yj and Uyx is the number of pairs for which yj > 
xi. Any pairs for which yj = xi, count Y2 a unit to both Uxy and Uyx. Either of 
these statistics can be used for the MIN test, with exactly equivalent results 
(Armitage et al 2002). We shall use Uxy and henceforth refer to it as U without 
the subscripts. For example, for the CPSW study, PNoether, will be estimated 
from the U value from the MINtest comparing the equality of the distribution of 
HRQoL scores in between the (Intervention and Control) groups divided by 
the product of the samples sizes for the Intervention and Control groups. 
If possible, 5Binary, and ORBinary will be estimated from the proportions of 
patients scoring 100 "good" health vs. "less than good health" (i. e. a HRQoL 
score < 100) in the two groups. 
Finally the OROrdinal will be estimated by fitting a proportional odds or 
cumulative logit model to the data (McCullagh and Nelder, 1989) with the 
HRQoL score as the dependent outcome variable and the treatment group as 
a covariate or independent or predictor variable. (Full details of the 
proportional odds model will be given in Chapter 7, Walters et al 2001a and 
Lall et al 2002). We shall also carry out a score test of the proportional odds 
assumption which underlies this model. 
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The developers of the SF-36 have suggested that using the GH dimension a 
five-point difference (on the 0-100 scale) is the smallest score change 
achievable by an individual and considered as "clinically and socially relevant" 
(Ware et al 1993). Angst et al (2001) found the MCID ranged from 3.3 to 5.3 
points on the PF dimension and 7.2 to 7.8 points on the BP dimension in 
patients with osteoarthritis of the hip or knee. Hays and Morales (2001) also 
provide information on what a clinically important difference is for the SF-36 
scales. They conclude that the MCID for the SF-36 is "typically In the range of 
3-5 points", although they also recommend caution in interpreting 3-5 points 
on the SF-36 dimensions as the MCID. 
The studies 
The data used in this chapter comes from five studies which used the SF-36 
including cross-sectional surveys, randomised controlled trials, and 
observational studies. All of the effect sizes are for simple cross-sectional two 
group comparisons. 
Observed Effect sizes for the CPSW study 
As we have already mentioned the effect sizes for the CPSW study will be 
based on comparison of six-week HRQoL scores between women 
randomised to the Intervention (extra post-natal support) and Control groups. 
Table 5.1 shows that patients in the Control group had significantly higher 
scores (compared to the Intervention group patients) on two dimensions of the 
SF-36, the RIP and SF dimensions, using the p-values from the two 
independent samples Mest and a cut off p :50.05 for statistical significance,. 
The observed Normal or Gaussian effect sizes ANormal ranged from -0.01 to 
0.23 and were all in the 'small' range using Cohen's (1988) classification. The 
probability that a randomly chosen value (or subject) from the Control group 
was greater (i. e. had a better HRQoQ than a randomly chosen value (or 
subject) from the Intervention group, i. e. PNoetherranged from 0.499 to 0.568. 
51 
If,. 
5-: 1i 
iz 
CL 
CO) i 
ul Iq 
-ø 
U) 
r. 
c 
go Z 
c4 
co 0) P-: CC) C14 C%4 Clq 0 LO co CY) cq 'm V) cc 
V- 
to ! =:, 
a) l4t U) N C) (7) Mt 0 C', ca 
9 17 q q q CD CD 0 ý% 
C> 0 0 C) 0 c; C; 6 11 2 Z) CD . 
e: s -0 04 cle) (Y) 00 1- CII) 0 co co CV) IRt 008 Cf) ce) Q) c -ý 
Nt Ci clq N q cr C') co 00 
C) 0 0 C) 00 00 cc C5 c; C; a 6 C5 
CZ cm 4 
CF) (D C) 
e 
CD m co 
' 
CY) 
- 
(n 0 
lq; r (0 c ) N 0 IT T 0) 13 
Lc) Rt 0 1- to LO Cf) C14 
Cý 
0 
R 
14, Itt CF) C) Uý 
fl- 
CY! 
ýZ0 
0 0 0 0 0 0 0 0 
0 
A 
rx 
T- co N 04 lq: t TI. LO (3) CD 
Uý 
(D 
Uý 
Lf) 3 V- CD 
Uý 
V- 
Uý 
CY) 
CL Cý 
0 CT) 0 U') (0 0) CY) co 0) Lf) C%j It ce) CN 0 N co ý 
C! CR 7 It 0 t- a) C) qT 0 C5 c; ci ci Q 11 
tFz ca LLI 
F- M r- CV) co 0 cf) 
N 
- 
C14 7 CD 
0 
cg 0 CD 0 0 0 ci 0 
CV) T- 04 
A 
'a 
04 43 to cl. 
z 11 
Uý CC) T- to P- CO I, - Lf) : 
I- r- 
* 
I- CN mt Lf) 04 t- So o ;4 W .q Ld C6 c3i cli cli r-. C6 C; - Cý Ili 66 r-ý (6 -. co ýo , Cf) ce) CN N T- V- NN N C'4 Cf) CV) V- V- a 
0 0 r .x 
Cý cl cfý C4 (D (D I, - Cf) T- 00 to CY) CY) 00 0) T- 2 5ýý CY) tl- 'IT tf) ui 1; rlý L(i -: C)i 1: C6 r-.: C6 cli cli co co r- co t*- r- r- t- U) 144, co r- t- t- 
U') lq: t U) It I* LO It U') lql* 
C14 04 04 N C%4 04 04 CN 04 N NN NN C14 04 
A 
a r_ C C C C C C 
0 0 0 0 0 0 0 0 
Q 
W - ': (D 'ý C: a) , r- 0 a) - ': - C: - c- 1c (D -0 . tt-: :: - 11 1 ? 
- - 
i-> , - ý, - 2: i! - ?. ý 2: 6 25 ZD r_ 0 
0ý 
C 0) 
0- 
C (1) 
0ý 
C: (1) 0 ý, 
a (1) 0ý 
C 4) 0ý C: a) C: a) 0 ý, .cV. K ct, o to 
U. S -ý Q) 0: . %n F: 0 C-i 
N C co (Tj I Lýz 
- (b 
: SN E-6 - 
E; z crj co c a0 E r- Crj a) 
0 
tE 0 
z it 
0 
co 12 0 co Lý 0 0: ul 0) Z :t uj Cri CL 
04 
U) 
Chapter 5: Observed effect sizes 
The OROrdinal estimates from the proportional odds model were greater than 
unity for seven out of the eight dimensions of the SF-36 (the exception being 
the MH dimension). Odds ratios greater than unity imply that the odds of being 
in a given category or less (i. e. having better HRQoQ is greater for patients in 
the Control group compared to the odds of being in a given category or less in 
the Intervention group. The p-values from the Wald test for the significance of 
the regression coefficient for the group term were almost identical to the p- 
values obtained from the MIN test and so are not reported. Ordinal regression 
is equivalent to the MIN test when there is only one independent 0/1 variable 
in the regression (Campbell, 2001). Although the advantage of ordinal 
regression over non-parametric methods is that we get an efficient estimate of 
a regression coefficient and we can extend the analysis to allow for other 
confounding variables. 
Finally the test of proportional odds which underlies the model suggested that 
on three dimensions of the SF-36, PF (p = 0.032), RP (p = 0.04) and GH (p = 
0.001) this assumption may not be valid. 
The effect sizes, 5Binary, and ORBinany also reflect that more patients in the 
Control group reported "good" health i. e. scoring 100 compared to the 
Intervention group. Again Odds Ratios greater than one imply that the odds of 
scoring 100 (i. e. having good HRQoL) is greater for patients in the Control 
group compared to the odds of scoring 100 being in the Intervention group. 
For the V dimension the ORBinary statistic could not be calculated as no person 
in either group scored 100. 
Observed Effect sizes for the OA Knee study 
For the OA Knee study the effect sizes are based on a comparison of the 
difference in HRQoL scores between the Rheumatology and Surgical groups 
at initial assessment. 
Table 5.2'shows that patients in the Rheumatology group had significantly 
different scores (compared to the Surgery patients) on four dimensions 
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Chapter 5: Observed effect sizes 
of the SF-36, the PF, GH, V and MH dimensions, using the p-values from the 
two independent samples Mest and a cut off p-value :50.05 for statistical 
significance. 
Ignoring the sign the absolute values of the Normal effect sizes ANorma, ranged 
from 0.02 to 0.57 and were in the 'small' to 'moderate' range using Cohen's 
(1988) classification. 
PNoether ranged from 0.34 to 0.60, reflecting that for some dimensions e. g. PF, 
(Pftether, ý 0.60) patients in the Rheumatology group had a better HRQoL than 
patients in the Surgical group. That is the probability of a randomly chosen 
patient from the Rheumatology group having a better HRQoL score than a 
randomly chosen subject from the Surgical group was greater than a half. For 
other dimensions e. g. GH (PNoether -ý 0.34) patients in the Rheumatology group 
were more likely to have a poorer HRQoL than patients in the Surgical group. 
The OROrdinal estimates from the proportional odds model varied from 0.37 to 
1.79. Odds ratios greater than one imply that the odds of being in a given 
category or less (i. e. having better HRQoL) is greater for patients in the 
Rheumatology group compared to the odds of being in a given category or 
less in the Surgical group. Conversely odds ratios less than one imply that the 
odds of being in a given category or less (i. e. having better HRQoQ is lower 
for patients in the Rheumatology group compared to the odds of being in a 
given category or less in the Surgical group (i. e. patients in the Rheumatology 
group have poorer HRQoL than patients in the Surgical group). Finally the test 
of proportional odds which underlies the model suggested that on three 
dimensions of the SF-36, PF, GH and V (p: 5 0.001), this assumption may not 
be valid. 
In this study the proportion of patients in both groups scoring 100 on any 
dimension was low, less than 5% except for the SF and RE dimensions. So 
the absolute value of the effect size, 8BInary, was less than 0.05 for all eight 
dimensions of the SF-36. 
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Observed Effect sizes for the Leg Ulcer data 
For the Leg Ulcer data the effect sizes are based on a comparison of the 
difference in baseline HRQoL scores between those leg ulcer patients who 
walk freely without an aid and the leg ulcer patients who walked with an aid or 
were bed bound. 
Table 5.3 shows that leg ulcer patients able to walk freely without an aid had 
significantly higher scores (compared to the Intervention group patients) on 
five dimensions of the SF-36, (PF, RP, BP, V and SF), using the p-values 
from the two independent samples Mest and a cut off p :50.05 for statistical 
significance. The observed Normal effect sizes ANý,,, aj ranged from 0.08 to 
1.45 and were all in the 'small' to 'moderate' range using Cohen's (1988) 
classification, except for the PF dimension which had a 'large' effect size 
ANormai -z 1.45. 
The probability that a randomly chosen value (or subject) from the Control 
group was greater (i. e. had a better HRQoL) than a randomly chosen value 
(or subject) from the Intervention group, i. e. PNoether ranged from 0.518 to 
0.833. 
The ORordinal estimates from the proportional odds model were greater than 
unity for all eight dimensions of the SF-36. Odds ratios greater than one imply 
that the odds of being in a given category or less (i. e. having better HRQoL) is 
greater for patients in the Walk freely group compared to the odds of being in 
a given category or less in the Walk with aid group. The p-values from the 
Wald test for the significance of the regression coefficient for the group term 
were almost identical to the p-values obtained from the MIN test and so are 
not reported. Finally the test of proportional odds which underlies the model 
suggested that on three dimensions of the SF-36, GH (p = 0.001), V (p = 
0.033) and SF (p = 0.005) the assumption of proportional odds may not be 
valid. 
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Observed Effect Sizes for the NAMEIT data 
The observed effect sizes for the NAMEIT data were based on a comparison 
of the HRQoL scores between the Neoral and Placebo group patients at 48- 
week follow-up. 
Table 5.4 shows that patients in the Neoral group had significantly higher 
scores (compared to the Placebo group patients) on one dimension of the SF- 
36, the RP dimension, using the p-values from the two independent samples 
Mest and a cut off p :50.05 for statistical significance. The effect sizes ANormal 
ranged from 0.2 to 0.32 and were all in the 'small' range using Cohen's (1988) 
classification. 
The probability that a randomly chosen value (or subject) from the Neoral 
group was greater (i. e. had a better HRQoL) than a randomly chosen value 
(or subject) from the Placebo group, i. e. PNoetherranged from 0.501 to 0.576. 
The OROrdinal estimates from the proportional odds model were greater than 
unity for all eight dimensions of the SF-36. Odds ratios greater than one imply 
that the odds of being in a given category or less (i. e. having better HRQoL) is 
greater for patients in the Neoral group compared to the odds of being in a 
given category or less in the Placebo group. The p-values from the Wald test 
for the significance of the regression coefficient for the group term were 
almost identical to the p-values obtained from the MIN test and so are not 
reported. Finally the test of proportional odds which underlies the model 
suggested that on three dimensions of the SF-36, GH, V and SF this 
assumption may not be valid. 
Observed Effect sizes for the SF-36 general population data 
For these data we show the results of three separate effect size calculations, 
with various different groups: 
(1) Male vs. female subjects 
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Chapter 5: Observed effect sizes 
(2) General practitioner consultation in the previous 2 weeks (Yes vs. No) 
(3) Outpatient Attendance in the previous 3 months (Yes vs. No) 
Tables 5.5,5.6 and 5.7 show the various effect sizes for the three 
comparisons. The absolute values of AN,,,,.,,,, ranged from 0.06 to 0.82 and 
were mainly in the 'small' to 'moderate' range using Cohen's (1988) 
classification. The values for PNoether ranged from 0.302 to 0.644. 
The OROrdinal estimates from the proportional odds model ranged from 0.26 to 
2.45 for the three different effect size comparisons for the general population 
data. The assumption of proportional odds appears to be valid for seven out of 
eight dimensions of the SF-36 for the gender (male vs. female) comparison. 
The exception being the GH dimension, where there is some reliable 
statistical evidence that this assumption may not be valid (p = 0.001). The 
assumption of proportional odds appears to be reasonable for eight 
dimensions for the GP consultation comparison. However for the outpatient 
attendance in the last three months comparison there is some suggestion that 
the proportional odds assumption may not be valid for five dimensions (PF, 
RP, GH, SF and RE) with p<0.05 from the test of proportional odds. 
Tables 5.1 to 5.7 suggest that large dramatic differences in HRQoL between 
groups are unlikely and the observed effect sizes ANormaj, were mainly in the 
$small' to 'moderate' range (0.2 to 0.5) using Cohen's criteria (Cohen, 1988). 
The results of fitting a proportional odds model also suggest that dramatic 
effects (differences in HRQoL) are unlikely. The results also suggest that with 
increasing numbers of categories it is less likely that the proportional odds 
assumption is true. 
Combining effect sizes 
The five effect sizes, ANonnal, PNoether, 5Binary, ORBinary and OROrdinal, can all be 
regarded as different numerical expressions of treatment efficacy. 
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If a and c are the number of positive responses from a binary outcome for the 
Intervention and Control groups respectively for a classical two group 
randomised control trial (see Table 5.8) then we have already seen that 
f( ab 
OR, 
6i,, ary 
a+b)l(a+b)l 
- 
ad (5.6) 
c /( d) bc 
c+d) c+d 
Table 5.8: Binary outcomes from a standard two group randomised 
controlled trial 
Group 1 
(Intervention) 
x 
Group 2 
(Control) 
y 
Outcome + ve a C 
ve b d 
a+b=n, c+d= n2 
and the Absolute Risk Reduction: 
ac ARR = -- =S (5.7) a+b c+d 
Binary 
and the Number-Needed-to-Treat: 
I 
NNTBinary 
= ARR 
(5.8) 
The effect size statistics ANormalt hinaq and ORBiwy have the weakness of 
being applicable to only certain data types and therefore cannot be universally 
applied, making the comparison of effect sizes across different outcomes and 
studies problematic. 
The problem is that the standardised effect size AN,,,,,,,, is only appropriate to 
continuous outcomes and the 513inary, ORBinary effect size statistics are only 
applicable to binary outcomes. Three possible solutions to this problem 
(Shepstone, 2001) are: 
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Chapter 5: Observed effect sizes 
(1) Dichotomise the continuous outcome; 
(2) Categorise the continuous outcome into more than 2 categories; 
(3) Use an approximation. 
Shepstone (2001) suggests option (3) and that a useful statistic for the 
quantification of the treatment effect in a two group (Control and Intervention) 
context is the A statistic. If X and Y are the values of an outcome (higher 
values more preferable) for randomly selected individuals from the 
Intervention and Control groups respectively, then Axy = Pr(X > Y) Le. the 
probability that the Intervention patient has an outcome preferable to that of 
the Control patient, this is equivalent to the effect size statistic (4.5) PNoether. 
If we let Ayx = Pr(Y > X) i. e. the probability that a random individual from group 
2 (Control) has a better outcome than a random individual from group 1 
(Intervention) and 
A= Axy - Ayx = Pr(X > Y) - Pr(Y > X) (5.9) 
and 
,q= 
ýxy 
= 
Pr(X > Y) 
Ayx Pr(Y > X) ' 
For a2x2 table (Table 5.8 above), Pr(X > Y) i. e. the probability that an 
individual in group 1 (Intervention) has a positive outcome (alnj) and an 
individual in group 2 (Control) has a negative outcome (dln2) is a-d (since 
n, n2 
the two events are independent). Therefore Axy = Pr(X > Y) = ad and 
n, n2 
bc 
Ayx = Pr(Y > X) -. Hence, n, n2 
A= Axy _Ay 
ad-bc a(c+d)-c(a+b) an2- cn, =aC x=-= ARR, (5.1 n, n2 n, n2 n, n2 n, n2 
and 
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ad 
Axy, 
= 
n, n2 
=ad 
n, n2 
= 
ad 
= OR. A yx 
Tc- n -, n -bc bc 
n, n2 
Therefore for a binary outcome A= Pr(X > Y) - Pr(Y > X) is equivalent to the 
Absolute Risk Difference (ARR), which is the inverse of the NNT and 0= Pr(X 
Y)/Pr(Y > X) is the equivalent of the ORBInary. 
If we consider the case of two treatment groups with an ordered categorical 
outcome (higher scores are more desirable) with three levels 0,1, and 2 
(Table 5.9). 
Table 5.9: Ordinal outcomes from a standard two group randomised 
controlled trial (higher scores are more desirable) 
Outcome 
Group 0 1 2 
Group 1 Intervention X a b C n, 
Group 2 Control y d e f n2 
MO MI M2 
Then 
Axy = Pr(X > Y) =b-d+c-d+c-e 
n, n, n, n, n, n2 
and 
Pr(X = Y) =a-d+b-e+cf 
n, n2 n, n2 n, n. 
and 
Ayx = Pr(Y >X)= 
e-a+f-a+f-b. 
n2 n, n2 n, n, n, 
(5.13) 
(5.14) 
(5.15) 
F, flif2j Eflif2j Eflif2j 
in general, A, = 'ý'j , AYX = 
J>i and Pr(X = Y) = "I , where f1i n, n2 n, n2 njn2 
is the cell count for Group 1, row 1 and column i of the general 2 by k 
contingency table of outcomes (i =1 to k where k is the number of ordinal 
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categories). Axy and Ayx can be estimated by Axy = 
Uxy 
and Ayx = 
UY" 
n, n2 n, n2 
where Uxy and Uyx are the values of the Mann-Whitney U statistics. 
If the outcomes are continuous and/or can be fully ranked and there are no 
ties in the data then Pr(X = Y) =0 and A= Axy- Ayx = Pr(X > Y) - Pr(Y > X) 
and 0= AxylAyx = Pr(X > Y)lPr(Y > X) can be estimated exactly. Conversely, if 
there are a large number of ties in the data, i. e. x, = yi, (which is likely for 
HRQoL outcomes, with their discrete response categories) then Pr(X = '0 > 0. 
In this case any pairs for which xi = yi, contribute Y2a unit to both UXY and UýX. 
Hence the two A statistics Axy and Ayx can only be estimated approximately 
and thus the approximate estimates of 0 and A in the case of ties will be 
denoted by fil and Xrespectively. 
Shepstone (2001) shows that by re-conceptualising the ARR and the OR in 
terms of Axy and Ayx a generalisation can be made to non-binary outcomes. 
We have already seen (Chapter 4) that Axy and Ayx, or their equivalent 
statistics Pr(X > ýq and Pr(Y >X) can be calculated by either a parametric 
approach for continuous outcomes (equation 4.7) via a theoretical distribution 
(e. g. Normal) or a non-parametric approach without any distributional 
assumptions via the Mann-Whitney U statistic. 
Thus, these statistics Axy, Ayx, A and 0 can be generalised to ordinal and 
continuous outcomes with no distributional assumptions. Therefore, the NNT 
and OR statistics can be generalised to all data types with analogous 
interpretations. Figure 5.1 shows the relationship between Pr(X > ýq or its 
equivalent Axy and A (the ARR) and 0 (the OR). 
In the case of a Normal or Gaussian outcome, Shepstone (2001) shows that 
the generalised NNTx is a function of the effect size ANorinal (see Table 5.10). 
Therefore by conceptualising the ARR and the OR in this fashion a simple and 
universal approach to expressing group differences and effect sizes is 
obtained. 
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Figure 5.1: The relationship between Pr(X >Y) and A (ARR) and O(OR) 
Tables 5.11 to 5.17 show that Odds Ratio effect size estimates 0' and ORordinal 
are of similar magnitude, but are not identical. The OROrdinal estimate 
consistently tends to be larger than the corresponding estimate 61. The 
ORordinal is parametric estimate as it assumes that the proportional odds 
assumption for the cumulative logit model is valid. On the other hand the 
estimate of Owe have used (which is derived from the Mann-Whitney U test) 
is a non-parametric estimate and makes no distributional assumptions. Also 
the cumulative logit model is estimating log 
I 
YJ 
, where y, = 
Pr(Y <= yj) i. e. 
I 
Yj 
- 
the probability of being in category or less, not Pr(Y < yj). If there are a large 
number of ties in the data, i. e. xi yi, (which is likely for HRQoL outcomes, 
with their discrete response categories) then Pr(X = '0 > 0. In this case any 
pairs for which xi = yi, contribute Y2a unit to both Uxy and UYX. Hence the two 
odds ratio effect size estimates Oland OROrdinal are likely to diverge further. 
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Table 5.10: The relationship between the Gaussian effect size ANormals A 
0, Cohen's criteria and the NNT% (adapted from Shepstone 2001) 
Effect 
Size 
ANormal 
(ARR) 
Axy-Ayx 
A 
(OR) 
AxylAyx 
0 NNTx' Interpretation 2 
0 0 1.0 00 No effect 
0.2 0.11 1.25 8.9 Small effect 
0.5 0.28 1.76 3.6 Moderate effect 
0.8 0.43 2.50 2.3 Large Effect 
1.0 0.52 3.17 1.9 
2.0 0.84 11.66 1.2 
1. The inverse of X can be interpreted as the NNT. 
2. Based on Cohen's (1988) interpretation of the effect size, ANormal. 
Again using Cohen's (1988) interpretation (from Table 5.10) the 0, A and N NT 
statistics are mainly in the 'no effect' to 'moderate effect' range. Thus large 
dramatic differences in HRQoL between groups are inconsistent with the 
observed data. 
Summary 
In this chapter we have calculated several effect size statistics for the eight 
SF-36 dimensions across a variety of studies with different populations. We 
have also shown how the different numerical expressions of effect size can be 
unified via the A (ARR), 0 (OR) and ININT statistics. The results suggest that 
large differences in HRQoL (as measured by the SF-36) between groups are 
unlikely, particularly from the randomised controlled trial comparisons and the 
observed effect sizes were mainly in the 'small' to 'moderate' range (0.2 to 
0.5) using Cohen's (1988) criteria. 
We shall use these estimates of effect size 5, ANcminzi, and OR as our MID in the 
calculation of sample sizes in the next chapter. In this chapter we will compare 
the power of various methods of sample size estimation described in the 
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preceding chapter for simple two group cross-sectional comparisons via 
bootstrap simulation. 
Table 5.11: CPSW Study Generallsed Effect Sizes and NNTs for Control 
vs. Intervention Groups 
SF: ý36 
Dimension 
Mean 
diff S 
ES 
ANr,,, 
Pr(x > Y) 
RN00(her ORordl,,,, 
ARR 
V 
OR 
09 NNT): 
Physical 2.6 0.17 0.561 1.49 0.123 1.28 8.1 
Function 
Role 9.1 0.23 0.568 1.66 0.137 1.32 7.3 
Physical 
Bodily 4.0 0.17 0.552 1.39 0.105 1.23 9.5 
Pain 
General 2.4 0.13 0.542 1.26 0.084 1.18 11.9 
Health 
Vitality 1.3 0.06 0.514 1.09 0.028 1.06 36.4 
Social 4.7 0.20 0.561 1.48 0.122 1.28 8.2 
Function 
Role 1.1 0.03 0.515 1.13 0.029 1.06 34.1 
Emotional 
Mental -0.2 -0.01 0.499 0.99 -0.002 1.00 541.7 
Health 
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Table 5.12: OA Knee Study Generallsed Effect Sizes and NNTs for 
Rheurnatology vs Surgical Groups 
SFL36 
Dimension 
Mean 
diff 9 
ES 
ANo,,,,, 
Pr(x > Y) 
pvoeth.,. 
- 
ORorft, 
ARR 
fv 
OR 
of NNTx- 
Physical 7.0 0.34 0.595 1.79 0.190 1.47 5.3 
Function 
Role -1.4 -0.06 0.501 0.99 0.001 1.00 950.4 
Physical 
Bodily -4.3 -0.20 0.454 0.75 -0.092 0.83 -10.8 
Pain 
General -13.4 -0.57 0.339 0.37 -0.321 0.51 -3.1 
Health 
Vitality -5.4 -0.28 0.419 0.61 -0.162 0.72 -6.2 
Social -0.5 -0.02 0.494 0.96 -0.013 0.97 -78.9 
Function 
Role -3.0 -0.07 0.482 0.88 -0.036 0.93 -27.5 
Emotional 
Mental -5.5 -0.28 0.420 0.61 -0.160 0.72 -6.3 
Health 
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Table 5.13: Leg Ulcer Study Generallsed Effect Sizes and NNTs for 
Walks freely vs. Walks with aid groups 
SF-36 
Dimension 
Mean 
diff 5 
ES 
dNormat 
Pr(x > Y) 
PNOether OR0rd,,,, 
ARR 
V 
OR 
of NNTx. 
- 
Physical 35.9 1.45 0.833 1.27 0.666 4.98 1.5 
Function 
Role 18.9 0.47 0.623 2.25 0.246 1.65 4.1 
Physical 
Bodily 12.8 0.46 0.629 2.23 0.258 1.69 3.9 
Pain 
General 4.4 0.20 0.564 1.44 0.127 1.29 7.9 
Health 
Vitality 7.6 0.36 0.611 1.99 0.221 1.57 4.5 
Social 13.7 0.46 0.624 2.18 0.247 1.66 4.0 
Function 
Role 6.6 0.16 0.544 1.38 0.088 1.19 11.4 
Emotional 
Mental 1.7 0.08 0.518 1.12 0.037 1.08 27.3 
Health 
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Table 5.14: NAMEIT Study Generalised Effect Sizes and NNTs for Neoral 
vs. Placebo Groups 
SF-36 
Dimension 
Mean 
diff 9 
ES 
ANormal 
Pr(x >w 
Noether ORQ, -d'n. 1 
ARR 
V 
OR 
of NNTv 
Physical 5.1 0.20 0.560 1.44 0.119 1.27 8.4 
Function 
Role 13.1 0.32 0.576 1.67 0.153 1.36 6.5 
Physical 
Bodily 4.3 0.19 0.560 1.45 0.121 1.27 8.3 
Pain 
General 3.2 0.15 0.550 1.36 0.101 1.22 9.9 
Health 
Vitality 3.4 0.17 0.550 1.35 0.099 1.22 10.1 
Social 5.0 0.23 0.570 1.54 0.139 1.32 7.2 
Function 
Role 0.7 0.02 0.506 1.04 0.011 1.02 88.1 
Emotional 
Mental 0.3 0.02 0.501 1.00 0.001 1.00 990.9 
Health I 
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Table 5.15: Sheffield General Population Survey Generallsed Effect Sizes 
and NNTs for Male vs. Female Groups 
SF-36 
Dimension 
Mean 
diff 5 
ES 
AN0, M', 
Pr(x > Y9 
PNOether OROdl,,, 
ARR 
V 
OR 
of NNTI. 
Physical 2.0 0.10 0.548 1.36 0.096 1.21 10.4 
Function 
Role 5.7 0.18 0.544 1.55 0.087 1.19 11.4 
Physical 
Bodily 4.0 0.18 0.553 1.41 0.106 1.24 9.4 
Pain 
General 1.3 0.06 0.518 1.12 0.036 1.08 27.6 
Health 
Vitality 8.5 0.41 0.621 2.10 0.241 1.64 4.1 
Social 5.8 0.29 0.580 1.88 0.160 1.38 6.3 
Function 
Role 7.2 0.22 0.552 1.70 0.104 1.23 9.6 
Emotional 
Mental 8.6 0.46 0.644 2.45 0.288 1.81 3.5 
Health I I 
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Table 5.16: Sheffield General Population Survey Generallsed Effect Sizes 
and NNTs for GP consultation in last 2 weeks vs No GP consultation 
SF-36 
Dimension 
Mean 
diff S 
ES 
JNormaf 
Pr(x > Y) 
PNoether OR0rdn., 
ARR 
v 
OR 
of NNTv 
Physical -6.7 -0.34 0.410 0.55 -0.180 0.70 -5.6 
Function 
Role -21.0 -0.68 0.363 0.30 -0.274 0.57 -3.7 
Physical 
Bodily -14.6 -0.66 0.333 0.33 -0.335 0.50 -3.0 
Pain 
General -10.0 -0.49 0.375 0.45 -0.251 0.60 -4.0 
Health 
Vitality -11.0 -0.53 0.354 0.40 -0.291 0.55 -3.4 
Social -13.1 -0.66 0.345 0.32 -0.310 0.53 -3.2 
Function 
Role -11.1 -0.34 0.423 0.50 -0.154 0.73 -6.5 
Emotional 
Mental -9.0 -0.48 0.370 0.44 -0.261 0.59 -3.8 
Health I 
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Table 5.17: Sheffield General Population Survey Generalised Effect Sizes 
and NNTs for Outpatient Attendence in last 3 months vs. No Attendance 
SF46 
Dimension 
Mean 
diff t$ 
ES 
ANormal 
Pr(x > Y) 
Noether ORording 
ARR 
X! 
OR 
of NNTv 
Physical -13.4 -0.69 0.355 0.37 -0.291 0.55 -3.4 
Function 
Role -21.5 -0.70 0.365 0.30 -0.270 0.57 -3.7 
Physical 
Bodily -18.1 -0.82 0.302 0.26 -0.396 0.43 -2.5 
Pain 
General -13.5 -0.67 0.327 0.33 -0.347 0.48 -2.9 
Health 
Vitality -8.0 -0.38 0.399 0.53 -0.203 0.66 -4.9 
Social -13.6 -0.68 0.363 0.35 -0.274 0.57 -3.7 
Function 
Role -9.1 -0.28 0.451 0.62 -0.098 0.82 -10.2 
Emotional 
Mental -5.7 -0.30 0.432 0.65 -0.136 0.76 -7.3 
Health I - 
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Chapter 6: Comparing the power of various methods of 
sample size estimation via bootstrap simulation for simple 
two group cross-sectional designs 
Introduction 
We have already seen that HRQoL outcome measures may not meet the 
distributional requirements (usually that the data have a Normal distribution) of 
parametric methods of sample size estimation and analysis. Therefore non- 
parametric methods are most often used to analyse HRQoL data. In this 
chapter, we describe a non-parametric bootstrap method for estimating 
sample size and power, when the primary outcome of the study is HRQoL 
measure (which usually have bounded and non-standard distributions). The 
aim of this chapter is to compare the power of various methods of sample size 
estimation (described in Chapter 4) when using HRQoL measures as 
outcomes using bootstrap simulation and to provide pragmatic guidance to 
researchers on what method to use. 
For simplicity in this paper we will assume the SF-36 is being used as the 
primary HRQoL endpoint in a two group comparative clinical study, at a single 
time point, to assess the superiority (not equivalence) of a new treatment over 
a control treatment. 
To illustrate this, we use some HRQoL data from a randomised controlled 
trial, the Community Postnatal Support Worker (CPSW) Study, which aimed to 
compare the difference in health status in a group of women who were offered 
postnatal support (Intervention) from a community midwifery support worker 
compared with a control group of women who were not offered support. The 
primary outcome (used to estimate sample size for this study) was the GH 
dimension of the SF-36 at six weeks postnatally. 
In Chapter 4, we described five methods of sample-size estimation for the SF- 
36 for a simple two group cross-sectional comparison of HRQoL. 
77 
Chapter 6: Comparing the power of various methods 
Method (1) Equation (4.4) assumes the various individual dimensions 
of the SF-36 are continuous and Normally distributed. The 
effect size is ANormal (4.3). 
Method (2) Equation (4.6) assumes the SF-36 dimensions are 
continuous but with no other distributional assumptions. 
The effect size is pN,,,, th., (4.5). 
Method(3) Equations (4.8 or4.10) assumes the HRQoL outcomes 
are measured on binary scale or that the HRQoL 
outcomes can be dichotomised into a binary scale. The 
effect size is ORBi,,,, 3y (4.9). 
Method (4) Equation (4.12) assumes the SF-36 is an ordered 
categorical outcome. The effect size is OROrdinaf(4.111). 
Method (5) Bootstrap approach (random sampling with replacement). 
Figure 6.1g shows the overall distribution of the SF-36 GH dimension in a 
general population sample of women aged 16 to 45 years. The GH dimension 
does not appear to be Normally distributed and appears to be negatively 
skewed, with more people reporting better health in this general population 
sample. 
Method 1: Continuous Normally distributed HRQoL data 
Suppose we have two independent random samples x =(XIP X2v-.., xm) and y 
(yi, Y29 .... Yn) of size m and n respectively. The x's and y's are random 
samples from continuous distributions having cdfs, Fx and Fy respectively. We 
will consider situations where the distributions have the same shape, but the 
locations may differ. Thus if Sdenotes the location difference (i. e. mean (y) - 
mean (x) = 6), then Fy(y) = Fx(y - 8), for every y. We shall focus on the null 
hypothesis Ho: S=0 against the alternative HA: S#0. We can test these 
hypotheses using an appropriate significance test (e. g. MW or t-test). With a 
Normal distribution under the location shift assumption and with n=m, the 
necessary sample size to achieve a certain power is given by (4.4). 
When planning the CPSW study we went through Pocock's (1983) five key 
questions regarding sample size. 
78 
Chapter 6: Comparing the power of various methods 
Figure 6.1: Distribution of the eight SF-36 dimensions in the Sheffield 
population, females aged 16-45 (n = 487) 
R iq vv 5t It vvk, rwws 
SV35 PHYSICAL FUWTONI 
SF 30 SOCIAL FUNCTIONING 
SF, M ROLE4-WYSICAL 
MEN 
SF. 35 ROLE-EMOTIONAL 
SF-36 PAIN INDEX 
SF-38 GENERAL HEALTH PERCEPTIONS SF-38 MENTAL HEALTH INDEX 
.. .1 --. -- 11 . .. ", -1 --.. -- ýo .-- 
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What is the main purpose of the trial? 
To assess whether additional postnatal support by trained Community 
Postnatal Support Workers could have a positive effect on the mother's 
general health. 
What is the principal measure of patient outcome? 
When planning the CPSW study we decided that the primary outcome was 
the SF-36 general health perception (GH) dimension at six weeks postnatally. 
How will the data be analysed to detect a treatment difference? 
We believed that the mean difference in GH scores between the two groups 
was an appropriate comparative summary measure and that a two- 
independent samples Mest or multiple linear regression would be used to 
analyse the data. 
What type of results does one anticipate with standard treatment? 
Unfortunately no information was available from previous studies of new 
mothers to calculate a sample size based on the GH dimension of the SF-36. 
Therefore as the CPSW study was only going to involve women of 
childbearing age we estimated the standard deviation of the GH outcome from 
a previous survey of the Sheffield general population using females aged 16 
to 45 (Figure 6.1g). This gave us an estimated SID of 20. 
How small a treatment difference is it important to detect and with what 
degree of certainty? 
Using the GH dimension of the SF-36, a five-point difference is the smallest 
score change achievable by an individual and considered as "clinically and 
socially relevant" (Ware et al 1993). 
Therefore, using Method 1, assuming a standard deviation a of 20 and a 
location shift or mean difference 6AT - PC) of 5 or more points (i. e. 5= 5) 
between the two groups is clinically and practically relevant gives a 
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standardised effect size, ANormal (from 4.3), of 0.25. This is equivalent to a 
'small' effect using Cohen's (1988) interpretation and is of similar magnitude 
to the effect sizes calculated from the various datasets described in Chapter 
5. Using this standardised effect size, equation (4.4) with a two-sided 5% 
significance level and 80% power gives the estimated number of subjects per 
group, nNormal, as 244. 
Transformations 
If the SF-36 outcome data were continuous but had a skewed distribution they 
may be transformed using a logarithmic transformation. The transformed 
variable may have a more symmetric distribution that is better approximated 
by the Normal form. One problem with transforming data is that some HRQoL 
measures (such as the SF-36 dimensions) are scored on 0 to 100 scales and 
the natural logarithm of zero does not exist. Another difficulty with the use of 
transformations is that they distort HRQoL scales and make interpretation of 
treatment effects difficult (Fayers and Machin, 2000; Walters et al 2001b). 
Unfortunately log-transforming the GH data in Figure 6.1g did not make the 
distribution of the data more symmetric. 
Method 2: Continuous HRQoL data with no distributional assumptions 
If the GH dimension outcome of the SF-36 is assumed to be continuous and 
plausibly not sampled from a Normal distribution then the most popular (not 
necessarily the most efficient) non-parametric test for comparing two 
independent samples is the two-sample Mann-Whitney U test. 
Noether derived a sample size formula for the MW test equation (4.6), using 
an effect size PNoether, (4-5) which is an estimate of the probability that an 
observation drawn at random from population X would exceed an observation 
drawn at random from population Y i. e. (Pr(X > Y)), that makes no 
assumptions about the distribution of the data (except that it is continuous), 
and can be used whenever the sampling distribution of the test statistic U can 
be closely approximated by the Normal distribution, an approximation that is 
usually quite good except for very small n. 
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Thus to determine the sample size, we have to find the 'effect size' PN .. Ith', 
There are several ways of estimating pN,,. th., under various assumptions, one 
non-parametric possibility is PNoether 7- Ulnm. Unfortunately, this can only be 
estimated after we have collected the data and calculated the U statistic or by 
computer simulation (as we shall see later). If we assume that X- N(I. Ix, cr 2 X) 
and Y- N(py, Cy2y) then a parametric estimate of Pr(X > Y) using the sample 
estimates of the mean and variance (ji &x, A,, er, 2) is given by (4.7). /JX 
If we assume the SF-36 is Normally distributed then equation 4.7 allows the 
calculation of two comparable 'effect sizes' Pftefher and ANOnnal thus enabling 
the two methods of sample size estimation (4.4 and 4.6) to be directly 
contrasted. If this SF-36 is not Normally distributed then we cannot use (4.7) 
to calculate comparable effect sizes and must rely on the empirical estimates 
Of PNoether 'ý Ulnm calculated post hoc from the data. Alternatively, under the 
location shift assumption, we can use bootstrap methods to estimate PNoether. 
As before if we assume a mean difference of 5 (i. e. (F=px- A,, =5) and a 
common standard deviation of 20 (i. e. 6, = &x = oy = 20) for the GH 
dimension of the SF-36, then using (4.7) this leads to a parametric estimate of 
the effect size PNoether = Pr(X > Y) of 0.57. Which leads to an estimated ARR, 
AP = 0.57 - 0.43 = 0.14 and an estimated OR 01 = 0.57/0.43 = 1.33. 
Substituting PNoether = 0.57 in (4.6) with a two-sided 5% significance level and 
80% power gives the estimated number of subjects per group, nNon-non,, as 
258. 
Method 1 (nNonnal = 244) gave a slightly smaller sample size estimate than 
Method 2 (nNon-normal = 258). The two methods can be regarded as equivalent 
when the two distributions have the same shape and equal variances. When 
the two distributions are Normally distributed with equal variances, the MW 
test will require about 5% more observations than the two-sample t-test to 
provide the same power against the same alternative (Elashoff, 1999). For 
non-Normal populations, especially those with long tails, the MW test may not 
require as many observations as the two-sample t-test. 
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Table 6.1 shows the estimated samples sizes for the other seven dimensions 
of the SF-36, besides GH, using both Method 1 and Method 2 and with a 
parametric estimate (4.7) of pNoether. The nNon-norma, estimate using Method 2 of 
the required sample size is about 5% greater than the nN,,., estimate 
(Method 1) for all eight dimensions of the SF-36. 
Empirically, calculating a parametric estimate of Pr(X > Y) from the observed 
effect size data (using the observed sample means and standard deviations) 
in Tables 5.1 to 5.7 (of Chapter 5), leads to values very similar to the non- 
parametric estimate (data and calculations not shown). For example for the 
GH dimension in the CPSW data in Table 5.1, the observed non-parametric 
(N-P) estimate of Pr(X > Y) was 0.542 compared to a parametric (P) estimate 
of 0.537. An absolute difference (N-P estimate -P estimate) of 0.005 and a 
relative difference or ratio (P: N-P) of 0.991. 
However, Noether's method is very sensitive to variations in the effect size 
pNoether. From the bootstrap resampling (assuming bounded outcomes and a 
location shift of five points, see below for more details) the mean observed 
effect size estimate from the bootstrap replications was PNoether "ý 0.58, 
compared to 0.57 assuming a Normal distribution and equation (4.7). 
Although only a difference of 0.01, this leads to estimated sample size of 205 
subjects per group when PNoether -ý 0.58 in equation (4.6) with a two-sided 5% 
significance level and 80% compared to 258 when PNoether ý 0.57. 
Method 3: Dichotomous categorical HRQoL data - comparing two 
proportions 
From equations (5.9) and (5.10) once we have an estimate of Pr(X > Y) we 
can calculate two other statistics A and 0 For a binary outcome, from (5.9) .4= 
Pr(X > Y) - Pr(Y > X) is equivalent to the Absolute Risk Difference (ARR), 
which is the inverse of the NNT and from (5.10), O= Pr(X > Y)/Pr(Y > X) is the 
equivalent of the ORBinary. 
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Table 6.1 shows the estimates of 6F (the OR) based on parametric estimates 
of Pr(X > Y) and Pr(Y > X) for the eight dimensions of the SF-36. For the GH 
dimension a parametric estimate of the OR 61 is 1.33. 
If we assume the HRQoL outcomes are measured on a binary categorical 
scale, for example, "good health" and "poor health", or can be dichotomised 
into a binary scale then an appropriate summary measure of the outcome 
data will usually be the sample rate or proportion in the sample with "good" 
HRQoL. When comparing two groups or a single group over time, appropriate 
comparative summary measures may include the difference in rates or 
proportions, the relative risk or the odds ratio. 
We dichotomise the SF-36 dimensions into two categories i. e. those with a 
score of 100 classified as "good health" and those with a score less than 100 
classified as having "less than good health" or "poor health". Table 6.1 shows 
the estimated proportions scoring 100 (P100) or good health in the Control or 
reference group. For the GH dimension the proportion in the control scoring 
100 or reporting "good health" was 7%. 
If we assume a proportion of patients of 0.07 scoring 100 in the control group 
(i. e.; rc = 0.07, Then, for a given OR = OR&nary = 1.33, the anticipated 
proportion (1-. -r) of patients scoring 100 or good health in the treatment T group 
is given by: 
'TT =- 
ORBinary)TC 
ORBinary)TC + (1 - -TC 
1.33 x 0.07 
-=0 09 . (6.2) 
; rT= 
(1.33 x 0.07) + (I - 0.07) 
This is equivalent to a5Binary '= (nT - TEC) *=0.09 - 0.07 = 0.02. Using ORBinary= 
1.33 and ;f= (0.09 + 0.07)/2 = 0.08 in equation (4.10) gives a sample size per 
group of nOR Bin,,, y = 2509 patients. 
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Table 6.1 shows that the noRestimates of sample size are far greater than the 
nNorml and nNon-normal estimates for all eight dimensions of the SF-36. 
Method 4: Ordered categorical (Ordinal) HRQoL data 
If the HRQoL outcomes are measured on an ordinal scale, then the most 
popular (but not necessarily the most efficient) statistical hypothesis test used 
in this instance (to compare two independent groups) is the Mann-Whitney U 
test with allowance for ties or Chi-squared test for trend. 
For sample size estimation for ordinal outcomes, Whitehead (1993) suggested 
an effect size of the log odds ratio OR (0Rodi,. I), which is the odds of a subject 
being in a given category or lower in one group compared with the odds in the 
other group. To estimate the required sample size using Method 4 (equation 
4.12) we must also know or specify the proportion of subjects (; rj) in each 
scale category for one of the groups. Whitehead's method relies on the 
assumption of a constant odds ratio for the data and also assumes a relatively 
small log odds ratio and a large sample size, which will often be the case in 
HRQoL studies where dramatic effects are unlikely (as we have seen in 
Chapter 5). 
If we assume OROrdinal -= ORBinary =-- OR = 1.33 and proportional odds. The 
assumption of proportional odds specifies that the ORordinallwill be the same 
for all 34 categories of the GH dimension. If we also assume the proportion of 
subjects in each category in the control group is the same as in Figure 6.1g. 
Then (4.12) gives the number of subjects per group n for a two-sided 
significance level (x and power 1-P. 
Under the assumption of proportional odds ORordina, = 1.33, the anticipated 
cumulative proportions (, YT) for each category of treatment Tare given by: 
YiT '= 
OROrdinalYIC 
i=I to M. (6.3) OROrdinalYIC + (1 - YIC ) 
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After calculating the cumulative proportions (; 1T), the anticipated proportions 
falling into each treatment category, ; rT can be determined from the 
difference in successive rT. Finally, the combined mean (3F, ) of the 
proportions of treatments C and T for each category is calculated. 
k 
Substituting OROrdinal -= 1.33 and F77:, 3=0.0067 In (4.12) with a two-sided 5% 
significance level and 80% power gives the estimated number of subjects per 
group as 584. 
With a sample size of 584, proportions in each category in the control group 
as shown in Figure 6.1 g and an ORordinal Of 1.33, then the estimated mean GH 
score will be 77.6 in the treatment group compared to an estimated mean GH 
score of 75.0 in the control group. This is an estimated mean difference of 2.6 
points, which is smaller than the five-point mean difference used in (4.4) to 
calculate nNormal. 
Assuming proportions in each category in the control group as shown in 
Figure Mg and proportional odds shift. Then an OROrdinal Of 1.63 and 
k 
3 0.007 with a two-sided 5% significance level and 80% power leads 
to a sample size estimate of 199 subjects per group. With 199 subjects per 
group and proportional odds of 1.63 this leads to estimated sample mean GH 
scores of 74.8 and 79.8 in the control and intervention groups respectively i. e. 
a mean difference of approximately five-points between the groups. 
If the number of categories is large it is difficult to postulate the proportion of 
subjects who would fall in a given category. Whitehead (1993), Campbell et al 
(1985) and Julious et a/ (1997) point out that there is little increase in power 
(and hence saving in the number of subjects recruited) to be gained by 
increasing the number of categories beyond five. Categories that are equally 
likely to occur lead to the greatest efficiency. 
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Table 6.1 shows the estimated sample sizes for the eight dimensions of the 
SF-36 using Methods 1 to 4. The smallest estimates of the required sample 
come from Method 1 (nNormal). All of the effect size estimates for the eight 
dimensions are in the 'small' to 'moderate' range using Cohen's (1988) 
classification and are consistent with the empirical estimates observed In 
Chapter 5 (Tables 5.1 to 5,17). 
Figure 6.2 shows the estimated power curves for the SF-36 GH dimension for 
the four methods for a range of sample sizes. The curves for Method I and 
Method 2 are broadly similar. On the scale shown the curve for the Method 3 
does not even reach the 80% power level and so large sample sizes are 
required (over 2500 subjects per group (see Table 6.11). The GH dimension of 
the SF-36 has over 30 discrete categories (most of which are occupied in the 
control population (Figure 6.1g) so it would seem sensible to regard this scale 
as either ordinal or continuous. Therefore for the bootstrap simulation for the 
GH dimension we will ignore Method 3. 
Method 5: - computer simulation - Bootstrap methods 
Figure 6-1g shows the skewed distribution of the GH dimension and that the 
underlying assumption of Normality of the distribution required for Method 1 
may not be appropriate. Furthermore the, GH dimension is bounded by 0 and 
100. Thus, if a new mother already has a GH score of 100 in the control 
group, then under the intervention no extra improvement can be seen, at least 
not by the GH dimension of the SF-36. Seven percent of women (35/487) in 
the Sheffield data had a GH score of 100 and 14.2% (70/487) had a score of 
95 or more. 
Individual improvements of five points on the GH dimension should 
correspond to a lower difference on average. A mean difference of 5 implies 
an average improvement ascribable to the intervention of only 4.5 on the GH 
scale. 
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Figure 6.2: Power curves for Methods 1 to 4 for estimating sample sizes 
for CPSW study with the SF-36 general health dimension as the primary 
outcome 
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Table 6.1 shows that for other dimensions of the SF-36 the proportion scoring 
100 (P100) in the reference/control group is greater than 50% for four out of the 
eight dimensions (PF, RP, SF and RE). 
Methods 1 and 2 assume the outcome is continuous and the simple location 
shift model is appropriate. Here this would imply that, on a certain scale, the 
difference in effect of the intervention compared to the control is constant or, 
at least that the intervention shifts the distribution of the GH scores under the 
control to the right (or to the left if the intervention is harmful) thereby keeping 
its shape. However, the boundedness of the SF-36 outcomes renders this 
simple location shift assumption questionable, especially if the proportion of 
cases at each bound is high. 
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We used bootstrap methods to compare the power of the Mest and MIN test 
with allowance for ties for detecting a shift in location using the SF-36 GH 
dimension as an outcome. Suppose (as before) we have two independent 
random samples xj, X2, .... xm and YI, Y2v ... sYno from continuous distributions 
having cdf s, Fx and Fy respectively. Again, we will consider situations where 
the distributions have the same shape, but the locations may differ. Thus if dy 
denotes the location difference (i. e. mean (y) - mean (x) = 6), then Fy(y) = Fx(y 
- 6), for every y. We shall focus on the null hypothesis Ho: S= 0 against the 
alternative HA: S# 0. We can test these hypotheses using an appropriate 
significance test (e. g. MIN or Mest), and will let 7c (F, 6, a, n) denote the power 
function of the test. 
The bootstrap strategy is to use pilot data to provide a non-parametric 
estimate P of F and to use a simulation method for finding the power of the 
test associated with any specified sample size n if the data follow the 
estimated distribution functions under the null and alternative hypotheses. If 
we denote the distribution function estimate by 6, under the alternative 
hypothesis . 5, we can estimate the approximate power, ;ý 
(G, S, a, n) by the 
following computer simulation procedure. 
Algorithm 6.1 
Power and samRle size estimation using the bootstrap 
(1) Draw a random sample with replacement of size 2n from P. The first n 
observations in the sample form a simulated sample of x's, denoted by 
xi*,..., Xn*, with estimated cdf P. Then Jis added to each of the other 
n observations in the sample to form the simulated sample of y's, 
denoted by yl*,..., Yn*, with estimated cdf 6*. (The y's and x's have 
been generated from the same distribution except that the distribution 
of the y's is shifted 3units to the right. ) 
.. f (2) The test statistic t(x ,y, Mann-Whitney or t-test) is calculated for the 
x's and y*'s, yielding t(x*, y*). if t(x*, y*) ý: Tl-,, /2, (where Tl-&2is the 
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critical value of the test statistic) a success Is recorded; otherwise a 
failure is recorded. 
(3) Steps 1 and 2 are repeated B times. The estimated power of the test, 
; r(G, c$, a, n), is approximated by the proportion of successes among the 
B repetitions. (In all cases discussed in this paper, B= 10,000). 
The above bootstrap procedure assumes a simple constant location shift 
model. For bounded outcome scores the procedure is in principle the same 
but more imagination is needed to specify the effect of the new treatment in 
comparison with the control treatment. Under the simple location shift model, 
individual improvement of 8 is assumed and this is equal to the improvement 
of the population scale measured by a location parameter. For bounded 
outcome scores we have to assume an effect 8(x) such that x+ 8(x) remains 
in the interval determined by the lower and upper boundary. In the case of the 
SF-36 GH dimension between 0 and 100. One function is to assume a 
constant treatment effect whenever possible Le. 81(x). For 51(x), we assumed 
a constant additional effect of 5 points, until a GH score of 95. Patients with a 
GH score of 95 or more were truncated at 100. This is shown in Figure 6.3. 
Draw a random sample with replacement of size 2n from P. The first n 
observations in the sample form a simulated sample of x's, denoted by 
xl*,..., Xn*. Then 51(x), is added to each of the other n observations in the 
sample to form the simulated sample of y's, denoted by yl*,..., y,, *. The y*'s 
and x*'s have been generated from the same distribution except that the 
distribution of the y*'s is shifted 81(x), units to the right. 
The software Resampling Stats was used for the bootstrapping (Simon, 
2000). Two examples of the Resampling Stats programs for carrying out the 
bootstrapping are listed in Appendix 4. The bootstrap computer simulation 
procedure involved using SF-36 data from a general population survey based 
on 487 women aged 16-74 as the pilot dataset. Figure 6.1g shows the non- 
symmetric distribution of the GH dimension. 
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Figure 6.3: Effect of treatment with bounded outcomes. dl(x) represents 
Figure 6.4 shows the estimated power curves for Methods 1,2,4 and 5 (the 
two bootstrap methods, t and MIN tests) at the 5% two-sided significance level 
for detecting a location shift (mean difference) 5=5 in the SF-36 GH 
dimension using the data from the general population as our pilot sample, for 
sample sizes per group varying from 50 to 600. For these general population 
data a location shift of J= 5 is equivalent to a standardised effect size ANormal 
= 0.25 and a parametric estimate of pNoether = Pr(X > Y) = 0.57. The bootstrap 
methods taking into account the bounded and non-normal distribution of the 
data suggest an observed mean difference d of approximately 4.5 and an 
observed PNoether = Pr(X > Y) = 0.58. (These values are calculated from the 
average observed effect sizes across the bootstrap replications. ) 
The power curve for Method 4 is based on an OROdi,,,, = 1.63 effect size, 
which with 199 subjects per group (the estimated sample size to have an 80% 
chance of detecting this ORordinal effect size as statistically significant at the 
5% two-sided level) and proportions in the control group as in Figure 6.1g 
leads to estimated group means of 75 and 80 points in the control and 
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intervention groups respectively. This Is equivalent to an observed mean 
difference between groups d of approximately five points on the GH scale. 
The GH dimension (Figure 6.1g) of the SF-36 has a large number (> 30) of 
discrete values or categories, most of which are occupied, and the proportion 
of scoring 0 or 100 is low. So the power curves shown In Figure 6.4, do not 
diverge too greatly and thus, the simple location shift hypothesis Is a useful 
working model. 
However, Figure 6.5 shows the estimated power curves for the RIP dimension 
of the SF-36, which can only take one of five discrete values (Figure 6.1c), for 
detecting a location shift (mean difference) 9= 5. For these data a location 
shift of 9=5 is equivalent to a standardised effect size AN ....... I=0.17 and 
PNoether = Pr(X > Y) = 0.55. Since three-quarters of the pilot sample scored 
100, the bootstrap methods under the location shift model, taking into account 
the bounded and non-Normal distribution of the data suggest an observed 
mean difference d of 1.2 and p= Pr(X > Y) = 0.51. So the power curves 
shown in Figure 6.5 diverge greatly and the simple location shift model 
alternative hypothesis may be inappropriate for this outcome. 
Figures 6.6 to 6.11 show the power curves for the other six dimensions of the 
SF-36. Again the curves diverge for four out of six dimensions (BP, PF, SF 
and RE), where the proportions at the upper boundary scoring 100 is more 
than 40%, but are reasonably close for the two other dimensions (V and MH), 
where the proportions scoring 100 are small (less than 1%) 
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Chapter 6: Comparing the power of various methods 
Location and scale changes 
We have considered a simple location shift alternative hypothesis for 
estimating sample sizes for comparing the distributions of two groups of 
HRQoL outcomes xj, X2, -.., x,,, and Y1, Y2v ... PYn, with cdfs Fx and Fy 
respectively. I. e. Ho: F., = Fy vs. the alternative hypothesis HA: Fy ý Fx(y, 5) for 
every y. Here 8 represents a simple location shift between the two 
distributions of HRQoL responses. 
Hilton and Mehta (1993) and Hilton (1996) describe both location shift and 
scale shift parameter changes. In this case the alternative hypothesis is of the 
where 8 denotes the location parameter and T the form, HA: FY = F, 
scale parameter. When the outcomes are continuous we can transform them 
Y-9 directly to specify location and scale changes, i. e. y'= However, when 
the data are categorical, we transform instead the distribution of the data to 
specify location and scale-type alternatives 
Using Hilton's (1996) notation for ordered categorical outcomes, then for 
sample one (the Control group say) then the cumulative probability of 
responding in categories 1 tOi is YJ ý TEI + R2 + ... + 7rj, where njis the proportion 
in the sample with a response in discrete category j. Then, yi-I < -yi, j=1,..., k 
and Yk 'ý 1. For sample two (the Intervention or treatment group) define 7' 
analogously. An infinite number of alternative hypotheses can be defined by n 
= (711,7121 .... 7rj) and 7c' = 
(TC19 71'2, -- ., irj'), the vectors of the proportions in each 
sample responding to category j. Rather than specify the parameters 
arbitrarily, Hilton suggests it is preferable to produce a family of alternatives 
against which power functions can be determined. For ordinal data Hilton and 
Mehta (1993) proposed the use of the proportional odds model of McCullagh 
and Nelder (1989) to specify this alternative hypothesis. So we can now 
express hypotheses for ordinal data in terms of y= (Y19 72,..., yk. j) and of yl = 
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(Y'19 Y'29--. 1 yk-1). The null hypothesis is Ho: yj = yj for all j and an alternative 
hypothesis is HA: y'j ý: yj or yj: 5 yl, for all j, with inequality for at least one J. 
The proportional odds model is: 
logitý; ) = logitýj) -A, j=1,..., k-1, (6.4) 
where 5c (-oo, oo) with A=0 representing the null case. It expresses the 
difference between the two distributions (y and y') in terms of a single 
'location-type' parameter A. Here A is the log odds ratio that compares the two 
samples' odds of responses in categories 1 to j (versus j+1 to k). (It should not 
be confused with the effect size Hilton (1996) extends this model to 
also allow differences in scale: 
logitW = 
logitý, ) -AW, (6.5) 
exp(-r) 
where T c: (-oo, oo) with A=0 andr =0 under Ho. 
Hilton (1996) shows how the effects of the scale and location parameters 'r 
and A can be illustrated graphically by plotting the cumulative distribution 
functions of 7 and y' respectively. Figure 6.12 shows three cumulative 
probability distributions for the five category SF-36 RIP dimension, the 
reference population is the cumulative distribution for females aged 1645 
from the Sheffield population with 7c = (0.06,0.05,0.06,0.08,0.75) and X= 
(0.6,0.11,0.17,0.25,1.0). The two other curves represent the effect of a 
location shift alone (yll), with an odds ratio of 1.5 (or log odds ratio A=0.41) 
and both a scale and location shift (y2) with scale and location parameters of 
A=0.41 andc = 0.9 respectively. 
In the case of scale changes, r tends to make y' cross y, so that neither yj ý: yj 
for all j nor 7j: 5 yj for all j holds (Hilton, 1996). So in the presence of both scale 
and location shift changes the cumulative probability distribution function 
curves will tend to cross. Figure 6.12 illustrates that this is not always the case 
and that it is difficult to distinguish location changes from scale and location 
effects combined. 
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Figure 6.12: Three cumulative distribution functions for the SF-36 Role 
Physical dimension under reference (y), and location (71) and scale and 
location changes (y2) 
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Hilton (1996) also compared the power of three tests, the Mann-Whitney 
statistic, O'Brien's generalised Wilcoxon statistic (O'Brien, 1988) and the 
omnibus Smirnov statistic (Smirnov, 1939) for two sample studies with ordinal 
responses. Hilton found that when location shifts alone were present, the MW 
test had the greatest power of the three tests. As the influence of the scale 
parameter grew relative to the location parameter, so did the power of the 
Smimov and O'Brien test until they exceeded the power of the MIN test. 
The difference in distributions between groups with HRQoL outcomes may 
result from a location shift alone or to a combination of location and scale 
changes. Figure 6.13 which compares the outcomes for the Intervention and 
Control group mothers from the CPSW study suggests that the difference in 
HRQoL is predominately a shift in location. 
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Figure 6.13: Cumulative distribution function graphs for the eight 
dimensions of the SF-36 for the Control and Intervention Groups 
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at the upper bound (i. e. scoring 100) is high (e. g. PF, SF and BP dimensions 
in our general population sample example dataset, Figures 6.1a, 6.1d and 
6.1 e), then we would recommend using Whitehead's Method 4 to estimate the 
required sample size. In this case the alternative hypothesis of a simple 
location shift model is questionable and the proportional odds model may 
provide a suitable alternative with such bounded discrete outcomes (Figures 
6.4,6.5 and 6.6), although with larger numbers of ordinal categories it Is less 
likely for the proportional odds assumption to hold. 
If the HRQoL outcome has a larger number of discrete values (greater than or 
equal to seven categories), most of which are occupied and the proportion of 
cases at the upper or bounds (i. e. scoring 0 or 100, in the case of the SF-36) 
is low (e. g. MH, VT and GH dimensions in our general population sample 
example dataset, Figures 6.1e, 6.1f and 6.1h), then the simple location shift 
model appears to be a useful working hypothesis. We would therefore 
recommend using Methods (1) or (2) to estimate the required sample size. 
Computer simulation (Figure 6.7) has suggested that if the distributions of the 
HRQoL dimensions are reasonably symmetrical, and the proportion of 
patients at each bound is low, then under the simple location shift alternative 
hypothesis, the power curves for the t-test and MIN test tend to coincide and 
the differences in power for a given sample size n are small. Therefore if the 
distribution of the HRQoL outcomes is symmetrical or expected to be 
reasonably symmetric and the proportion of patients at the upper or lower 
bounds is low then pragmatically Method 1 could be used for sample size 
calculations and analysis. The use of parametric methods for analysis (i. e. t- 
test) also enables the relatively easy estimation of confidence intervals, which 
is regarded as good statistical practice. 
If the distribution of the HRQoL outcome is expected to be skewed then the 
MIN test appears to be more powerful at detecting a location shift (difference 
in means) than the t-test. So in these circumstances the MIN test is preferable 
to the t-test and Method 2 could be used for sample size calculations and 
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analysis. However, using Method 2 for sample size estimation requires the 
effect size to be defined in terms of Pr(X > Y), which is difficult to quantify and 
interpret. 
If the HRQoL data have a symmetric distribution the mean and median will 
tend to coincide so either measure is a suitable summary measure of location. 
If the HRQoL data have an asymmetric distribution, then conventional 
statistical advice would suggest that the median is the preferred summary 
statistic (Altman, 2000). However, a case when the mean and mean 
difference might be preferred (even for skewed outcome data) as a summary 
measure is when heath care providers are deciding whether to offer a new 
treatment or not to its population. The mean (along with the sample size) 
provides information about the total benefit (and total cost) from treating all 
patients, which is needed as the basis for health care policy decisions 
(Thomson and Barber, 2000). We cannot estimate the total benefit (or cost) 
from the sample median. 
If the sample size is "sufficiently large" then the CLT guarantees that the 
sample means will be approximately Normally distributed (Hogg and Tanis, 
1988). So, if the investigator is planning a large study (which is likely to be the 
case with HRQoL outcomes, where large effects are unlikely) and the sample 
mean is an appropriate summary measure of the HRQoL outcome, 
pragmatically there is no need to worry about the distribution of the HRQoL 
outcome and we can use equation (4.4) to calculate sample sizes. Strictly 
speaking, the Normal distribution is only the limiting form of the sampling 
distribution of the sample mean as the sample size n increases to infinity, it 
provides a remarkably good approximation to the sampling distribution even 
when n is small and the distribution of the data is far from Normal. Generally, 
if n is greater than 25, these approximations will be good. 
If a reliable pilot or historical dataset of HRQoL data is readily available (to 
estimate the shape of the distribution) then bootstrap simulation (Method 5) 
will provide a more accurate and reliable sample size estimate than Methods 
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I to 4, as it allows us to check the sensitivity of various assumptions including 
the treatment effect. 
Use of the bootstrap and other Issues 
Bootstrap simulation has illustrated that under the simple location shift 
assumption with bounded outcome scores (like the SF-36) then conventional 
methods of sample size determination (Methods 1 and 2) can underestimate 
the required sample size (or power). This is because the observed mean 
difference d between the groups is likely to be less than the hypothesised 
mean difference 5, as is the observed pNoeiher, due to the bounded nature of 
the outcome variables. 
Thus with bounded HRQoL outcome scores the simple location shift 
alternative hypothesis becomes increasingly questionable, particularly when 
the proportion of patients at the upper (or lower) bound of the HRQoL 
outcome is large. A useful alternative to the location shift model, especially for 
HRQoL outcomes which tend to have a limited number of discrete values is 
the proportional odds model. 
The bootstrap power and sample size method can easily be extended to apply 
to other models and statistical tests. The extension is accomplished by using 
the desired test statistic and critical value in place of T and T,, in step 2 of the 
Algorithm 6.1 described under Method 5. The bootstrap method has a 
straightforward extension to studies with three or more groups, in which for 
example, it could be used to estimate the sample size for a one-way ANOVA 
or Kruskal-Wallis test. 
One can also use bootstrapping to create an adaptive non-parametric test. 
That is to produce an algorithm for selecting a powerful test procedure and 
associated sample size to use for the main experiment. For example, one 
could estimate the power curve for several alternative test statistics and base 
the sample size calculations on the test statistic having the largest estimated 
power. 
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The bootstrap sample size estimator of this chapter was applied in the 
situation in which the alternative to the null hypothesis was a simple location 
shift. The bootstrap method, can however, be adapted to alternative 
hypotheses other than a location shift (such as an odds ratio transformation). 
For example, consider the alternative Fy = Fvx for some v ý: 1. Then the power 
and the required sample size are functions of v instead of 8. In this situation, 
one could alter step 1 of the simulation procedure in Algorithm 6.1 as follows: 
Draw a random sample with replacement of n x*'s, from Gx; then draw a 
sample of n y*'s, from Gvx. 
When using the proportional odds model to estimate sample size, Whitehead 
(1993) and Julious et al (1997) have pointed out that there is little increase in 
power (and hence saving in the number of subjects recruited) to be gained by 
increasing the number of categories beyond five. Although the model is robust 
to mild departures from the assumption of proportional odds, with increasing 
numbers of categories it is less likely that the proportional odds assumption 
remains true. Therefore we shall use the four and five discrete category 
outcomes respectively of the RE and RP dimensions of the SF-36 to illustrate 
the effect of the bootstrap sample size estimator when the alternative to the 
null hypothesis is an odds ratio transformation. 
Figures 6.14 and 6.15 show the power curves for Mest and MIN test for the 
RP and RE dimensions of the SF-36 assuming the alternative hypothesis is 
proportional odds shift in HRQoL of OROdi,,, = 1.50. Ordinal regression is 
equivalent to the MIN test when there is only on independent 0/1 variable in 
the regression (Campbell, 2001). Although the advantage of ordinal 
regression over non-parametric methods is that we get an efficient estimate of 
a regression coefficient and we can extend the analysis to allow for other 
confounding variables. 
As one would expect the bootstrap power curves in Figures 6.14 and 6.15 
show that the MIN test or the equivalent proportional odds model is more 
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powerful than the Rest when the alternative hypothesis is an odds ratio shift, 
although the differences in power for a given sample size are small. 
Figure 6.14 Estimated power curves for the SF-36 Role Emotional 
dimension to detect an Odds Ratio shift using general population data 
(females aged 16-45) 
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Sample sizes of over 450 patients per group are required to have an 80% 
chance of detecting this 'small to moderate' odds ratio (OR = 1.5) effect as 
statistically significant at the 5% two-sided level. With such 'large' sample 
sizes then the CLT guarantees that the sample means will be approximately 
Normally distributed. Thus, ensuring the relatively good performance of the t- 
test in detecting an OR style location shift. The robustness of the two 
independent samples Mest when applied to three-, four- and five-point ordinal 
scaled data has previously been demonstrated by Heeren and D'Agostino 
(1987) for far smaller sample sizes than this (as small as 20 per group). 
The simulation results show that sample choice with HRQoL outcomes is far 
from an exact science. In practice one could use the bootstrap determined 
sample size as a suggestion and then taking account of the uncertainty, adjust 
the bootstrap sample size up or down as dictated by the circumstances of the 
experiment at hand. 
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Figure 6.15: Estimated power curves for the SF-36 Role Physical 
dimension to detect an Odds Ratio shift using general population data 
(females aged 16-45) 
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Longitudinal comparisons 
In this chapter and Chapter 4 we have described sample size calculations for 
simple cross-sectional study designs. Many studies are longitudinal and as 
with cross-sectional studies, investigators need to know in advance the 
number of subjects approximately required to achieve a specified power. 
Diggle et a/ (2002) give sample size formulae for longitudinal studies for 
comparing two groups for continuous and binary responses. Frison and 
Pocock (1992) also provide sample size formulae for comparing two groups 
with continuous outcomes in clinical trials with pre-treatment (before) and 
post-treatment (after) repeated measurements. A recent paper by Strickland 
and Lu (2003) describes power and sample size calculations for two-sample 
ordinal outcomes under before and after study designs. 
For estimating sample sizes for longitudinal studies, compared with cross- 
sectional study designs the following additional quantities are needed, the 
number of repeated observations per person and the correlation among the 
repeated observations, p. As with the between subject measurement 
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variance, a2, the correlation p can sometimes be estimated from either pilot 
studies or similar studies previously reported in the literature. When this is not 
possible (as is frequently the case), the statistician must make a reasonable 
guess at its value. 
Pragmatically, with longitudinal designs one could choose one time point as 
the most important and estimate a sample size using formulas for Methods 1 
to 4 for cross sectional designs. Thus, we could base the sample size 
calculation on a simple cross-sectional comparison (of means say), but use 
statistical methods for analysing longitudinal data such as relatively simple 
ANCOVA methods (Frison and Pocock, 1992) or more complex models for 
longitudinal data (Hand and Crowder, 1996; Diggle et al 2002). When the 
sample size for a longitudinal study is based on a simple cross-sectional 
comparison, considerably more patients than necessary may be recruited 
(Phillips and Campbell, 1997), subsequently, possibly increasing the cost and 
completion time of the study. 
However, this over estimation of the required sample size for longitudinal 
studies is less likely to be a problem with HRQoL outcomes. This is because 
large or dramatic differences in HRQoL between groups are unlikely (see the 
small to moderate effect sizes shown in Chapter 5). Therefore, larger sample 
sizes will be required to detect clinically meaningful differences in HRQoL (as 
we have seen earlier on in this chapter). Secondly, missing HRQoL 
assessment data may also be a problem (Fayers and Machin, 2000). So the 
required sample size may need to be inflated anyway to take into account 
patients who drop out completely or who do not complete the HRQoL 
assessments. 
Clinically meaningful effect sizes 
More work is required on what is a clinically meaningful effect size for the SF- 
36 and other HRQoL outcomes. To illustrate the various methods of sample 
size calculation we assumed a mean difference 8 of 5.0 in SF-36 scores was 
the MCID worth detecting. 
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There maybe considerable uncertainties in estimates of such quantities as the 
standard deviation and the treatment effect. Sample size calculations are 
sometimes based on estimates "pulled out of thin air". If an investigator is 
uncomfortable with the assumptions then it is good practice to calculate 
sample sizes under a variety of scenarios so that the sensitivity to 
assumptions can be assessed. We would recommend that various anticipated 
benefits be considered, ranging from the optimistic to the more realistic, with 
sample sizes being calculated for several scenarios within that range. It is a 
matter of judgement, rather than an exact science, as to which of the options 
is chosen for the final study size (Fayers and Machin, 2000; Walters et al 
2001 b). 
In this chapter we have concentrated on the issue that HRQoL outcome data 
(such as the SF-36) may not meet the distributional requirements of 
parametric methods of sample size estimation and statistical analysis. There 
are other equally important problems with HRQoL measures such as ordinal 
scaling, linearity of the scale, floor/ceiling effects, non-constant variance and 
missing data which are discussed more fully in Walters et al 2001 a; 2001 b. 
Conclusions 
Given that the end goal of using HRQoL outcomes in research studies is to 
assess a patient's health and well being, using the right type of HRQoL 
outcome in the right setting with an appropriate sample size calculation is 
crucial. 
If the HRQoL outcome has a limited number of discrete ordered values (less 
than seven categories) and/or the proportion of cases at either of the bounds 
is high, then we would recommend using Whitehead's (1993) Method 4 to 
estimate the required sample size. In this case the alternative hypothesis of a 
simple location shift model is questionable and the proportional odds model 
may provide a suitable alternative with such bounded discrete outcomes. 
Method 4 is particularly appealing if interest lies in comparing the relative 
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frequencies or cumulative probabilities in the ordered categories between 
treatment groups. 
If the number of categories is large it is difficult to postulate the proportion of 
subjects who would fall into a given category. Even if there is little prior 
knowledge of the full distribution of scores for the HRQoL outcome, sample 
size calculation may not be too problematical. Using the ordinal approach to 
sample size calculation, knowledge of the anticipated distribution within four or 
five broad categories is usually sufficient to determine the required number of 
subjects (Whitehead, 1993; Julious et al 1997). 
If the HRQoL outcome has a larger number of discrete values (greater than or 
equal to seven categories say), most of which are occupied and the proportion 
of cases at the upper or bounds are low, the simple location shift model is a 
useful working alternative hypothesis. This implies our interest lies in the 
comparison of means of the outcome variable between the two treatments. I 
would therefore recommend using Methods (1) or (2) to estimate the required 
sample size. If the distribution of the HRQoL outcome is expected to be 
reasonably symmetric then Method 1 is more appropriate for sample size 
calculations. If the distribution of the HRQoL outcome is expected to be 
skewed then the MIN test appears to be more powerful at detecting a location 
shift (difference in means) than the t-test. So in these circumstances the MW 
test is preferable to the t-test and Method 2 could be used for sample size 
calculations and analysis, although pragmatically we would recommend 
Method 1 as the effect size ANormal is rather easier to quantify and interpret 
than the effect size PNoether required for sample size estimation using Method 
2. If a reliable pilot or historical dataset is readily available (to estimate the 
shape of the distribution) then bootstrap simulation (Method 5) may provide a 
more accurate and reliable sample size estimate than Methods 1 to 4. 
We had a reliable historical data set of over 400 subjects so we had a large 
sample to estimate the cdfs F, and Fy under the null and alternative 
hypotheses using Method 5. Lesaffre et a/ (1993) show that bootstrap can 
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give fairly unbiased estimates of power, though for small pilot samples with 
large variability. In the absence of a reliable pilot set, bootstrapping is not 
appropriate and conventional methods of sample size estimation or simulation 
models will need to be used. Fortunately with the increasing use of HRQoL 
outcomes in research, historical datasets are becoming more readily 
available. White and Thompson (2003) suggest the estimation of P (and 
hence G) should be derived from a pilot dataset, and that the use of baseline 
data or related data sets (which we have used) is somewhat less satisfactory. 
They suggest a third possibility for estimating F is to use follow-up data 
viewed in a blinded manner, although only when the blinding can 
demonstrably be preserved. 
Strictly speaking our results and conclusions only apply to the SF-36 HRQoL 
outcome measure. Further empirical work is required to see whether or not 
these results hold true for other HRQoL outcomes. However, the SF-36 has 
many features in common with other HRQoL outcomes, such as the NHP and 
QLQ-C30, i. e. multi-dimensional, ordinal or discrete response categories with 
upper and lower bounds, and skewed distributions. Therefore we see no 
theoretical reason why these results and conclusions with the SF-36 may not 
be appropriate for other HRQoL measures. 
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Chapter 7: Analysing HRQoL data (one outcome measurement 
or one outcome and a baseline measurement) using the 
bootstrap 
Introduction 
In Chapters 4 to 6 we discussed the estimation of sample sizes for studies 
with HRQoL outcomes. Once we have carried out the study and collected the 
data we will then need to analyse the HRQoL outcomes. So how should 
investigators analyse HRQoL data? Conventional methods of analysis of 
HRQoL outcomes are extensively discussed in Fayers and Machin (2000) and 
Fairclough (2002). However, neither of these texts used the bootstrap to 
analyse HRQoL outcomes. Therefore in this chapter and the next we will 
concentrate on comparing and contrasting the bootstrap with standard 
methods of analysing HRQoL outcomes as described in Fayers and Machin 
(2000) and Fairclough (2002). 
In this chapter we will concentrate on the analysis of HRQoL data collected 
from simple cross-sectional designs or studies with two HRQoL assessments 
(baseline and follow-up). The subsequent chapter will look at more complex 
longitudinal studies where HRQoL outcomes are collected at three or more 
time points. 
We will apply conventional and bootstrap methods to the data from the CPSW 
study and the OA Knee study. The CPSW study was a two group RCT, but it 
was unusual since no baseline HRQoL assessment was made. It was felt that 
it was inappropriate to assess HRQoL just prior to or immediately after 
childbirth. We will use this data set to illustrate various methods for two group 
cross-sectional comparisons of HRQoL ranging from a simple comparison of 
mean scores (using conventional and bootstrap hypothesis tests) through to 
more complex regression analyses including ordinal regression. 
The OA Knee study involved the collection of HRQoL data at two time-points 
(baseline and follow-up) six months apart. Since there was a difference in the 
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baseline HRQoL and socio-demographic characteristics (age and gender) of 
the Rheumatology clinic and TKIR surgery groups, we use this dataset to 
illustrate multiple regression/ANCOVA methods with follow-up HRQoL as the 
outcome variable and baseline HRQoL, age, gender and group as covariates. 
We will compare conventional OLS estimates of SE and Cl for the group 
regression coefficient with their bootstrap counterparts. 
Analysis of CPSW data 
Figures 7.1 and 7.2 show the histograms of the SF-36 dimension scores at six 
weeks post-natally for Intervention and Control groups. The graphs clearly 
show the skewed and discrete nature of the outcome data for the SF-36 from 
this study. 
Suppose the HRQoL measure has a large number of ordered categories, 
most of which should be occupied if the underlying scale really is continuous, 
but the scale is measured imperfectly by an instrument with a limited number 
of discrete values. It is often worth treating this discrete scale as if it were 
continuous. An informal rule of thumb (Walters et al 2001a) is that this 
discrete scale should be treated as continuous if it has seven or more 
categories and as ordinal otherwise. So for example with the eight dimensions 
of the SF-36 six out of eight have more than seven discrete categories and 
only two i. e. the RP and RE scales have less than seven discrete categories. 
Walters' et al (2001 a) base this informal rule of thumb on Whitehead's (1993) 
sample size formula for ordinal data. Whitehead illustrates the dependence of 
sample size n on the number of categories c. It is assumed that all categories 
are equally probable (W, = jF2 = ... h: kfor all c). 
It follows from (7.1) that the 
sample size (denoted by n(c)) required when there are c equally probably 
categories, keeping OR, a and P constant, is, 
n(c) = 
0.75 
2 n(2). I-1/c 
In the limit as c --o oo, n(c)-4 0.75n. 
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Figure 7.1: Distribution SF-36 dimensions from CPSW data by group 
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Figure 7.2: Distribution SF-36 dimensions from CPSW data by group 
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The limiting case is approached in large samples in which a full ranking of 
patient outcomes is achieved. A full ranking is equivalent to a categonsation 
with one patient in each category. So for continuous data the sample size 
using equation (4.12) tends to be 75% of the binary outcome case. Equation 
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(7.1) says that little is gained by using more than five categories, as the 
hypothesis test will be (0.75/0.78) x 100 = 96% efficient relative to the use of a 
full ranking. When the data truly are Normally distributed with equal variances 
the Mann-Whitney test for untied data is 96% efficient relative to the t-test 
(Armitage et al 2002). Thus with five equally probable categories the test is 
92% efficient relative to the t-test, when the data are truly Normally distributed. 
These relative efficiencies are all asymptotic, and are only valid for moderate 
to large sample sizes, so it is reasonable to require more than five categories 
in the assumption. Note that occasionally it will be obvious that the 
assumption of a continuous scale does not hold, such as when one of the 
categories is death. 
Heeren and DAgostino (1987) demonstrated the robustness of the two- 
independent samples Mest when applied to ordinal data (with three, four or 
five categories) and samples of size 20 or less, although they assumed the 
scales were equally spaced and cautioned on generalising the results to 
scales with more than five values. However, the CLT is likely to ensure the 
robustness of the Mest if the sample size is large and there are seven or more 
occupied categories. 
Comparing two independent groups - Ordinal HRQoL measures (with <7 
categories) 
If the HRQoL outcomes are measured on an ordinal scale, with less than 
seven categories, then the statistical hypothesis test used in this instance (to 
compare two independent groups) is the Mann-Whitney U test with allowance 
for ties or Chi-squared test for trend. In general the MIN test gives very similar 
p-values to the Chi-squared test for trend (Altman, 1991). The difficulty with 
this method is that it does not allow covariates, and does not provide 
estimates of population parameters. 
The simplest approach to analysing ordinal data is to dichotomise the data 
and use logistic regression. However this method ignores useful information in 
the data, may not be very powerful (Armstrong and Sloan, 1989) and 
introduces the problem of where to choose the cut point. If one were to keep 
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the ordinal structure then there are number of models possible (Ananth and 
Kleinbaum, 1997; Manor et al 2000; Walters et al 2001a; Lall et al 2002). 
These include proportional odds, continuation ratio, polytomous and 
stereotype. We will illustrate these various models using the CPSW data and 
the five category RP dimension of the SF-36. Table 7.1 shows the frequency 
distribution of the RP dimension at six weeks postnatally for new mothers in 
the Control and Intervention groups respectively. Table 7.1 also summarises 
three potential confounding variables or covariates, age at delivery, parity and 
type of delivery. 
Proportional odds or cumulative logit model 
The proportional odds or cumulative logit model is based on the cumulative 
response probabilities rather than the category probabilities (McCullagh and 
Nelder, 1989). 
For example consider an HRQoL outcome variable Y with c categorical 
outcomes YI denoted by i=1,..., c and let p be a set of covariates (xi, X2, ... Xp)- 
The cumulative logit or proportional odds model is 
y, = Pr(Y., 5 YIjXI, X2I ... I Xp 
exp(a, + . 
81x, + 
J82X2 
+-+ 
JflpXP 
)i 
c-1. (7.2) 
+ 
*81XI 
+ 
*82X2 
+* -+ 
8pXp) 
This can be expressed equivalently in logit (yj) form as 
Yi Pr(Y: 5 y, x,,..., logit (r, log log 
Xp 
ai + AXI + AX2 ++ flpXp 
11-Y11 
=[ Pr (Y > y, Ix,,.. -, xp 
i= 1'..., C-l, (7.3) 
where 7i = Pr(Y :5 yi I xi, x2,..., xp ) is the cumulative probability of being in 
category i or lower given the set of covariates (note that for i=c; Pr(Y: 5 yi I xi, 
x2,..., xp) = 1). The a, (i = 1,..., c-1) and ý6p) parameters are treated 
as unknown and the intercept parameters (xi must satisfy the condition (xi -5 CC2 
:5... :! ý ctc-1 (McCullagh and Nelder, 1989). The regression coefficient flP for a 
binary explanatory variable xp (e. g. Control or Intervention group) is the log- 
odds ratios for the Y by xp association controlling for the other covariates in 
the model. That is the treatment effect on HRQoL after adjusting for 
prognostic factors such as age, parity and type of delivery. 
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Table 7.1: Descriptive statistics for SF-36 Role Physical Dimension at 6 
weeks for Control and Intervention group mothers from the CPSW trial 
N=241 
N 
Control 
Cumulative 
% 
n=254 
n 
Intervention 
Cumulative 
C/JO YO 
Odds 
Ratio 
Int/Con 
RP Score 
0.0 35 (14.5) 14.5 45 (17.7) 17.7 0.79 
25.0 19 (7.9) 2Z4 27 (10.6) 28.3 0.73 
50.0 15 (6.2) 28.6 34 (13.4) 41.7 0.56 
75.0 21 (8.7) 37.3 25 (9.8) 51.6 0.56 
100.0 151 (62.7) 100.0 123 (48.4) 100.0 
Total 241 100.0 254 100.0 
Mean 74.3 65.2 
SD 38.1 39.5 
Median 100.0 75.0 
25th percentile 50.0 25.0 
75th percentile 100.0 100.0 
Age (years) 
Mean 28.1 28.0 
SD 5.6 5.7 
ER ft N N n N 
First child 119 (49.4) 133 (52.4) 
Second or 
more 122 (50.6) 121 (47.6) 
Normal 
Delive 
No 76 (31.5) 81 (31.9) 
Yes 165 (68.5) 173 (68.1) 
The {fl,,, flp) regression parameters do not depend on the category 1, so 
that the model (7.3) assumes that the relationship between each of the 
covariates and Y (HRQoL) is independent of i (the response category). This 
assumption of identical log-odds ratios across the c categories is the 
proportional odds assumption. 
The proportional odds model is useful when one believes HRQoL is a 
continuum, which is measured imperfectly by an instrument with a limited 
number of values. The proportional odds model is invariant when the codes 
for the response Y are reversed (i. e. yj recoded as yct Y2 recoded as yc., and 
123 
Chapter 7: Cross-sectional analysis of HRQoL data 
so on). Also the proportional odds model is invariant under the collapsibility of 
adjacent categories of the ordinal response implying that when yJ and Y2 are 
combined, the estimate of the odds ratio remains essentially the same as the 
odds ratios obtained for the individual categories (Greenland, 1994). 
Continuation ratio modeL 
An alternative method to the proportional odds model is the Continuation ratio 
modeL This may be relevant when an ordinal HRQoL scale may be thought of 
as a progression through various stages, so that people start with 'excellent' 
and deteriorate to 'poor' and are unlikely to reverse this trend. The cumulative 
probabilities yj = Pr(Y :! ý yj Ixi, x2,..., xp ) of being in category i or lower in the 
cumulative logit model (7.3) are replaced by the probability of being in 
category i [i. e. 7c, = Pr(Y = yi)] divided by the probability of being in a category 
higher than i [i. e. Pr(Y > yi)] for the continuation ratio model. 
Pr(Y = y, lx,,..., xp)- logit log log- . =a, +()61X, +fl2X2+'. +, 8p'% 
Pr(Y > 7, llx,,..., xp) 
i C- 1. (7.4) 
When the 'logit' expansion is replaced by the 'complementary log-log' link 
function in model (7.4), the resulting model (7.5) is 
log log 'T' 
)] 
= a, 6i= (7.5) 
I- 
I -yj 
+ (flIXI + fl2X2 +'** +j 
pXp) 
which is the Cox proportional-hazards model for survival data in discrete time. 
The continuation ratio model is not invariant under the collapsing or reversal 
of categories. The continuation ratio model is best suited to circumstances 
where the individual categories of the HRQoL scale are of interest and a 
monotonic progression through the individual categories is expected. 
Armstrong and Sloan (1989) have given a useful comparison of the 
proportional odds and continuation ratio models. 
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Chi-squared Q 2) score tests are available for tests of the proportional odds 
assumption but these lack power (Brant, 1990; Peterson and Harrell, 1990). 
Also the model is robust to mild departures from the assumption of 
proportional odds. A crude test would be to examine the odds ratios and if 
they are all greater than unity, or all less than unity, then a proportional odds 
model will suffice (Walters et a/ 2001 a), although with increasing numbers of 
categories it is less likely that proportional odds assumption remains true. 
The ordinal regression method also allows us to adjust the treatment effect for 
other prognostic factors and covariates (such as centre, sex and age). The 
regression coefficients and their standard errors also enable confidence 
intervals to be calculated. The statistical packages SPSS, SAS and sTATA 
have procedures for fitting proportional odds or continuation ratio models. 
Stereotype logistic model 
For the cumulative logit model (7.3), the HRQoL outcome variable Y is 
assumed to have an unobserved underlying variable (say Z), which takes on a 
continuous form. For example, 'Ago' may be represented by ordered 
categories, which take on the form 'young', 'Middle-aged, 'olcf and 'very o/cf. 
In this case, there is an underlying variable, calendar age. 
HRQoL scales are sometimes constructed in such a way that there is no 
underlying variable that directly links to the ordered y-response categories. 
(Although as mentioned in the Introduction this is one of my key assumptions, 
that there actually is an underlying latent continuous HRQoL variable. ) For 
instance when assessing 'pain' one may use a rating scale of the form 'none', 
'mild', 'moderate' and 'severe'. Here pain is rated depending on other factors 
such as its severity and type of pain. Although the rating scale is in principle 
ordered, there may be no underlying variable (continuous or otherwise) that 
directly relates the factors and links these up with the categories on the scale. 
Anderson (1984) recognised these types of ordered categories as being truly 
discrete and referred to the response as a judged or assessed variable. As 
the cumulative logit model would be inappropriate for analysing such 
variables, Anderson introduced another model known as the stereotype 
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model. One of the main advantages of the stereotype model over other 
regression models is that it does not assume a priori ordering of the y- 
response categories. 
The stereotype model is based on the polytomous regression model 
(Anderson, 1984), which does not impose any restrictions on the ordering of 
the categories. The ordinality is in-built into it by imposing a structure on the 
regression coefficients. Consider an HRQoL outcome variable Y with c 
ordered categorical outcomes yj denoted by i=1,2,..., c, and let xi, X2, .... XP 
denote a set of p covariates. The ordinary polytomous regression model can 
be written as 
Pr(Y = yj I XI 9 X2 1-4 xp)= , 
exp (ai + 8,, x, + 812 X2 + **' + Ap XP (7.6) 
exp (a, + 6,, x, + A2 X2 + "' + 181P XP 
where a. =0 and flck =0 (k = 1,..., p) to assure identiflability. The log- 
probability ratios are formed for model (7.6) by comparing each response 
category (yi) with a reference category (yc). The choice of the reference 
category is arbitrary but we shall use the first category. Thus, the log- 
probability ratio can be represented by a linear model of the form 
log 
- Pr(Y = y, 
Ix, 
, x,,..., xP) ai + AIXI +A2X2 + *- + 
fllpXp i=2 to c. (7.7). 
-Prýy 
= YI 
IXI 
9 X21 .... xp)- 
The regression coefficient 4p for the e covariate xp corresponds to the log- 
probability ratio comparing (Y = yj) versus (Y = yi) for a unit increase in xp. 
From model (7.7) it is clear that the ordinal nature is not accounted for in any 
way. The ordinality can be built into this model by imposing a structure on the 
regression coefficients 4. k (k = 1,..., p). Anderson (1984) proposed modelling 
the regression coefficients, 4. k, by imposing the relationship 
ý6jk = 0j, 6" i=Z..., c; k=1,..., p, (7.8) 
where 6k is a list of new parameters and the & can be thought of as the 
scores attached to the response yi. Note that since 61k 'ý 0, we have 01 = 0. 
and a further constraint, 0: =1 (in order to uniquely identify the parameters 
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when using estimated scores). Substituting (7.8) into (7.7) yields the 
stereotype model 
log- 
Pr(Y = YIIXIIIX29***, Xp 
]=a, 
+ 01(gi XI + AX2 +-+ J8pXp) 
i=2 to C. (7.9) 
P rTY = Y1 
IXI 
I X2 9'.., x 
Thus, it can be seen that the stereotype model determines a set of 
parameters {VVs) for the dependent variable and a single parameter A for 
each covariate. The ýs are decided upon for the response variable and are 
directly tied up with the effect of the explanatory variables. Thus, with a 
positive A, when the log probability ratios {OXsl form a decreasing trend, the 
0 parameters also become ordered such that: 
Oc, gk 2w 
....... 
0, ßk 2: 0. ßk =0 then 1=0; 2: 01 = 0. 
Here we can say that the effect of the covariates upon the first log probability 
ratio is greater than their effect upon the second and so on, (or the effect is 
the same upon the consecutive log probability ratios), and that provided (7.10) 
holds model (7.9) is an ordered regression model. 
The model fitted does not necessarily require the O's to be ordered; whether 
there is ordering or not is purely determined by the empirical evidence 
provided by the data. Two categories denoted by c, and C2 are 
indistinguishable with respect to the covariates if 0: 1 = Ot2v that is the effect of 
the covariates is the same in the two categories. The product 04 for the pth 
covariate xp corresponds to the log-probability ratio comparing (Y = yi) versus 
(Y = yj) for a unit increase in xp. 
Greenland (1984) argues strongly in favour of the stereotype model when 
there is no underlying continuum that is directly related to the response 
categories, but where each state is assessed. The statistical package sTATA 
has a procedure for performing stereotype regression via constrained 
polytomous logistic regression (Hendrickx, 2000). The stereotype model can 
also be fitted in SAS using PROC CATMOD. Further details of the stereotype 
model when applied to HRQoL outcomes are given in Lail et al 2002 (See 
Appendix 3 for more details). 
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Table 7.2 shows the results of fitting a binary logistic model, cumulative logit 
model, continuation ratio model, polytomous model and stereotype model to 
the RP data with group, delivery and parity as factors and age as a covariate. 
For the logistic model the outcome variable is dichotomised into a score of 
100 "good health" and less than 100 ("less than good health"). The OR of 0.54 
(95% Cl: 0.37 to 0.78) for the binary logistic model implies that the odds of 
new mothers in the Intervention group having 'good' health Is 0.54 times that 
of mothers in the Control group after allowing for age, parity and delivery. That 
is new mothers in the Intervention group are significantly less likely to report 
good health than Control group mothers. 
Similarly the proportional odds model implies that having been randomised to 
the Intervention group carried with it an odds ratio of 0.56 (95% Cl: 0.40 to 
0.80) compared to that of women randomised to the Control group for being in 
a given category or below (i. e. better HRQoL) after allowing for age, parity and 
delivery. As the proportional odds model assumes a constant OR for all 
categories, Table 7.1 and Figure 7.3 show how the four (c - 1) observed ORs 
compare with the estimated common OR of 0.56 from the model. All observed 
ORs are less than 1 and seem similar to the model estimate. However, a chl- 
squared score test of proportional odds was X2 = 112.1 on 12 df, p=0.0001. 
Thus, there is strong statistical evidence to reject the assumption of 
proportional odds. So the proportional odds model may not be appropriate, 
although the model is robust to mild departures from the assumptions. 
Similarly, the continuation ratio model OR estimate implies that being 
randomised to the Intervention group carried with it an odds ratio of 0.60 (95% 
Cl: 0.44 to 0.80) compared to that of new mothers randomised to the Control 
group for better HRQoL after allowing for age, parity and delivery. 
The polytomous logistic model implies that the probability of having a RP 
score of 25 compared to 0 is 1.04 times the probability for women in the 
Intervention group compared to women in the Control group; the probability of 
having a RP score of 50 as opposed to 0 is 1.64 times the probability for 
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Chapter 7: Cross-sectional analysis of HRQoL data 
women in the Intervention group compared to women in the Control group-, the 
probability of having a RIP score of 75 as opposed to 0 is 0.87 times the 
probability for women in the Intervention group compared to women in the 
Control group and the probability of having a RP score of 100 (as opposed to 
0) is 0.59 times the probability for new mothers in the Intervention group 
compared to new mothers in the Control group. For the last three categories 
the trend in the probability ratios is monotonic as the health status goes from 
the 'poor' stage (i. e. score of 50) through to the better stages (i. e. RP scores 
of 75 or 100). 
Figure 7.3: Observed and proportional odds ratio estimates from the SF- 
36 Role Physical Dimension at six weeks postnatally for Control and 
Intervention group mothers from the CPSW trial 
0.90 
0.80 
0 0.70 
o 0.60 
0.50 
to 
0.40 
0 30 Observed 0 . OR Intervention/Control 
w 0.20 Proportional 
0 OR Intervention/Control 0.10 
0 0.00 
0.0 25.0 50.0 75.0 100.0 
SF-36 RP score/category 
Attaching a set of scores to the beta parameters in the polytomous model, 
leads to the formation of the stereotype model (Table 7.2). The 01's are 
decided upon for the response variable and are directly tied up with the effect 
of the explanatory variables (age, delivery, parity and group). The model does 
not necessarily require the Oj's to be ordered and indeed the empirical 
evidence provided by the data, suggests the 0, 's are not ordered. 
In this model the probability of having an RIP score of 25 compared to a score 
of 0 is 0.70 times the probability for subjects in the Intervention group 
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compared to subjects in the Control group; the probability of having an RP 
score of 50 as opposed to 0 is 0.65 times the probability for subjects in the 
Intervention group compared to subjects in the Control group; the probability 
of having an RP score of 75 as opposed to 0 is 0.71 times the probability for 
subjects in the Intervention group compared to subjects in the Control group 
and the probability of having an RP score of 100 (as opposed to 0) is 0.63 
times the probability for subjects in the Intervention group compared to 
subjects in the Control group. 
Comparing two independent groups - HRQoL scales with more than 
seven categories 
When the HRQoL scale has more than seven categories, it is important to 
check in any particular situation that most of the categories are occupied, to 
rule out having only a few of potentially a large number of categories 
occupied. Where the distribution is spread over a number of categories, then it 
is useful to assume that the data were generated from a continuous 
distribution, especially if there is reason to believe the underlying scale is 
linear. In this case the usual parametric tests such as the Mest or a non- 
parametric test such as the MIN can be used. A further advantage to this 
assumption is that multiple regression can be used to adjust for confounding 
variables such as baseline covariates. 
The proportional odds model is appropriate when interest lies in comparing 
the relative frequencies or cumulative probabilities in the ordered categories 
between groups. As such, a limitation of the non-parametric and proportional 
odds modelling approaches is in their interpretation. If the goal of the analysis 
is to assess the magnitude of the treatment effect on the ordered HRQoL 
outcome, then our interest lies in comparing location between two treatments. 
Therefore a more appealing approach is to assign numeric scores to the 
ordered categories and to use a more familiar linear regression model for 
analysis. It is common for HRQoL outcomes to assign numeric scores to the c 
ordered categories (for example, 0,1,2, (c - 1) (or 0,25,50,75, and 100 in 
the case of the five category SF-36 RP dimension) and to compare means 
between the groups. Furthermore, Heeren and D'Agostino (1987) have 
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demonstrated the robustness of the two-independent samples Mest applied to 
three-, four- and five-point ordinal scaled data when using assigned scores, 
even for sample sizes as small as 20 per group. 
Many HRQoL instruments such as the SF-36, NHP and EORTC QLQ-C30 are 
multi-dimensional with individual dimensions measured on a variety of 
discrete scales with both less than seven categories and seven or more 
categories. Therefore it may be sensible and indeed preferable to use one 
method of analysis such as linear regression for all dimensions of the HRQoL 
instrument, rather than use ordinal regression for some dimensions (with less 
than seven categories) and linear regression for other dimensions (with ý! 7 
categories). 
For the rest of this thesis we are going to assume the underlying latent 
HRQoL variable is continuous but quantification of the outcome is limited to 
ordered categories and that our interest lies in comparing location between 
two treatments or groups. So we will concentrate on statistical methods for 
comparing means such as the Mest and linear regression. 
If we assume the HRQoL data are continuous and approximately Normally 
distributed then Fayers and Machin (2000) suggest an appropriate summary 
statistic is the mean. They go on to suggest that assuming the HRQoL data 
have an approximately Normal form then two treatment groups can be 
compared by calculating the difference between the two respective means by 
a two independent samples t-test. 
Suppose we wish to test the null hypothesis (Ho) that the means from two 
populations (p;, and py), estimated from two independent samples, are equal 
i. e. ([tz = py), against the alternative (HA) that they are different i. e. (Pz # py). 
if sample I has n subjects, with sample mean Y, and sample standard 
deviation sz. Similarly, sample 2 has m subjects, mean j7, standard deviation 
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sy. Then to test the null hypothesis pz = py, when az and ay are unknown but 
equal (aý = cry =a) we take: 
Z-y 
ýn+ 
where sp is a pooled estimate (5.5) of the common standard deviation cr. 
Under the null hypothesis, (7.11) is distributed as Student's t-distribution with 
n+m-2 degrees of freedom. If we assume the two variances are equal then 
the two sample Mest is not only a comparison of means, but also a 
comparison of populations or distributions i. e. a test of F, = Gy. 
The three assumptions for carrying out a two-sample Mest (Campbell and 
Machin, 1999) are 
(1) The data are plausibly Normally distributed. 
(2) The data (or samples) are independent. 
(3) Standard deviations from the two populations are equal. 
As we have seen in Chapter 2, HRQoL data, with their discrete and bounded 
scores are unlikely to be Normally distributed and may not have constant 
variance. Although the importance of the Normality assumption should not be 
overstated, since the method is valid because the sample size is sufficient to 
take care of non-Normality through operation of the CLT. The two-sample t- 
test is exactly correct if the two samples are from Normal distributions with 
equal variances, and otherwise is approximately valid, where the 
approximation improves with increasing n and m and the closer the 
distributions are to Normality (Armitage et al 2002). With larger n and m then 
the more non-Normality can be tolerated. 
If we are still worried about the assumptions of Normality and equality of 
variances we can either try and transform the HRQoL data to Normality and 
constant variance or use a non-parametric test. If we use a non-parametric 
test then the most popular (but not necessarily the most efficient) for 
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comparing two groups is the Mann-Whitney U test. The MW test is a test of 
the null hypothesis that the two populations are identical (i. e. F= G). What if 
we wanted to test only whether their means are equal? (Again more on this 
later). 
Analysis of CPSW data - comparison of two means 
Table 5.1 in Chapter 5 shows the two sample Mest (with equal variances) and 
MIN comparisons of the eight SF-36 dimension scores. If we assume a cut-off 
of p :: g 0.05 for statistical significance, then the Mest suggests significant 
differences on two dimensions of the SF-36, RP and SF. On two other 
dimensions PF (p = 0.060) and BP (p = 0.065) the p-values are close to the 
arbitrary cut-off of 0.05, suggesting some differences although these may not 
be statistically reliable. The results of the MIN tests suggest significant 
differences on four dimensions (PF, RIP, BP and SF) of the SF-36. The only 
major contrast between the interpretation of the results of the MIN and t tests 
is on the BP and PF dimensions, where the former test suggests a difference 
and later not. Although Altman (1991) suggests that the p-value cut-off of 0.05 
for statistical significance and rejecting the null hypothesis is arbitrary and it is 
ridiculous to interpret the results of a study differently according to whether the 
p-value obtained was, say 0.055 or 0.045. 
Hypothesis testing with the bootstrap 
As we mentioned in Chapter 3, bootstrap methods can also be used for 
hypothesis testing. The two quantities that we must choose when carrying out 
a bootstrap hypothesis test are a test statistic t(x) and a null distribution PO for 
the data under the null hypothesis (Ho). Given these, we generate B bootstrap 
A 
values of the test statistic t(x*) under the null distribution for the data FO and 
estimate the achieved significance level (ASL) by calculating the proportion of 
the bootstrap values of the B test statistics t(x*), which are greater than or 
equal to the observed value of the test statistict(X)Obsfrom the original data. 
Le. ASL = ProbHo 
ý( 
X* 
) 
ýý 1 wobs 
1' 
(7.12) 
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Suppose we have samples z= (Zlo Z29---, zn) and y= (YI, Y2v---, Ym) from 
possibly different probability distributions F and G respectively, and we wish to 
test the null hypothesis Ho: F=G. A bootstrap hypothesis test, like 
conventional hypothesis tests is based on a test statistic. To emphasize that a 
test statistic need not be an estimate of a parameter such as 0, we follow 
Efron and Tibshirani (1993), and denote the test statistic by t(x). The quantity 
t(x) is fixed at its observed value, tobs and the random variable x has a 
distribution Fo specified by the null hypothesis Ho. 
If we let the combined sample of z and y be denoted by x and let the empirical 
distribution of this combined sample be P., putting probability 11(n + m) on 
each member of x. Under HO, FO provides a non-parametric estimate of the 
common population that gave rise to both z and y. Algorithm 7.1 derived from 
Efron and Tibshirani (1993) shows how the bootstrap test statistic and ASL is 
computed for testing F=G. 
Algorithm 7.1 
Computation of the bootstran test statistic for testing F=G 
1. Draw B samples of size n+m with replacement from x. Call the first n 
observations z* and the remaining m observations y*. 
2. Evaluate t(. ) on each sample, 
i(x, ) b=1,2,..., B. (7.13) 
3. Approximate ASLboot by 
ýSLbwt 
= 
#ý( 
B1 
(7.14) 
X")ý: t 
wheretobs "ý t(x) is the observed value of the statistic from the original data. 
More accurate testing can be obtained through the use of a studentized 
statistic (Efron and Tibshirani, 1993). In the above test, instead of 
t(x) =F- 3ý we could use, 
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'[I: 
n 
, 
(Zi 
_ j)2 + 
I: m 
I 
ýj 
_ ý)2 
1/2 
J. 
t(x) where [n+m-21 ýnl 
i; 
This is equivalent to the standard two-sample t test statistic (7.11) if we let 5: 
= sp. We shall denote the ASL from (7.15) by ASLstudent7.1. 
The previous algorithm (7.1) tests the null hypothesis that the two populations 
are identical, that is F=G. Suppose we want to test only whether their means 
are equal. One approach would be to use the two sample t statistic. Under the 
null hypothesis and assuming Normal populations with equal variances, this 
has a Student's t distribution with n+m-2 degrees of freedom. It uses a 
pooled estimate of the standard error F. If we are not willing to assume that 
the variances in the two populations are equal, we could base the test on 
t(x) 
S2 
+ 
SY2 
nm 
E. 
I 
(zi 
- F) 
21MI (YI 
_ j7)2 
where S2 = I= and s' = i. are the estimated sample z n-I Y M-1 
variances. With Normal populations, the quantity (7.16) no longer has a 
Student's t distribution and a number of approximate solutions have therefore 
been proposed (Satterthwaite, 1946; Welch, 1947). Using Satterthwaite's 
formula t(x) in (7.16) is distributed Student's t with v degrees of freedom, 
where v is given by: 
s., sy, 
n, m 
LS2 2/My Ijn 
+ 
(Sy 
n-I M-1 
The equal variances assumption is attractive for the Mest because it simplifies 
the form of the resulting distribution. In considering a bootstrap hypothesis for 
comparing the two means, there is no compelling reason to assume equal 
variances and so we do not make this assumption. To proceed we need 
estimates of F and G that use only the assumption of a common mean. 
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Letting Y be the mean of the combined sample, we can translate both 
samples so that they have mean 5E, and then resample each population 
separately. The procedure is shown in detail in Algorithm 7.2 taken from Efron 
and Tibshirani (1993). 
Algorithm Z2 
Computation of the bootstrap test statistic for testing equality of Means 
1. Let F put equal probability on the points F, = z, -F+ 5F, i=1, 
and G put equal probability on the points y, - 5; + 2,.. 
where F and 37 are the group means and 3F is the mean of the 
combined sample. 
2. Form B bootstrap data sets (z*, y*) where z* is sampled with 
replacement from and y* is sampled with replacement from 
Yl 9 Y2 9-9 Ym 
3. Evaluate t(. ) defined by (7.16) on each data set, 
-* -0 ( )= Z -y Xb 
21' F 2* Sy 
2! 
n M 
4. Approximate ASLb,,,, t by 
kLbool 
= 
4ý(Xb)ýý to 
B 
where tobs 'ý t(x) is the observed value of the statistic from the original 
sample. 
Efron and Tibshirani (1993) state that ASL,,,,,, has no interpretation as an 
exact probability, but like all bootstrap estimates is only guaranteed to be 
accurate as the sample size goes to infinity. On the other hand, the bootstrap 
hypothesis test does not require the special symmetry that is needed for a 
permutation test, and so can be applied much more generally. For instance in 
the two-sample problem a permutation test can only test the null hypothesis F 
= G, whilst the bootstrap can test equal means and equal variances or equal 
means with possibly unequal variances. 
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Table 7.3 shows the results of applying Algorithms 7.1 (ASLmean7.1 and 
ASLStudent7.1) and 7.2 (ASLbooff. 2) to the CPSW data. Algorithm 7.1 was applied 
using SPSS v1 1 (SPSS, 2001) and Algorithm 7.2 in sTATA v8 (StataCorp, 
2003), see Appendix 4 for more details and examples of the programs. It 
compares and contrasts the results of the p-values from three bootstrap 
hypothesis tests (ASLmean7.1, ASLstudent7.1 and ASLbooff. 2) with the p-values from 
the standard two sample Mest with equal variances, the MIN test and two 
sample Mest with unequal variances. The p-values from ASI-boot7l tests are 
very similar to the unequal variances Mest, which is to be expected as the two 
methods use the same test statistic (7.16). 
The other hypothesis tests (ASLmean7.1 and ASLstudent7.1) are effectively tests of 
the equality of distributions (i. e. F= G). Although they report quantitatively 
different p-values, the magnitudes are similar, and if we use a cut-off of p< 
0.05 for statistical significance then the qualitative interpretation of the tests is 
the same. So in this example dataset there appears to be little advantage in 
using the bootstrap hypothesis tests compared to conventional hypothesis 
tests, such as the MW test, for testing equality of distributions. 
Estimation and confidence intervals (CI) 
A major limitation of non-parametric methods such as the MW and the 
bootstrap hypothesis tests (Algorithms 7.1 and 7.2) is that they do not allow 
for the estimation of confidence intervals for parameters or allow for the 
adjustment of confounding variables such as baseline covariates. Journals 
such as the British Medical Journal and Lancet now expect scientific papers to 
contain confidence intervals when appropriate. Indeed several statisticians 
have argued strongly for a change of emphasis in statistical analysis from 
hypothesis testing to estimation (Altman et al 2000). 
One way to estimate non-parametric Cls, is via the bootstrap method. Table 
7.4 compares and contrasts the Normal Mest (equal variances) based 
confidence intervals with the bootstrap BCa ones. 
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Chapter 7: Cross-sectional analysis of HRQoL data 
Both sets of confidence intervals were estimated using the bootstrap 
procedure in STATA v8 (StataCorp, 2003). According to Efron and Tibshirani 
(1993) each interval d. P) can 
be described by its length and shape, 
A 
O. 
P 
0 
length ý, 
P and shape =.. 
(7.20). 
0-01" 
A 'Shape' measures the symmetry of the interval about the point estimate 0. 
Shape > 1.00 indicates greater distance from d., to 0^ than from 0 to 0,,. 
Conversely, Shape < 1.00 indicates a greater distance from 0 to 0,,, than 
from 0,, 
P 
to 0. The standard Normal (or t-distribution based) intervals are 
symmetrical about d, having shape = 1.00 by definition. Therefore shape is a 
measure of skewness of the Cl about the point estimate. A shape > 1.00, 
implies the Cl is 'positively' skewed, with a long 'tail' to the right. Whereas 
shape, < 1.00 implies the Cl is 'negatively' skewed. 
The estimates and lengths of the Cis are almost identical. Table 7.4 also 
shows that the shape of the BC, Cis is almost symmetric about the point 
estimate of the mean difference except for the RE dimension, where there is 
some evidence of asymmetry. So again in this example dataset there appears 
little advantage in using the bootstrap BC, confidence intervals compared to 
conventional methods of confidence interval estimation. 
The bootstrap (and Normal) confidence intervals are calculated for a 
characteristic of the distributions (for example mean difference). The groups 
may have differences in distributions but similar characteristics e. g. means. 
(Morrell et al 2000). For example the MW tests suggests a significant 
difference (in distributions) for the PF, RP, BP and SF dimensions, but the 
bootstrap and Normal confidence limits for two out of four of these dimensions 
(PF and BP) includes zero suggesting no differences in the mean HRQoL 
between the groups. 
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Table 7.4: Comparisons of parametric and bootstrap estimates of 
confidence intervals for the eight dimensions of the SF-36 from the 
CPSW Study for Control vs. Intervention Groups 
SF-36 
Dimension 
Mean 
Difference 
cis 
Lower Upper 
A 010 up 
Interval 
Length_ Shape 
Physical Normal (t-test) -2.6 -5.2 0.1 5.4 1.00 
Function Bootstrap BCA -5.2 0.0 5.2 0.98 
Role Normal (t-test) -9.1 -16.0 -2.3 13.7 1.00 
Physical Bootstrap BCA -15.8 -2.3 13.5 1.02 
Bodily Normal (t-test) -4.0 -8.2 0.2 8.4 1.00 
Pain Bootstrap BCA -8.1 0.3 8.4 1.03 
General Normal (t-test) -2.4 -5.6 0.8 6.4 1.00 
Health Bootstrap BCA -5.6 0.8 6.4 0.99 
Vitality Normal (t-test) -1.3 -5.0 2.5 7.5 1.00 
Bootstrap BCA -5.1 2.4 7.5 0.98 
Social Normal (Mest) -4.7 -8.9 -0.6 8.3 1.00 
Function Bootstrap BCA -8.7 -0.6 8.1 1.03 
Role Normal (t-test) -1.1 -7.5 5.3 12.7 1.00 
Emotional Bootstrap BCA -7.1 5.6 12.7 1.11 
Mental Normal (t-test) 0.2 -2.8 3.2 6.0 1.00 
Health Bootstrap BCA -2.8 3.2 6.0 0.98 
Mean difference d= Intervention mean - Control mean 
BCa confidence intervals based 5000 bootstrap replications. 
When a hypothesis is tested using the bootstrap, the resampling is carried out 
assuming the null hypothesis Ho is true. Whereas when confidence intervals 
for mean differences between two groups are estimated the resampling is 
carried out separately for each group. A useful analogy is with the comparison 
of proportions in two independent groups. Here the standard error for the 
hypothesis test is different to the standard error of the difference between the 
observed proportions used for estimating a confidence interval (Altman, 
1991). 
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Adjusting for other variables 
If we suspect that the observed differences (imbalance) between the groups 
at the start of the trial may have affected the outcome we can take account of 
the imbalance in the analysis. Adjusting for other variables requires the use of 
analysis of covariance (ANCOVA) or some form of multiple regression 
analysis. For the rest of this chapter we will be concerned with linear 
regression in which the mean of the HRQoL response Y observed at a value 
or vector x of p explanatory variables or covariates (X1, X2v ... PXP) is: 
8 (7.21) E(Y JX1 I X21 ... IXJ PW = flOX0 + AXI +J82X2 + *- +, pXp * 
The model is completed by specifying the nature of the random variation, 
which for independent responses amounts to specifying the form of the 
variance var(Y I x). The multiple linear regression model is: 
Yi '= AXOi + AXIi +)62X2i + "" + 
flpXpi + el i=1,..., n, (7.22) 
where for models with an intercept xoj = 1. 
The multiple regression model assumes: 
(1) The relationship between the outcome variable (Y) and the predictor 
variables (xi, X2, --- vXp) iS linear. 
(2) The variability of Y, as assessed by the variance or standard deviation 
a, corresponding to a particular set of values xj, X2, ... Xp is the same, 
regardlessOf XI, X2P ... IXP- 
(3) The values of the outcome variable Y should have a Normal distribution 
for each set of values of the predictor variables xj, X2, ... vXp 
The regression coefficients are estimated using the ordinary least squares 
(OLS) method (McCullagh and Nelder, 1989; Dobson, 1990). 
Multiple regression does not involve any assumptions about the distribution of 
the x values (Armitage et al 2002). If the above three assumptions hold then 
the residuals cis should be uncorrelated, Normally distributed with zero mean 
and have the same variance a2 throughout the range of fitted values (i. e. 
el - N(O, a')). 
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These assumptions can be checked graphically using histograms, Normal 
plots and scatter diagrams of the residuals from the model. Assumption (1) 
can be checked by plotting the residuals against each of the predictor 
variables in turn. We expect to see no association if the true relationship is 
linear. A plot of the residuals against the fitted or predicted values can assess 
assumption (2). No pattern should be discernable. In particular, the variability 
of the residuals should be constant across the range of the fitted values. For 
assumption (3) we can produce a Normal plot of the residuals, which should 
fall on a straight line if the residuals are Normally distributed. 
In general, lack of Normality of the residuals is unlikely to affect seriously the 
estimates of a regression equation although Campbell and Machin, (1999), 
have pointed out that it may effect the standard errors (and hence confidence 
interval estimates) and the size of the p-value. Similarly, a lack of constant 
variance of the residuals is unlikely to seriously affect the estimates, but again 
will have some influence on the final p-value and confidence intervals. In 
either case Campbell and Machin's advice is to proceed with caution, 
particularly if the p-value is close to some critical value such as 0.05. The lack 
of linearity is more serious, and would suggest either a transformation of the 
data before fitting the regression, or a model involving quadratic (squared) or 
higher terms using multiple regression. 
For linear regression with Normal random errors having constant variance, the 
least squares theory of regression estimation and inference provides clean 
exact methods for analysis (Davison and Hinckley, 1997). But for 
generalisations to non-Normal errors and non-constant variance, exact 
methods rarely exist, and we are faced with approximate methods based on 
linear approximations to estimators and CLTs. So, just as in the simpler 
context of hypothesis testing, resampling methods have the potential to 
provide more accurate analysis. 
Bootstrap regression analysis. 
Standard errors and confidence intervals for regression coefficients can also 
be obtained using bootstrap methods. However, as we mentioned in Chapter 
143 
Chapter 7: Cross-sectional analysis of HRQoL data 
3, two different approaches are possible, case and model (residual) 
resampling. 
Algorithm 7.3 
Case-based resampling in linear regression 
With the simple linear model yj = Po + Pixi + F. 1; with E(q) = 0, if the data are w 
(XI, YI), (X2v Y2), ... (Xn, Yn). 
1. Case-based resampling involves drawing a bootstrap sample of size n, 
with replacement from these n pairs. The bootstrap data set is of the 
form: 
W**0*000 = U1. I X1. ý ý11' I X1. ý ... I ý, *. I X1. )10 where ii, i2, ..., In is a random sample of integers 1 through n. 
2. Ordinary least squares is then used to estimate the regression 
coefficients A0 and for this bootstrap sample of paired cases. 
3. We do this repeatedly, say B times, so we now have B bootstrap 
samples and B estimates of the regression coefficients, one from each 
Vo- 
ý 
ý1' )2 
9 ... 99 bootstrap sample, JV0 
), 
91 
^' 
4. The standard error of these estimated coefficients seVO) and seW is 
simply the standard deviation of these B estimates. As before if these 
estimates are ordered in increasing value, 
" ')(1) 
10 
1 ')(2) 
9-9 
1 ')(B) a MI, V1, V1, 
simple 95% bootstrap percentile confidence interval for the coefficient 
would be from the 0.02513th to the 0.975Býh largest values. 
For multiple regression a case or "pair' in step 1 of the above algorithm 
consists of a vector (yi, x1j, x2j,..., xpj) of the response variable yj and p 
covariates for the th case. 
Case-based resampling may be entirely natural for situations where is it 
plausible that the (x, y) pairs have been drawn from a bivariate distribution 
function F (x, y) of the pairs. However, case based resampling is less 
appealing if the x values were controlled for in some way, perhaps by the 
design of the study. In this situation the alternative model or residual based 
procedures could be used. 
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Algorithm Z4 
Model or residual based resampling in linear regression 
For model based resampling using the simple linear regression model (Yj = Po 
+ Pjxj + cl, with E(F. 1) =0). 
1. Conventional fitted values yir" and residuals ej are first obtained from 
the observed data using ordinary least squares estimation Le. 
"=. +. obs fit yjf fl(, flx, and e, = y, - y, = y, 
e,. ), where 2. A bootstrap sample of the residuals is drawn e* (e, * 
il, i2,..., i, is a random sample of integers 1 through n. 
3. The bootstrap sample for the regression z* = ý, *, x, *) comprises the x 
values (x, * = x, ) from the original data and y values computed by 
adding the fitted values to the bootstrap residuals i. e. 
+ ý, x, + e,. . Note that 6% and 8, are the coefficient estimates Y, A 
from the original sample. The bootstrap data set is of the form 
U- z= jW" + AX, A, +e, * , x. 
)j, +eI, 
9XjV0 
+, 
ýIX2 
+eI, 
9X2)-9V0 
+ 
4x 
where 11, i2,... jn is a random sample of integers 1 through n. 
4. Ordinary least squares is then used to estimate the regression 
coefficients A00 and for this bootstrap sample. 
5. As before the process is repeated B times to estimate standard errors 
and confidence intervals for the B regression coefficients from the 
bootstrap samples. 
For the multiple regression, the bootstrap sample in step 3 of the above 
algorithm consists of a vector z* = ý, *, x, *,, x;,,... 'XPj and comprises the x 
values (x,, = x,... 'xP, = xPj from the odginal data and y values computed by 
adding the fitted values to the bootstrap residuals. 
The model based resampling is an example of the "parametric bootstrap" 
when the residuals from a parametric model are bootstrapped to give 
estimates of the standard error of the parameters. There is considerable 
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debate about which form of resampling is more appropriate (see Table 7.5a 
below). 
Both Algorithms (7.3 and 7.4) can be easily implemented in S-PLUS 2000 
(MathSoft, 1999) using S-PLUS functions from the bootstrap library developed 
by Davison and Hinckley (1997). Appendix 4 provides examples of the S- 
PLUS programs for case and residual resampling and estimation Of BCa 
confidence intervals. 
Adjusted Analysis of CPSW data 
For the CPSW study we thought that age, parity and delivery might affect 
HRQoL. The analysis involved using OLS to fit the linear regression model 
below, 
fl 
ro el. 
(7.23) Yi A +AgeXAgej +J8PariryXParity_1 +JaDeliveryXDeliveryJ +G upXGroup_1 + 
Equation (7.23) has the six week postnatal HRQoL score as the dependent 
variable, Yi and XAge_i (age in years); xp,, r1, Y_, 
(parity, coded 0 for first child 
and 1 for second or subsequent child), x,,, 
_, 
(type of delivery, coded 0= 
normal and 1= abnormal) and treatment group xG,..,,,, 
_, 
(coded 0= Control, 1= 
Intervention) as covariates. The term flo is the intercept or constant and e, is a 
N(O, U2 
) random error term. 
The regression coefficient estimate, ftaupf represents the difference in six 
week HRQoL between the Intervention and Control groups after adjustment 
for the mother's age, parity and type of delivery. A positive value for the 
regression coefficient indicates the Intervention group has a better mean 
HRQoL at six weeks postnatally than the Control group after adjustment for 
the other covariates. 
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Figures 7.4 and 7.5 show the residual plots for the eight dimensions of the SF- 
36 after using OLS to regress SF-36 dimension score on age, parity, delivery 
and treatment group. The right hand column of the figures shows a Normal 
probability plot of standardised residuals. Only on the Vitality dimension Is the 
Normal plot reasonably straight. The Normal plots for the other seven 
dimensions indicate the distribution of the residuals departs somewhat from 
Normality particularly for the two Role dimensions. 
The plots of residuals against the fitted response (left hand column of Figures 
7.4 and 7.5) show the variability of the residuals may not be constant for some 
dimensions of the SF-36. For example, for the PF, BP and SF dimensions 
there is some suggestion that the variability of the residuals is decreasing as 
the fitted values increase. Therefore, if the distribution of errors is very far 
from Normal or heteroscedastic (unequal variances), then standard OLS 
results may not be reliable and resampling methods may offer a genuine 
improvement, particularly case resampling which is robust to the failure of the 
model assumptions (Davison and Hinckley, 1997). 
Table 7.5b compares the OLS and bootstrap standard errors and confidence 
interval estimates for the treatment group coefficient from the CPSW data. All 
models include age, delivery and parity as covariates in the regression. For 
the bootstrap methods the standard errors are the standard deviations of the 
coefficients from the 5000 bootstrap re-samples. For ease of interpretation 
and comparison only the estimates for the treatment group coefficient are 
shown. As can be seen from Table 7.5b the standard error estimates are 
almost identical for the three methods. Similarly the length of the confidence 
intervals is virtually the same for all three methods. The bootstrap intervals 
have a tendency to be non-symmetric around the point estimate of the 
regression coefficient. Qualitatively all of the intervals from the three methods 
either include or exclude zero so the interpretation of the treatment group 
regression coefficient is the same. Therefore in this example dataset there 
appears to be little advantage in using bootstrap case or model based re- 
sampling to estimate standard errors and confidence intervals compared to 
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conventional methods of confidence interval estimation from the OLS multiple 
regression model. 
Figure 7.4: Residual plots from CPSW data (left column Residuals 
against predicted response; right column Normal plot of residuals) 
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Figure 7.5: Residual plots from CPSW data (left column Residuals 
against predicted response; right column Normal plot of residuals) 
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Table 7.5b: Multiple regression, case and model based resampling SE's 
and Confidence Intervals estimates from the CPSW data 
Dependent GROUP coefficient 95% Cl Interval 
Variable Model SE 
ýISE 
p Lower Upper Length Shape- 
Physical OLS -2.6 1.32 -2.00 0.046 -5.23 -0.05 5.19 1.00 
Function Case 1.31 -2.01 -5.24 -0.13 5.11 0.96 
Model 1.33 -1.98 -5.29 -0.04 5.25 0.98 
Role OLS -9.2 3.30 -2.80 0.005 -15.73 -2.75 12.98 1.00 
Physical Case 3.28 -2.81 -15.86 -3.06 12.80 0.93 
Model 3.29 -2.81 -15.89 -2.90 12.99 0.95 
Bodily OLS -4.1 2.09 -1.95 0.052 -8.16 0.04 8.19 1.00 
Pain Case 2.07 -1.96 -8.14 0.03 8.17 1.00 
Model 2.09 -1.94 -8.11 0.15 8.26 1.04 
General OLS -2.5 1.62 -1.57 0.117 -5.72 0.64 6.36 1.00 
Health Case 1.61 -1.58 -5.76 0.65 6.41 0.99 
Model 1.58 -1.61 -5.70 0.44 6.14 0.95 
Energy OLS -1.4 1.88 -0.73 0.465 -5.08 2.33 7.40 1.00 
Case 1.91 -0.72 -4.94 2.54 7.48 1.10 
Model 1.88 -0.73 -5.08 2.26 7.34 0.98 
Social OLS -4.8 2.08 -2.33 0.02 -8.92 -0.75 8.16 1.00 
Function Case 2.07 -1.96 -8.91 -0.78 8.13 0.99 
Model 2.09 -2.32 -8.79 -0.74 8.05 1.03 
Role OLS -1.3 3.22 -0.41 0.681 -7.64 5.00 12.64 1.00 
Emotional Case 3.21 -0.41 -7.41 5.05 12.46 1.05 
Model 3.17 -0.42 -7.66 4.74 12.40 0.96 
Mental OLS 0.2 1.53 0.11 0.909 -2.83 3.18 6.00 1.00 
Health Case 1.53 0.11 -2.90 3.02 5.92 0.92 
Model 1.53 0.11 -2.81 3.22 6.03 1.02 
N= 495. 
Changes from baseline 
Although it is common to use the patients' status at the end of the study 
period as the outcome of interest, sometimes it is more appropriate to take the 
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change (or difference) from the pre-treatment, or baseline, measurement as 
the prime outcome measure. 
When changes from baseline are analysed it is misleading to perform 
separate analyses (either hypothesis tests or Cls) within each treatment 
group. A better approach is to calculate each patient's change from baseline, 
and then compare directly the changes in the different groups. 
Analysis of changes from baseline 
Given the distribution of the changes or differences in outcome measures are 
more likely to be symmetric and Normally distributed, parametric tests can be 
used to compare differences in changes between groups, especially if we 
assume that for a seven-point HRQoL scale going from 2 to 1 is the same as 
a change from 7 to 6 say. Parametric Cls for means and their differences can 
then be calculated. Multiple regression can be used (with change from 
baseline as the dependent Y variable) to compare groups and adjust for other 
covariates and factors (such as baseline HRQoL, age, sex and treatment 
centre). 
Bajorski and Petkau (1999) describe a non-parametric method of comparing 
changes from baseline on ordinal responses for two independent groups. 
(This method is based on performing several MWtests on the follow-up up 
HRQoL scores stratified by baseline HRQoL score. These separate MWtest 
statistics for each strata are then weighted and summed together to produce 
an overall test statistic). Unfortunately, this method is purely a hypothesis test 
and does not allow estimation of Cls and so does not appear particularly 
useful for the analysis of HRQoL data. Furthermore, Sullivan and D'Agostino 
(2003) have demonstrated the robustness and power of the two sample Mest 
on change scores (and ANCOVA) when applied to ordinal scales of three, 
four, or five points in a clinical trials setting comparing two treatments, with 
sample sizes as small as 20 per group. This suggests that a simple Mest on 
change scores may be more suitable than a non-parametric test. 
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Frison and Pocock (1992) demonstrate that ANCOVA is the method of choice 
for analysis of pre-treatment (baseline) and post-treatment (follow-up) means. 
They show that ANCOVA is superior to both analysis of post-treatment means 
and analysis of mean changes. Therefore we will concentrate on such 
methods for HRQoL outcomes from the OA Knee data, which measured 
HRQoL at baseline and 6 months follow-up in two groups of patients (Surgical 
and Rheumatology). 
Analysis of the OA Knee Data 
Table 7.6 shows the baseline socio-demographic and HRQoL characteristics 
of the two groups of OA patients those awaiting total knee replacement 
surgery (Surgical) and those having pharmacological treatment 
(Rheumatology). The group of patients awaiting surgery is significantly older 
and has significantly more men than the Rheumatology group. The Surgical 
group has significantly lower levels of PF prior to total knee replacement 
surgery than the Rheumatology group. Conversely the Surgical group has 
significantly higher levels of GH, V and MH compared to the Rheumatology 
clinic patients. For the other four dimensions of the SF-36 (RP, BP, SF and 
RE) there was no evidence of any difference in HRQoL between the two 
groups. 
We were interested in seeing whether or not there was a difference in HRQoL 
in OA patients after TKR surgery compared with pharmacologically treated 
patients. From previous studies using the SF-36 (Brazier et al 1992; Walters 
et al 2001c) we know that HRQoL varies with age and gender. Since there 
was a difference in the baseline HRQoL and socio-demographic 
characteristics (age and gender) of the Rheumatology clinic and TKR surgery 
groups, we use this dataset to illustrate multiple regression/ANCOVA methods 
with follow-up HRQoL as the outcome variable and baseline HRQoL, age, 
gender and group (TKR surgery or Rheumatology clinic) as covariates. 
Therefore the analysis involved using OLS to fit the multiple regression model 
below, 
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Table 7.6: Baseline characteristics of the TKIR Surgery and 
Rheumatology Clinic patients from the OA Knee study. 
Rheumatology Surgical Mean 95% Cl 
p- 
N Mean SD N Mean SD Diff Lower Upper value 
Age (years) 102 64.2 (11.3) 109 71.1 (8.5) -6.9 -9.6 -4.2 0.001 
SF-36 
Dimensions 
Physical 
Function 97 28.2 (22.4) 95 21.2 (18.2) 7.0 1.2 12.8 0.019 
Role Physical 96 11.5 (22.0) 99 12.9 (26.3) -1.4 -8.3 5.4 0.684 
Bodily Pain 100 32.0 (19.5) 104 36.3 (23.4) -4.3 -10.3 1.6 0.154 
General 
Health 94 43.9 (22.9) 96 57.3 (23.8) -13.3 -20.0 -6.6 0.001 
Vitality 98 36.9 (19.0) 99 42.3 (19.3) -5.4 -10.8 0.0 0.050 
Social 
Function 100 53.1 (30.6) 101 53.6 (27.6) -0.5 -8.6 7.6 0.910 
Role 
Emotional 95 41.1 (44.2) 99 44.1 (44.6) -3.1 -15.6 9.5 0.632 
Mental Health 99 62.7 (20.9) 100 68.2 (18.8) -5.5 -11.0 0.1 0.054 
Gender 
Female 71 (69.6%) 59 (54.1%) (15.5%) (2.4%) (27.8%) 0.021 
Male 31 (30.4%) 50 (45.9%) 
Total 102 (100%) 109 (100%)- 
fl0 + ßAgeXAge i+ 
ßSexXSex 
1+ (7.24) 1-- 
ßBaseXBase_i +, ßGroupXGroup_I + -01 1 
where, Y, is the six month follow-up HRQoL for subject i; XAg, _, is the age in 
years at baseline; x, 
-, 
is the gender of the patient (coded 0 for males and 1 
for females); xB., 
-j 
is the baseline HRQoL and XGroupj is the treatment group 
variable (coded 0= Clinic, 1= Surgery). The term flo is a constant and e, is a 
N(O, a') random error term. Again the regression coefficient estimate, ý, 
flG. 
Up 
represents the difference in six-month follow-up HRQoL between the 
Rheumatology Clinic and TKR Surgery groups after adjustment for the 
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patient9s age, gender and baseline HRQoL. A positive value for the regression 
coefficient indicates the Surgery group has a better mean HRQoL at six 
months follow-up than the Clinic group after adjustment for the other 
covariates. 
Figures 7.6 and 7.7 show the residual plots for the eight dimensions of the SF- 
36 after using OLS to regress SF-36 dimension score at 6 months follow-up 
on age, gender, baseline HRQoL and group. The right hand column of the 
figures shows a Normal probability plot of standardised residuals. Only six out 
of eight of the dimensions the Normal plots are reasonably straight. The 
Normal plots for the two Role dimensions (RP and RE) indicate the 
distribution of the residuals departs somewhat from Normality. 
The plots of residuals against the fitted response (left hand column of Figures 
7.6 and 7.7) show the variability of the residuals may not be constant for the 
two Role dimensions of the SF-36. For the other six dimensions, no pattern in 
the residuals against the fitted values is discernable. 
Table 7.7 compares the OLS and bootstrap standard errors and confidence 
interval estimates for the group coefficient from the OA Knee data. All models 
include age, baseline HRQoL and gender as covariates in the regression. For 
the bootstrap methods the standard errors are the standard deviations of the 
coefficients from the 5000 bootstrap re-samples. For ease of interpretation 
and comparison only the estimates for the group coefficient are shown. 
The regression analysis suggests that at six month follow-up TKIR surgical 
patients have significantly better HRQoL than Rheumatology treated clinic 
patients on five dimensions of the SF-36 (PF, BP, GH, V and SF) after 
adjustment for age, gender and baseline HRQoL. As can be seen from Table 
7.7 the standard error estimates are almost identical for the three methods. 
Similarly the length of the confidence intervals is virtually the same for all 
three methods. Although the bootstrap Cls tend to be asymmetric about the 
point-estimate of the regression coefficient. 
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Figure 7.6: Residual plots from OA Knee data (left column Residuals 
against predicted response; right column Normal probability plot) 
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Figure 7.7: Residual plots from OA Knee data (left column Residuals 
against predicted response; right column Normal probability plot) 
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Qualitatively all of the intervals from the three methods either include or 
exclude zero so the interpretation of the group regression coefficient is the 
same. Therefore again in this example dataset there appears to be little 
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advantage in using bootstrap case or model based re-sampling to estimate 
standard errors and confidence intervals compared to conventional methods 
of confidence interval estimation from the OLS multiple regression model. 
Table 7.7: Comparison of multiple regression, bootstrap case and model 
based resampling SE and Cl estimates from the OA Knee data 
Dependent GROUP coefficient 95% CI Interval 
S1 
Variable Model N )6 SE P Lower Upper Length Shape 
Physical OLS 165 13.3 3.07 4.31 0.001 7.19 19.32 12.14 1.00 
Function Case 3.02 4.39 7.64 19.69 12.05 1.15 
Model 3.05 4.35 7.49 19.49 12.00 1.08 
Role OLS 1177 -0.5 4.89 -0.11 0.915 -10.16 9.12 19.29 1.00 
Physical Case 4.39 -0.12 -8.60 8.51 17.11 1.12 
Model 4.86 -0.11 -10.11 8.93 19.04 0.99 
Bodily OLS 200 14.7 3.39 4.34 0.000 8.01 21.38 13.37 1.00 
Pain Case 3.41 4.30 7.81 21.41 13.60 0.98 
Model 3.36 4.38 8.07 21.25 13.18 0.99 
General OLS 173 4.7 2.01 2.32 0.021 0.71 8.65 7.95 1.00 
Health Case 2.03 7.26 0.69 8.69 8.00 1.01 
Model 1.98 2.37 0.70 8.48 7.78 0.95 
Energy OLS 185 6.5 2.46 2.64 0.009 1.65 11.36 9.72 1.00 
Case 2.50 2.60 1.75 11.63 9.88 1.08 
Model 2.46 2.65 1.49 11.04 9.54 0.90 
Social OLS 194 9.1 3.70 2.46 0.015 1.82 16.41 14.59 1.00 
Function Case 3.52 2.59 2.14 16.06 13.92 1.00 
Model 3.65 2.50 1.72 16.09 14.37 0.94 
Role OLS 184 9.4 6.10 1.55 0.124 -2.60 21.48 24.08 1.00 
Emotional Case 5.89 1.60 -1.90 20.85 22.75 1.01 
Model 6.03 1.57 -2.37 20.90 23.27 0.97 
Mental OLS 191 1.1 2.15 0.51 0.613 -3.15 5.33 8.48 1.00 
Health Case 2.32 0.47 -3.54 5.42 8.96 0.94 
1 
Model 
1 
2.14 0.51 
1 
-3.17 5.12 8.28 
1 
0.95 
1 
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It should be noted that in the OA knee dataset there is a considerable amount 
of missing data. Two hundred and two patients were assessed at the six- 
month follow-up, but for example only 165/202 (82%) completed all ten items 
of the SF-36 PF dimension. Missing data is a common problem with HRQoL 
assessment data, particularly in longitudinal studies. The imputation of 
missing HRQoL scores and the analysis of HRQoL data with missing values is 
extensively discussed in several papers (Curran et al 1998; Fayers et al 1998; 
Troxel et al 1998) and book chapters (Fayers and Machin, 2000 Chapter 11; 
Fairclough, 2002 Chapters 4 to 8). As the subject of this thesis is the use of 
computer intensive methods in analysing HRQoL data and not missing value 
imputation we will not discuss the issue of missing values further. 
Summary and conclusions 
In this chapter we have shown how the bootstrap can be used for simple 
hypothesis testing (Algorithms 7.1 and 7.2) and more complex multiple linear 
regression analysis of cross-sectional HRQoL data and HRQoL data with a 
baseline and follow-up assessment (Algorithms 7.3 and 7.4). In the dataset 
studied, hypothesis testing with the bootstrap appears to offer no advantage 
over conventional significance tests such as the Mest and MIN test. Similarly, 
in the two datasets studied, both the case and model based bootstrap re- 
sampling methods for estimating SEs and Cls for linear regression models 
gave estimates almost identical to the conventional values estimated by OLS. 
In the next chapter we will look at methods of analysing HRQoL data collected 
at three or more time points including the simple analysis of summary 
measures and the more complex modelling of longitudinal HRQoL data. Again 
we will compare conventional estimates of SE and Cl for parameters with their 
bootstrap counterparts. 
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Chapter 8: Modelling Longitudinal HRQoL data and summary 
measures (three or more time points) using the bootstrap 
Introduction: Analysis of Longitudinal HRQoL data 
With one HRQoL observation on each experimental unit (e. g. the CPSW 
study), we are confined to modelling the population average of Y, called the 
marginal mean response; there is no other choice. With repeated HRQoL 
measurements, there are several different approaches that can be adopted. I 
will split these approaches into three broad classifications (Everitt, 2002): 
(1) Time by time analysis; 
(2) Response feature analysis - the use of summary measures; 
(3) Modelling of longitudinal data. 
The modelling of longitudinal data takes into account the fact that successive 
HRQoL assessments by a particular subject are likely to be correlated. The 
models are an extension of the linear regression model described in Chapter 
7. The three alternative modelling approaches I am going to discuss are 
repeated measures ANOVA, marginal (General Estimating Equations) models 
and random-effect (multi-level) models. All three models require the 
specification of the auto- or serial correlation, which is the strength of the 
association between successive longitudinal measurements of a single 
HRQoL variable on the same patient. 
In both the marginal and random-effect approaches we model both the 
dependence of the HRQoL response on the explanatory variables and the 
autocorrelation among the responses. With cross-sectional data, (as in 
Chapter 7), only the dependence of Y on x need be specified; there is no 
correlation as the responses (Y's) are independent. If we choose to ignore the 
correlation that exists in longitudinal data then Diggle et al (2002) mention 
three important consequences. 
(1) Incorrect inferences about regression coefficients, 8, 
(2) Estimates of 8which are inefficient, that is less precise than possible; 
(3) Sub-optimal protection against biases caused by missing data. 
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Notation 
We follow Diggle et al (2002)'s notation, and let YIj represent the HRQoL 
response variable and xil a row vector of length p of explanatory variables 
observed at time t#, for observation j=1,..., ni on subject i= The mean 
and variance of the HRQoL responses Yu are represented by E(YU) = uij and 
Var(Yij) = vy. The set of repeated HRQoL outcomes for subject i are collected 
into a nrvector, y/ = 
(Y,,, yi2,,.,, Y,,, ), with mean E(YI) = pi and n, x n, 
covariance matrix Var(Yi) = Vi, where the jkh element of Vi is the covariance 
between YU and Yjk, denoted by Cov(Yij, Yjk) = uijk. We shall use Ri for the nj x 
ni (auto-) correlation matrix of Y1. The responses for all patients are referred to 
as Y= (Yi, Y2,..., Ym), which is an N-vector with length N 
The longitudinal analyses we will consider will be based on an extension of 
the linear regression model (7.21), 
g++ flp Xup + Cii yij flixul +# 2XY2 
XIT jB+C, j 
where Jr = (, 81, fl2,...,, 8p) is a (p x 1) vector of unknown regression coefficients 
and c# is a zero-mean random variable representing the deviation from the 
model prediction, xijTg (XT denotes the transpose of the matrix). Typically, xqj 
=1 for all i and j, and 81 is then the intercept term in the linear model. 
In matrix notation, the regression equation for the th subject takes the form 
YI = Xiß+ Ei, (8.2) 
where X, is a ni xp matrix with xil in the I' row and cl = 
(eil 
) e12 II --i., 
)- 
Autocorrelation 
If Yi, and Yj2 represent the values of two successive HRQoL assessments by 
the same (th) patient and m represents the total number of patients 
completing both assessments in the sample. Then equation (8.3) measures 
the strength of association or auto-correlation between successive longitudinal 
measurements of HRQoL on the same patient, 
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(yll 
- 
'71 Xy12 
- 
'r2) 
m yr 9 
(8.3) 
1 1)2 2)2 
(yi j. EI. 
1 
(42 
where F, and T2 are the sample mean HRQoL scores at times t, and t2 
respectively. (This is equivalent to Pearson's product moment correlation 
coefficient. ) 
Suppose HRQoL is assessed on numerous occasions and the measurements 
at different times are Yjo, Y11, ... . YiTfor patient i at time T in the study. Then 
equation (8.3) can be utilised, one pair at a time, with the respective YU 
replacing the Y values. If there are assessments at T+1 time-points, there 
will be (T + 1)T/2 pairs of assessments leading to separate auto-correlation 
coefficients. For example, for T=6 there are (7 x 6)12 = 21 auto-correlation 
coefficients that may be calculated. 
In the NAMEIT study HRQoL assessment was carried out at 0,8,16,24,32, 
40 and 48 weeks (Le. 6+I time-points). Table 8.1 summarises the resulting 
21 auto-correlation pairs for the assessments until week 48. The pattern of the 
observed auto-correlation matrix R, gives a guide to the so-called error 
structure associated with the successive HRQoL measurements. Table 8.1 
shows that the autocorrelation coefficients range between 0.19 and 0.85. For 
three dimensions of the SF-36, PF, GH and MH, the autocorrelation 
coefficients are moderately large (between 0.5 and 0.85). The pattern of 
values suggests decreasing correlation as the observations become further 
apart. 
Several underlying patterns of the auto-correlation matrix R are used in the 
modelling of HRQoL data. The error structure is independent (sometimes 
termed random) if the off diagonal terms of the auto-correlation matrix R are 
zero. The repeated HRQoL observations on the same subject are then 
independent of each other, and can be regarded as though they were 
observations from different individuals. 
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Table 8.1 Auto-correlation matrices for the eight dimensions of the SF-36 
from RA patients In the NAMEIT study assessed at seven time points 
a) Physical Function (n = 218 e) Vitality (n = 216) 
Week 0 8 16 24 32 40 48 Week 0 8 16 24 32 40 48 
0 1.00 0 1.00 
8 0.61 1.00 8 0.55 1.00 
16 0.63 0.74 1.00 16 0.48 0.58 1.00 
24 0.57 0.69 0.75 1.00 24 0.47 0.54 0.71 1.00 
32 0.56 0.68 0.80 0.79 1.00 32 0.50 0.59 0.68 0.71 1.00 
40 0.55 0.67 0.77 0.81 0.86 1.00 40 0.42 0.49 0.67 0.68 0.77 1 . 00 
48 0.53 0.64 0.74 0.81 0.81 0.85 1.00 48 0.47 0.53 0.66 0.72 0.72 0.76 1.00 
b) Role Physical (n = 212) f) Social Function (n = 219) 
Week 0 8 16 24 32 40 48 Week 0 8 16 24 32 40 48 
0 1.00 0 1.00 
a 0.40 1.00 8 0.44 1.00 
16 0.35 0.53 1.00 16 0.43 0.53 1.00 
24 0.29 0.39 0.57 1.00 24 0.39 0.55 0.63 1.00 
32 0.19 0.30 0.56 0.67 1.00 32 0.36 0.46 0.63 0.70 1.00 
40 0.34 0.42 0.52 0.60 0.61 1.00 40 0.38 0.51 0.58 0.64 0.71 1.00 
48 0.27 0.40 0.59 0.67 0.64 0.71 1.00 48 0.34 0.45 0.58 0.64 0.71 0.71 1.00 
c) Bodily Pain (n = 219) g) Role Emotional (n = 206) 
Week 0 8 16 24 32 40 48 Week 0 8 16 24 32 40 48 
0 1.00 0 1.00 
8 0.43 1.00 8 0.46 1.00 
16 0.45 0.55 1.00 16 0.35 0.47 1.00 
24 0.44 0.47 0.61 1.00 24 0.34 0.40 0.59 1.00 
32 0.37 0.46 0.51 0.68 1.00 32 0.31 0.32 0.56 0.62 1.00 
40 0.40 0.42 0.57 0.60 0.69 1.00 40 0.34 0.46 0.53 0.56 0.54 1.00 
48 0.42 0.46 0.59 0.63 0.68 0.76 1.00 48 0.31 0.37 0.49 0.58 0.54 0.69 1.00 
d) General Health (n = 209) h) Mental Health (n = 218) 
Week 0 8 16 24 32 40 48 Week 0 8 16 24 32 40 48 
0 1.00 0 1.00 
8 0.55 1.00 8 0.57 1.00 
16 0.56 0.68 1.00 16 0.57 0.62 1.00 
24 0.60 0.67 0.80 1.00 24 0.55 0.59 0.72 1.00 
32 0.58 0.67 0.77 0.83 1.00 32 0.52 0.55 0.65 0.69 1.00 
40 0.59 0.65 0.72 0.79 0.84 1.00 40 0.50 0.54 0.70 0.70 0.74 1.00 
48 0.58 0.65 0.75 0.84 0.82 0.85 1.00 1 
48 0.56 0.55 0.68 0.72 0.73 0.77 1.00 
On the other hand, if all the correlations are approximately equal or uniform 
then the matrix of correlation coefficients is termed exchangeable, or 
compound symmetric. This means that we can re-order (exchange) the 
successive observations in any way we choose in our data file without 
affecting the pattern in the correlation matrix. 
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Frequently, as the time or lag between successive observations increases, the 
auto-correlation between the observations decreases. Thus, we would expect 
a higher auto-correlation between HRQoL assessments made only two days 
apart than between two HRQoL assessments made one month apart. This is 
in contrast to the uniform correlation model above. In such a situation one 
may postulate that the relationship between the size of the correlation and the 
"lag", that is the time tj and tkmay be of the form 
JOT(tj9tk 
)= 
P 
6-lkl 
. (8.4) 
The Itj - tki implies that if the difference between tj and tk is negative the sign 
should be ignored and 0 takes a constant value that is usually less than one. 
A correlation matrix of this form is said to have an autoregressive structure 
(sometimes called multiplicative or time series). Diggle (et al 2002) refers to 
this as the exponential correlation model. 
The auto-correlation pattern affects the way in which the computer packages 
estimate the regression coefficients in the corresponding statistical model, and 
so it should be chosen with care. 
We will concentrate on longitudinal data analysis problems where the 
regression of Y on x is the scientific focus and the number of experimental 
units (m) or patients in our case is much greater than the number of 
observations per unit (n). However, before we get into a more detailed 
discussion of the three longitudinal models (repeated measures ANOVA, 
marginal, and random-effect), I will briefly describe two simpler methods of 
analysing longitudinal HRQoL data as outlined in the introduction: the time-by- 
time analysis; and response feature analysis (the use of summary measures). 
1. Time by time analysis 
A series of two independent samples Mests (or the non-parametric 
equivalent) are used to test for differences between the two groups at each 
time point. (In examples with more than two groups, a series of one-way 
ANOVAs might be used). The procedure is straightforward but has a number 
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of serious flaws and weaknesses (Everitt, 2001). Consequently, it will not be 
pursued further here. 
2. Response feature analysis - the use of summary measures 
Here the repeated measures for each participant are transformed into a single 
number considered to capture some important aspect of the participant's 
response. A simple and often effective strategy (Diggle et al 2002) is to: 
(1) Reduce the repeated values into one or two summaries. 
(2) Analyse each summary as a function of covariates (xi). 
Diggle et al (2002) call this strategy a two-stage or derived variable analysis, 
and mention that it works well when xij = x, for all i and j (i. e. the important 
explanatory variables do not change over time), since the summary value 
which results from stage (1) can only be regressed on x, in stage (2). 
Table 8.2: Response features suggested in Matthews et al (1990). 
Type of 
data 
Property to be compared 
between groups 
Summary measure 
Peaked Overall value of response Mean or Area Under the Curve 
Peaked Value of most extreme response Maximum (minimum) 
Peaked Delay in response Time to maximum or minimum 
Growth Rate of change of response Linear regression coefficient 
Growth Final level of response Final value or (relative) difference 
between first and last 
Growth Delay in response Time to reach a particular value 
Examples of summary measures include the Area Under the Curve (AUC) or 
the overall mean of post-randomisation measures. Other possible summary 
measures are listed in Matthews et al (1990) and are shown in Table 8.2. 
Having identified a suitable summary measure, a simple Mest (or ANOVA) 
can be applied to assess between group differences. If the data for each 
patient can effectively be summarised by a pre-treatment mean and a post- 
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treatment mean, then the ANCOVA is the preferred method of choice (Frison 
and Pocock, 1992). It is superior to both analysis of post treatment means or 
analysis of mean changes. Diggle et al (2002) suggested that provided the 
data are complete, then the method of derived variables or summary 
measures can give a simple and easily interpretable analysis with a strong 
focus on particular aspects of the mean response. 
In lieu of reducing the repeated HRQoL responses to summary statistics, we 
can model the individual Yjj in terms of x1j. The next section will discuss three 
distinct strategies in analysing the repeated HRQoL responses. 
3. Modelling of longitudinal data 
(i) Repeated measures Analysis of Variance (ANOVA) 
In some situations HRQoL assessments may be made over a limited period 
rather than over an extended time span. In this case in may be reasonable to 
assume that all the subjects complete all the assessments. Thus instead of 
having a fragmented data file with the number of observations for each 
subject varying from subject to subject, the file has a regular or rectangular 
shape. This enables the repeated measures ANOVA approach to be 
considered (Fayers and Machin, 2000). 
Diggle et al (2002) say that ANOVA has limitations that prevent its 
recommendation as a general approach for longitudinal data. The first is that it 
fails to exploit the potential gains in efficiency from modelling the covariance 
among repeated observations. A second limitation is that, ANOVA methods 
usually require a complete balanced array of data. As Fayers and Machin 
(2000) point out this is the main difficulty with repeated measures ANOVA, in 
HRQoL research, since there are seldom equal numbers of QoL assessments 
recorded per patient. It is therefore better to use a regression modelling 
approach rather than repeated measures ANOVA for analysing longitudinal 
HRQoL data. 
Diggle et al (2002) point out that the use of repeated measures ANOVA 
implies an exchangeable auto-correlation between any two observations on 
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the same patient. This may not always be appropriate for HRQoL 
assessments. 
(fi) Marginal Models - Generalised Estimating Equations 
The second strategy is to model the marginal mean as in a cross-sectional 
study. Since repeated values are not likely to be independent, this marginal 
analysis must also include assumptions about the form of the correlation. For 
example, in the linear model we can assume that E(YI) = Xjfl, and Var(YI) = 
Vi(a) where 8 and a must be estimated. The marginal model approach has 
the advantage of separately modelling the mean and covariance. Valid 
inferences about 8 can sometimes be made even when an incorrect form for 
the V(a) is assumed. 
Marginal models are appropriate when inferences about the population 
average are the focus. For example, in a clinical trial the average difference 
between control and treatment is most important, not the difference for any 
one individual. In a marginal model, the regression of the response on 
explanatory variables is modelled separately from the within-person 
correlation. In regression, we model the marginal expectation, E(Yij), as a 
function of explanatory variables. By marginal expectation, we mean the 
average response over the sub-population that shares a common value of x. 
The marginal expectation is what we modelled in the analysis of the cross- 
sectional studies in the preceding chapter. 
A marginal model has the following assumptions (Diggle et al 2002): 
(1) the marginal expectation of the response, E(YU) = pd, depends on 
explanatory variables x1j, by h(, uij) = xjT, 6 where h is a known link 
function such as the logit for binary responses or log for counts; 
(2) the marginal variance depends on the marginal mean according to 
Var(Yq) = v(pij)o where v is a known variance function and 0 is a scale 
parameter which may need to be estimated; 
167 
Chapter 8: Modelling longitudinal HRQoL data 
(3) the correlation between Yjj and Yjk is a function of the marginal means 
and perhaps of additional parameters a, that is Corr(YU, Yjk) = p(g,, uik; 
where p(. ) is a known function. 
The marginal regression coefficients, 8, have the same interpretation as the 
coefficients from a cross-sectional analysis. Consider a simple linear 
regression model for HRQoL over time for a group of hospital patients 
following surgery say, 
yij ýA +fl2tij +Eiji (8.5) 
where t# is the time of the QoL assessment, say in months post surgery, of 
patient i at visit j, Yi, is the HRQoL at time tij post surgery and q is a mean- 
zero residual. Since patients' HRQoL will not all improve (or deteriorate) at the 
same rate, the residuals Ci, 5 CiV-11 Cin, I for patient i are likely to be correlated 
with one another. The marginal modelling approach is to assume 
(1) E(Yij)=fll+fl2tij ; 
(2) Corr (ey, eik) = p(ty, tik; a). 
Assumption (1) is that the average HRQoL for all patients in the population at 
any time t is fl, +, 82t., The parameter 82 is therefore the change per month 
in the population-average HRQoL. Assumption (2) specifies the nature of the 
autocorrelation; a specific simple example might be that 
Corr (ey, eik 
)= 
o(ty, tik; a)= a, (8.6) 
Le. a constant, so that the auto-correlation matrix is exchangeable or 
compound symmetric. In the marginal approach, we separate the modelling of 
the regression and the correlation either can be changed without necessarily 
changing the other (Diggle et al 2002). 
A more complex example would be to consider the same linear regression but 
this time let the errors follow an autoregressive structure introduced in (8.4). 
Again the mean response is E(Yj)=, 8, +, 6, tij. The covariance structure is now 
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given by Cov(Y,, Y,, )=u 
2 
exp(- dt, - 
tkl) and the variance is assumed to be 
independent of the mean. 
The marginal modelling approach uses Generalized Estimating Equations 
(GEEs) to estimate the regression coefficients (Liang and Zeger, 1986). In the 
GEE approach any required covariance structure and any link function may be 
assumed and the parameters estimated without specifying the joint 
distribution of the repeated observations. Estimation is via a multivariate 
analogue of a quasi-likelihood approach (Wedderburn, 1974). We briefly 
outline this approach in Appendix 5. In the marginal modelling approach, we 
only need to specify the first two moments of the responses for each person 
(i. e. the mean and variance). With Normal data, the first two moments fully 
determine the likelihood, but this is not the case for other members of the 
Generalized Linear Model (GLIVI) family (Diggle et al 2002). 
Since the parameters specifying the structure of the correlation matrix are 
rarely of great practical interest (they are what is known as nuisance 
parameters), simple structures (e. g. exchangeable or Ilst order autoregressive) 
are used for the within subject correlations giving rise to the so called working 
correlation matrix. Liang and Zeger (1986) show that the estimates of the 
parameters of most interest, i. e. those that determine the mean profiles over 
time, are still valid even when the correlation structure is incorrectly specified. 
Diggle et al (2002) conclude that the GEE method of estimation enjoys two 
useful and important properties: 
6 is nearly efficient relative to the maximum likelihood estimates of B 
in many practical situations provided that Var(YI) has been reasonably 
approximated. 
A (2) fl is consistent as m -> oo, even if the covariance of Yj is incorrectly 
specified. 
When the regression coefficients are the scientific focus, as in the examples in 
this chapter, one should invest the lion's share of time in modelling the mean 
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structure, while using a reasonable approximation to the covariance. The 
robustness of the inferences about fl can be checked by fitting a final model 
using different covariance assumptions and comparing the two sets of 
estimates and their robust standard errors. If they differ substantially, a more 
careful treatment of the covariance model may be necessary (Diggle et al 
2002). 
The process of fitting marginal models using GEE begins by assuming the 
simple independence form for the autocorrelation matrix R, and fitting the 
model as if each assessment were from a different patient. Once this model Is 
obtained the corresponding residuals are calculated and these are then used 
to estimate the autocorrelation matrix assuming it is of the exchangeable (or 
autoregressive) type. This matrix is then used to fit the model again, the 
residuals are once more calculated, and the autocorrelation matrix obtained. 
The iteration process is repeated until the corresponding regression 
coefficients that are obtained in the successive models converge or differ little 
on successive occasions (Fayers and Machin, 2000). 
(N) Random effects models 
A third approach, the random effects model, assumes that the correlation 
arises among repeated responses because the regression coefficients vary 
across individuals. Here we model the conditional expectation of Yq given the 
person-specific coefficients, 4, by E(Y#1,4) = xTjfl,. 
Since there are too little data on a single person to estimate 4 from (YI, Xj) 
alone, we further assume that the fls are independent realisations from some 
distribution with mean 8. If we write )q =8+U, where 8 is fixed and U, is a 
zero-mean random variable, then the basic heterogeneity assumption can be 
restated in terms of the latent variables, U1. That is, there are unobserved 
factors represented by the Uls that are common to all responses for a given 
person but vary across people, thus indicating the correlation. Random effects 
models are particularly useful when inferences are to be made about 
individuals, rather than the population average. 
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The advantage of the random effects model is that there are fewer regression 
parameters to estimate. It is based on the assumption that the subjects in the 
study are chosen at random from some wider patient population. This will 
seldom be true, at least in the context of a clinical trial for which trial patients 
are screened for eligibility and entered only after giving informed consent. 
However it is usually reasonable to assume that trial patients have been 
chosen at random from a large number of potentially eligible patients, and that 
they represent a random selection from this artificial population. Thus, a 
random effects model is frequently applied whenever a study includes a large 
numbers of patients (Fayers and Machin, 2000). 
If we assume a random effects model is appropriate, then models can be 
fitted using multi-level modelling statistical software which is implemented in 
MLw1N for example (Goldstein et al 1998). Use of multilevel modelling as 
opposed to marginal modelling allows examination of the "error" parts of the 
model in more detail. 
The random effects model is most useful when the objective is to make 
inference about individuals rather than the population average. Thus a 
random effects approach will allow us to estimate the HRQoL status of an 
individual patient. The regression coefficients, 8, represent the effect of the 
explanatory variables on an individual patient's HRQoL. This is in contrast to 
the marginal model coefficients, which describe the effect of the explanatory 
variables on the population average. 
Random-effects vs. Marginal Modelling 
The two approaches of random effect and marginal modelling, lead to different 
interpretations 'of between subject effects. In random effects models, a 
between subject effect represents the difference between subjects conditional 
on having the same random effect, whereas the parameters of marginal 
models represent the average difference between subjects. 
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Diggle et al (2002) demonstrate, that in the linear case, it is possible to 
formulate the two regression approaches to have coefficients with the same 
interpretation. That is coefficients from linear random effects models can have 
marginal interpretations as well. With non-linear link functions, such as the 
logit this is not the case. So in practice, this distinction is important only if link 
functions other than the identity link are used (Rabe-Hesketh and Everitt, 
2000). 
However, we tend to agree with Diggle et al (2002) that the choice of model 
should depend on the scientific question being asked. We will concentrate on 
marginal models since they are appropriate when inferences about the 
population average are the focus. In a clinical trial (such as the Leg Ulcer and 
NAMEIT studies) the average difference in HRQoL between the control and 
intervention groups is most important, not the difference in HRQoL for any one 
individual. However, first of all we will demonstrate the use of simpler 
summary measures or response features to analyse the Leg Ulcer dataset. 
Analysis of Leg Ulcer data 
The aim of this randomised controlled trial with one year of follow-up was to 
establish the relative cost-effectiveness of community leg ulcer clinics that use 
four-layer compression bandaging versus usual care provided by district 
nurses. Patients with venous leg ulcers were allocated at random to 
intervention (Clinic) or control (Home) groups. The intervention consisted of 
weekly treatment with four layer bandaging in leg ulcer clinic (Clinic group) or 
usual care at home by the district nursing service (Home group). The primary 
outcome was time to complete ulcer healing over the one-year follow-up. 
Secondary outcomes included HRQoL as measured by the SF-36 at baseline, 
three months and 12 months follow-up. Of the 233 patients randomised 
155/233 (66.5%) completed the 12-month HRQoL assessment (77 in the 
Home group and 78 in the Clinic group). We are interested in comparing the 
HRQoL over the one-year follow-up between the two groups. 
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We will base our analysis on these 155 patients, but again it should be noted 
that missing HRQoL assessments may be a serious problem with this dataset 
and the reasons for the missing data should be thoroughly investigated. We 
will assume that the data are Missing Completely at Random, (MCAR) and 
that this reduced dataset represents a randomly drawn sub-sample of the full 
dataset and the inferences drawn can be considered reasonable (Fayers and 
Machin, 2000). There is extensive discussion of the occurrence of dropouts 
and missing data in a special edition of Statistics in Medicine (Volume 17, 
1998) and both Fayers; and Machin (2000) and Fairclough (2002) devote 
several chapters to this topic. 
We use the Leg Ulcer data to illustrate various simple methods for analysing 
longitudinal data, including ANCOVA, with mean follow-up HRQoL (i. e. the 
average of the 3- and 12-month responses) as the dependent variable and 
baseline HRQoL and treatment group as covariates, and summary measures 
such as the AUC. We will compare and contrast conventional methods of 
standard error and confidence interval estimation with the corresponding 
estimates from the use of various bootstrap resampling methods. 
Table 8.3 shows the baseline HRQoL and socio-demographic characteristics 
of the 155 patients in the Leg Ulcer study. The two groups were well matched 
at baseline for age, gender and HRQoL, except for the RE dimension of the 
SF-36, where there was some reliable statistical evidence of a difference (p 
0.052). 
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Leg Ulcer A UC analysis 
The overall HRQoL of the leg ulcer patients over the 12-month study period 
(and three HRQoL assessments) can be summarised by the AUC. AUC were 
calculated using the trapezium rule as described in section 1 of Appendix 5. If 
we set the time units for the AUC calculation as a fraction of a year, then an 
AUC value of 100 implies the leg ulcer patient has been in "good health" for 
the entire 12-month follow-up period. Conversely an AUC value of 0 implies 
the leg ulcer patient has been in "poor health" for the entire 12-month follow- 
up period. Figures 8.1 and 8.2 show the histograms of the distribution of the 
AUC summary measure for the eight dimensions of the SF-36 separately for 
the Home and Clinic groups. Although the distributions are not symmetric, the 
histograms are not as skewed as the raw data at each time point. 
Table 8.4 gives the results of simple comparisons of differences in mean AUC 
between the groups using the two independent samples Mest, with unequal 
variances (7.16 and 7.17) and the bootstrap hypothesis test (using Algorithm 
7.2). We also show the results of the MIN test. All analyses were carried out in 
STATA va (StataCorp, 2003). 
The p-values from the Mest and the ASL from the bootstrap hypothesis tests 
are very similar. None of the p-values for the eight SF-36 dimensions are less 
than 0.05. Therefore there is no reliable statistical evidence to suggest a 
difference in mean ALIC between the Clinic and Home treated leg-ulcer 
patients. Only the results of the MW test on the RE dimension of the SF-36 
provide (p = 0.071) any evidence of a difference in AUC distributions between 
the groups, although even this p-value is not statistically significant using the 
conventional cut-off of 0.05. 
The table also contrasts the Normal theory based CI estimates from the Mest 
with the bootstrap BCa limits. The lengths of the intervals are very similar, 
although the bootstrap BCa intervals tend to have a non-symmetric shape. All 
the estimated Cis include zero, again suggesting no evidence of a difference 
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in mean AUC (HRQoL) between the Clinic and Home group patients in the 
Leg Ulcer study. 
Figure 8.1: Histograms of AUC summary from Leg ulcer data by group 
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Figure 8.2: Histograms of AUC summary from Leg ulcer data by group 
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Leg Ulcer analysis of covariance 
The final analysis of the Leg ulcer data involved a multiple regression analysis 
with the average follow-up HRQoL (the mean of the 3- and 12-month 
assessments) as the dependent variable, f,, and the baseline HRQoL (xB., 
-j 
) 
and treatment group (xG,,,,, P_i, coded Home = 0, Clinic = 1) as covariates. The 
linear regression model for the th subject was: 
(8.7) Y1 =A+ Awe XB=e 
-I+ 
flGroup XGroup 
_I+ 
el 
where a is a zero mean error term and, 81 is a constant. 
The regression coefficient estimate, Aroup I for group represents the 
difference 
in mean follow-up HRQoL between the Home and Clinic groups after 
adjustment for baseline HRQoL. A positive value for the regression coefficient 
fo r ýG,,, P 
indicates the Clinic group has a better mean HRQoL at follow-up 
than the Home group after adjustment for baseline HRQoL. 
We used OLS to estimate the regression coefficients and then applied the 
bootstrap model and case-based resampling Algorithms (7.3 and 7.4) in S- 
plus 2000 (MathSoft, 1999) and STATA (StataCorp, 2003) to estimate 
bootstrap standard errors and BC. confidence intervals for the regression 
coefficients. Again Appendix 4 provides examples of the programs for case 
and residual resampling and estimation of BCa confidence intervals. 
Table 8.5 compares the OLS and bootstrap standard errors and confidence 
interval estimates for the group coefficient from the Leg Ulcer data. For the 
bootstrap methods the standard errors are the standard deviations of the 
coefficients from the 5000 bootstrap re-samples. Again for ease of 
interpretation and comparison only the estimates for the group coefficient 
, aG,,, UP are shown. 
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Table 8.5: Multiple regression, OLS, bootstrap case and model based 
resampling SE's and Confidence Interval estimates from the Log Ulcer 
data with the mean of the two follow-up assessments as the outcome 
Dependent GROUP coefficient 95% cl Interval 
Variable Model N SE 
ýISE 
p Lower Upper Length Shape 
Physical OLS 147 -6.3 3.31 -1.91 0.058 -12.86 0.21 13.07 1.00 
Function Case 3.28 -1.93 -13.17 -0.27 12.90 0.89 
Model 3.34 -1.89 -13.09 -0.04 13.04 0.93 
Role OLS 146 -3.9 5.43 -0.72 0.474 -14.64 6.84 21.48 1.00 
Physical Case 5.42 -0.72 -14.18 7.15 21.33 1.08 
Model 5.39 -0.72 -14.64 6.52 21.17 0.97 
Bodily OLS 146 . 0.2 3.69 -0.06 0.954 -7.50 7.07 14.57 1.00 
Pain Case 3.65 -0.06 -7.14 7.34 14.48 1.09 
Model 3.66 -0.06 -7.13 7.06 14.19 1.05 
General OLS 146 0.9 2.54 0.34 0.733 -4.15 5.89 10.04 1.00 
Health Case 2.63 0.33 -4.10 6.11 10.21 1.05 
Model 2.60 0.33 -3.97 6.25 10.22 1.11 
Vitality OLS 145 1.4 2.52 0.57 0.569 -3.55 6.43 9.98 1.00 
Case 2.51 0.57 -3.56 6.38 9.94 0.99 
Model 2.50 0.58 -3.49 6.41 9.90 1.01 
Social OLS 146 0.7 4.06 0.18 0.855 -7.27 8.76 16.04 1.00 
Function Case 4.06 0.18 -6.99 8.75 15.74 1.03 
Model 4.10 0.18 -7.20 8.92 16.11 1.03 
Role OLS 145 -5.3 5.94 -0.90 0.370 -17.10 6.41 23.50 1.00 
Emotional Case 5.87 -0.91 -16.54 6.52 23.06 1.06 
Model 5.97 -0.90 -17.05 6.48 23.53 1.01 
Mental OLS 146 -0.4 2.15 -0.18 0.859 -4.63 3.86 8.49 1.00 
Health Case 2.16 -0.18 -4.59 3.75 8.34 0.98 
I 
Model 
I 
2.14 -0-18 -4.59 3.83 8.42 1.00 
I 
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The regression analysis shown in Table 8.5 suggests that there Is no reliable 
statistical evidence of a difference in average (3- and 12-month) follow-up 
HRQoL between Clinic and Home group treated leg ulcer patients on seven 
out of the eight dimensions of the SF-36 after adjustment for baseline HRQoL 
dimension score. Only on the PF dimension (p = 0.058) is there any 
suggestion of a difference. 
As can be seen from Table 8.5 the standard error estimates are almost 
identical for the three methods. Similarly the length of the confidence intervals 
is virtually the same for all three methods, although the bootstrap Cis tend to 
be asymmetric about the point-estimate of the regression coefficient. 
Qualitatively seven out eight of the intervals from the three methods either 
include or exclude zero so the interpretation of the group regression 
coefficient is the same. The only exception is the PF dimension where both 
the asymmetric case and model based bootstrap confidence intervals 
marginally exclude zero. Conversely the upper limit of the OLS estimate is 
also very close to zero, so the practical interpretation of all three confidence 
intervals should be the same, i. e. no consistent evidence of a difference in 
mean follow-up HRQoL between the groups. 
Therefore again in this example dataset there appears to be little advantage in 
using bootstrap case or model based re-sampling to estimate standard errors 
and confidence intervals compared to conventional methods of confidence 
interval estimation from the OLS multiple regression model. 
Analysis of NAMEIT data 
The NAMEIT trial was a 48-week, randomised, double blind RCT to compare 
Neoral with methotrexate (Neoral) versus placebo plus methotrexate 
(Placebo) in patients with early severe rheumatoid arthritis (RA). In order to 
assess the impact of the treatments on patients' health related quality of life, 
the SF-36 was completed by subjects at seven time-points, Week 0 
(baseline), Weeks 8,16,24,32,40, and Week 48. Of the 306 subjects 
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randomised, 223 (72.9%) completed the study, 111 in the Placebo group and 
112 in the Neoral group. 
We will base our analysis on these 223 patients, but again it should be noted 
that missing HRQoL assessments may be a serious problem with this dataset 
and the reasons for the missing data should be thoroughly investigated. We 
will assume that the data are MCAR, and that this reduced dataset represents 
a randomly drawn sub-sample of the full dataset and the inferences drawn 
can be considered reasonable. 
We use these data to illustrate various methods for analysing longitudinal 
data, including ANCOVA, with average follow-up HRQoL as the dependent 
variable and baseline HRQoL and treatment group as covariates, summary 
measures (e. g. AUC) and a marginal model analysis, incorporating all seven 
HRQoL assessments. Again we will compare and contrast conventional 
methods of standard error and confidence interval estimation with the 
bootstrap resampling methods. 
Graphical presentation of longitudinal data from NAMEIT study 
Both Diggle (et al 2002) and Fayers and Machin (2000) emphasise the 
importance of graphical presentation of longitudinal data prior to modelling. 
Figure 8.3 shows the mean levels of HRQoL in patients with RA, before and 
during treatment, for the eight dimensions of the SF-36. The curves for some 
dimensions of the SF-36 overlap (e. g. PF, GH, RE, and MH dimensions) 
suggesting that it may be unrealistic to assume that the mean difference in 
HRQoL values on these dimensions remains constant over time. For other 
dimensions such as BP, V and SF there is some evidence to suggest that for 
later HRQoL measurements the curves are parallel and that the mean 
difference between treatments is now fairly constant. 
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Figure 8.3: Profile of mean SF-36 scores over time by treatment group 
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The overlapping lines on some of the graphs in Figure 8.3 imply there may be 
a 'Treatment x Time' interaction. It is therefore Important to test for any such 
interaction in any regression model. Fortunately, with the marginal model 
approach this is relatively easy to do and simply involves the addition of an 
extra regression coefficient to the model. If treatment is coded as a 0/1 
variable (i. e. 0= Placebo and 1= Neoral) and assessment time as a 
continuous variable, then the additional interaction term is simply the product 
of these two variables (which will be 0 for all the Placebo group patients and 
equal to the HRQoL assessment time in the Neoral Group patients). 
Table 8.6 shows the baseline HRQoL and socio-demographic characteristics 
of the 223 patients in the NAMEIT study. The two groups of RA patients were 
well matched at baseline with respect to age, gender and HRQoL. 
Two simple response feature analyses are calculation of the ALIC for the 
seven repeated HRQoL assessments and the regression of the mean of the 
six follow-up HRQoL assessments against the baseline HRQoL and treatment 
group. 
NAMEIT A UC analysis 
The overall HRQoL of the RA patients over the 48-week study period (and 
seven HRQoL assessments) can be summarised by the ALIC. Again 
individual AUC were calculated using the trapezium rule as described in 
section I of Appendix 5. If we set the time units for the AUC calculation as a 
fraction of a year, then an AUC value of 100 implies the RA patient has been 
in "good health" for the entire 48-week follow-up period. Conversely an AUC 
value of 0 implies the RA patient has been in "poor health" for the entire 48- 
week follow-up period. For the NAMEIT study HRQoL was assessed at seven 
equally spaced time-points eight weeks apart, therefore the ALIC calculation is 
equivalent to the mean of all the seven HRQoL assessments. 
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Table 8.7 gives the results of simple comparisons of differences In mean AUC 
between the groups using the two independent samples Mest, with unequal 
variances (7.16 and 7.17) and the bootstrap hypothesis test (using Algorithm 
7.2). We also show the results of the MIN test. All analyses were carried out In 
STATA v8 (StataCorp, 2003). The ASL from the bootstrap hypothesis test 
and the BCa confidence interval estimates are based on 5000 re-samples. 
The p-values from the Mest and the ASL from the bootstrap hypothesis tests 
are very similar. Only one of the p-values using either of these two tests for 
the eight SF-36 dimensions was less than 0.05. So there is some reliable 
statistical evidence to suggest a difference in mean RP ALIC between the 
Placebo and Neoral treated RA patients. The results of the MIN test on the BP 
dimension of the SF-36 (p = 0.024) also provides some evidence of a 
difference in AUC distributions between the groups, although this p-value is 
not statistically significant using the conventional cut-off of p<0.05 for the t- 
test and bootstrap hypothesis test (with p-values of 0.056 and 0.054 
respectively). 
The Normal theory based Cl estimates from the Mest and the bootstrap BC, 
limits are calculated for a characteristic of the distributions (for example mean 
difference). The groups may have differences in distributions of HRQoL (e. g. 
BP) but similar characteristics e. g. means. The lengths of the intervals are 
very similar, although the bootstrap BC. intervals tend to have a non- 
symmetric shape. For seven out of the eight dimensions the estimated Cls 
include zero, again suggesting no evidence of a difference in mean AUC 
(HRQoL) between the Neoral and Placebo group patients in the NAMEIT 
study. The exception is the RP dimension where both the Mest and the 
bootstrap BCa limits suggest that the Neoral group has a better mean ALIC 
than the Placebo group. 
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NAMEIT analysis of covariance 
The second analysis of the NAMEIT data involved a multiple regression 
analysis with the average follow-up HRQoL (the mean of the six follow-up 
assessments at 8,16,24,32,40 and 48 weeks) as the dependent variable 
and the baseline HRQoL and treatment group (Placebo = 0, Neoral = 1) as 
covariates. The linear regression model was the same as (8.7), but this time 
the dependent variable (Y, ) was the average of the six follow-up HRQoL 
assessments. 
The regression coefficient estimate, &. up s 
for group represents the difference 
in mean follow-up HRQoL between the Placebo and Neoral groups after 
adjustment for baseline HRQoL. A positive value for the regression coefficient 
estimate for ýG,., indicates the Neoral group has a better mean HRQoL at 
follow-up than the Placebo group after adjustment for baseline HRQoL. 
We used OLS to estimate the regression coefficients and then applied the 
bootstrap model and case-based resampling Algorithms (7.3 and 7.4) in S- 
Plus 2000 (MathSoft, 1999) and sTATA (StataCorp, 2003) to estimate 
bootstrap standard errors and BCa confidence intervals for the regression 
coefficients. Again Appendix 4 provides examples of the programs for case 
and residual resampling and estimation of BC. confidence intervals. The 
bootstrap estimates are based on 5000 re-samples. 
Table 8.8 compares the OLS and bootstrap standard errors and confidence 
interval estimates for the group coefficient from the NAMEIT data. For the 
bootstrap methods the standard errors are the standard deviations of the 
coefficients from the 5000 bootstrap re-samples. Again for ease of 
interpretation and comparison only the estimates for the group coefficient are 
shown. 
188 
Chapter 8: Modelling longitudinal HRQoL data 
Table 8.8: Comparison of OLS and bootstrap SE's and Ci's - NAMEIT 
data with the mean of six follow-up assessments as the outcome 
Dependent Group coefficient 95% cl Interval 
Variable Model N 
A 
'8 SE 
ft/ SE p Lower Upper Length Shape 
Physical OLS 222 2.8 2.26 1.25 0.213 -1.63 7.28 8.91 1.00 
Function Case 2.24 1.26 -1.49 7.40 8.89 1.06 
Model 
1 
2.24 1.26 -1.63 7.20 8.83 0.98 
Role OLS 221 9.4 3.93 2.39 0.018 1.64 17.15 15.51 1.00 
Physical Case 3.87 2.43 1.96 16.96 15.00 1.02 
Model 3.98 2.36 1.51 17.05 15.54 0.97 
Bodily OLS 222 4.2 1.97 2.15 0.033 0.36 8.13 7.77 1.00 
Pain Case 1.98 2.14 0.30 8.08 7.78 0.97 
Model 1.97 2.15 0.36 8.07 7.71 0.99 
General OLS 221 4.6 1.96 2.36 0.019 0.76 8.50 7.73 1.00 
Health Case 1.99 2.32 0.58 8.35 7.77 0.92 
Model 1.96 2.36 0.82 8.54 7.72 1.03 
Vitality OLS 220 2.7 1.80 1.49 0.138 -0.87 6.23 7.10 1.00 
Case 1.81 1.48 -0.69 6.36 7.05 1.09 
Model 1.81 1.48 -0.86 6.29 7.15 1.02 
Social OLS 222 2.4 2.10 1.15 0.252 -1.73 6.54 8.26 1.00 
Function Case 2.10 1.14 -1.47 6.87 8.35 1.15 
Model 2.12 1.14 -1.80 6.49 8.29 0.97 
Role OLS 221 4.1 3.91 1.05 0.293 -3.58 11.82 15.40 1.00 
Emotional Case 3.99 1.03 -3.86 11.91 15.77 0.98 
Model 3.97 1.04 -3.51 11.99 15.51 1.03 
Mental OLS 221 1.5 1.64 0.94 0.349 -1.69 4.77 6.47 1.00 
Health Case 1.69 0.91 -1.88 4.74 6.62 0.94 
1 
Model 
1 
1.62 0.95 -1.63 4.66 
1 
6.29 0.99 
-I 
The regression analysis shown in Table 8.8 suggests that there is no reliable 
statistical evidence of a difference in average follow-up HRQoL between 
Neoral and Placebo group treated RA patients on five out of the eight 
dimensions of the SF-36 after adjustment for baseline HRQoL dimension 
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score. On three other dimensions RP (p = 0.018), BP (p = 0.033) and GH (p = 
0.019) there is some suggestion of a difference In average follow-up HRQoL. 
As can be seen from Table 8.8 the standard error estimates are almost 
identical for the three methods. Similarly the length of the confidence Intervals 
is virtually the same for all three methods, although the bootstrap Cls tend to 
be asymmetric about the point-estimate of the regression coefficient. 
Qualitatively all the intervals from the three methods either include or exclude 
zero so the interpretation of the group regression coefficient Is the same. For 
the RP, BP and GH dimensions there Is some suggestion that Neoral group 
has a better average follow-up HRQoL than Placebo group patients. 
Therefore again in this example dataset there appears to be little advantage In 
using bootstrap case or model based re-sampling to estimate standard errors 
and confidence intervals compared to conventional methods of confidence 
interval estimation from the OLS multiple regression model. Finally we will 
now use a marginal model to analyse all seven HRQoL assessments 
simultaneously. 
NAMEIT marginal model analysis 
The marginal model we used for the NAMEIT data for analysing the seven 
HRQoL assessments over time was, 
YiJ ý_ A+ AaseXBasej + AgeXAgej + flS. XSex_i + Almety + J8Gr,,, 
XGn,. p_I 
+ CIV 1 
(8.8) 
where Yy is the HRQoL at time tij post-baseline-, ti, is the time of the QoL 
assessment, in weeks post baseline, of patient i at visit j; xB., 
-i 
is the 
baseline HRQoL assessment for subject t, xA,,, 
_, 
is the age (in years) of 
subject i at time 0 (baseline); xs,, is the gender of subject t, xG,,,,,,, Js the 
treatment group (0 = Placebo, 1= Neoral) for subject i; fl, is a constant and ey 
is the residual error. The marginal modelling approach is to assume 
(1) E(Yu)=, gl +flB,,,, xB,., 
_, 
+.... +, gGmupxcroup_i 
9 (8.9) 
(2) Corr(cu, eik) = p(tij, tik; a). (8.10) 
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The marginal regression models were fitted in sTATA v8 (StataCorp, 2003) 
using the xtgee command with an identity link function (link (iden) ) and 
the robust standard errors option. We tried out three autocorrelation 
structures Cor+,, e,, )=, o(t,, t.; a) for the marginal model: 
(1) independent corr(indep) Cbrr(q,, e,, )=, o(t,, t,,; a)=O; 
(2) exchangeable corr (exc) Corr(ey, cjk) = p(lu, tik ; a)= ao; 
(3) autoregressive corr (arl) Cov(YU, Yk)= a2 CXP 
(- 01- tA 
The three autocorrelation structures above assume working correlation 
matrices R(a) of the identity matrix for the independent structure; a working 
I --> S=t correlation matrix of R,,, = ao -+ otherwise 
for the exchangeable structure and 
I -ý s=t finally a working correlation matrix of Rs, = 
al-'-'l -> other-wise 
for the 
autoregressive model. 
The (first) marginal model with the identity link, Normal family and with an 
independent correlation structure reproduces OLS estimators from the 
standard multiple linear regression model described in Chapter 7. 
The observed correlation matrices in Figure 8.1 clearly show the off-diagonal 
terms are non-zero and that the assumption of an independent auto- 
correlation matrix for the marginal model is unrealistic. Therefore we will not 
consider models with an independent auto-correlation structure any further 
and will concentrate on reporting the results of models with either an 
exchangeable (2) or autoregressive correlation (3). 
According to the STATA reference manual (StataCorp, 2003), the robust 
option specifies that the HuberMhite sandwich estimator of variance is to be 
used in place of the default Iteratively Reweighted Least Squares (IRLS) 
variance estimator. This produces valid standard errors even if the within 
subject correlations are not as hypothesised by the specified correlation 
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structure. It does, however require that the model correctly specifies the 
mean. As such, the resulting standard errors are labelled "semi-robust" 
instead of "robust". We will compare the robust SlEs and Cls with their 
bootstrap counterparts. 
Treatment x time interactions 
In a previous section we mentioned the importance of looking for a 'Treatment 
x Time' interaction. This can easily be done by creating a new variable x,,, 
_,, 
which is the product of the treatment group and time variables and adding this 
extra term 8,, t to model (8.8) and fitting this new model 
yy =A +)6BaseXBase_1 + AgeXAgej + flS. XS, 
_i 
+ Aimtjl + AroupXGroupj + 
*81n1X1n1_U 
+ CU 
(8.11) 
None of the coefficients for the eight SF-36 dimensions were statistically 
significant (from zero). Thus there was no reliable evidence of a 'Treatment x 
Time' interaction on any dimension of the SF-36 (p > 0.05), irrespective of the 
autocorrelation structure (independent, exchangeable or autoregressive). 
Therefore we will only report the results of the simpler model (8.8). 
Bootstrap Resampling for the marginal model 
We have mentioned that the marginal model approach is robust to miss- 
specification of the autocorrelation structure particularly as the sample size 
increases. Furthermore the generation of robust standard errors will produce 
valid standard errors even if the within subject correlations are not as 
hypothesised by the specified correlation structure. It does, however require 
that the model correctly specifies the mean. So will the bootstrap estimation of 
standard errors and confidence intervals offer any advantage? 
The rest of this section will describe a simple bootstrap resampling algorithm 
for marginal models. The remainder of the chapter will then show how the 
bootstrap estimates of standard errors and confidence intervals compare with 
the robust standard errors and confidence intervals from the conventionally 
fitted marginal model. 
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Suppose as before we have the linear regression model (8.1). In this simple 
multiple regression model the cy would be mutually independent N(O a) 
random variables. The longitudinal structure of the data means that we can 
expect the ed to be correlated within subjects. 
In Chapter 7 we described two bootstrap resampling algorithms (7.3 and 7.4) 
for multiple linear regression models - case and model or residual based 
resampling. If the repeated HRQoL responses on each subject were assumed 
to be independent with no autocorrelation (or we choose to Ignore the 
correlation that exists in longitudinal data) then we could use either bootstrap 
resampling algorithm as the marginal model has been reduced to a simple 
cross-sectional model. 
Unfortunately, it is very unlikely that the successive HRQoL observations (and 
the corresponding residuals from the regression model) on each subject are 
independent and uncorrelated (see Table 8.1). Therefore both the case and 
model based bootstrap resampling Algorithms 7.3 and 7.4 are inappropriate. 
We must choose a resampling method that takes into account the complex 
dependences within the observed data. 
Suppose we assume a simple uniform or exchangeable correlation between 
successive HRQoL measurements on the same subject. Then model (8.1) 
can be simplified to 
Y, =, U, +U, +Z,, i=ltom; j=l,..., n (8.12) 
where uu=E(Yu)=, glxijl+, 82Xij2+.... +, 8, xij,, and the U, are mutually 
independent N(O, t? ) random variables and the Z# are mutually independent 
N(O, Z2 ) random variables and the Uj and the Z# are independent of one 
another. Then the covariance structure of the data Cov(Y,, Y,, ) corresponds to 
v (8.13 (v 2 +, r2)' 
(which is equivalent to (8.6) with p= ao) with variance, 
222 
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Equation (8.14) implies the total error or variance can be decomposed into a 
between subject error (J) and a within subject error term (, r). 
Suppose we had a fully balanced data set with no missing data and equal 
numbers ni =n of HRQoL observations per subject i (with m subjects, Le. i=1 
to m). If we felt an exchangeable autocorrelation structure was appropriate for 
the model and the residuals, then we could fit the marginal model (with 
exchangeable autocorrelation) and calculate the n residuals (Cl, C2#---. Cn)' for 
each subject and then use a variation of Algorithm 7.4, this time resampling 
from the m blocks of residuals (of size n). Unfortunately this approach only 
has the ability to model the total error or variance cr 2 and assumes the 
contribution of the between (d) and within subject error (, r) to the total error 
a2 is the same across all subjects. Similar concerns would apply if we 
assumed an autoregressive autocorrelation structure and re-sampled blocks 
of residuals again. 
The beauty of the marginal model and the GEE methodology is that it is very 
flexible and can in principle deal with all the observed data from a HRQoL 
study. The subjects are not required to have exactly the same numbers of 
assessments, and even the assessments can be made at variable times. The 
latter allows the modelling to proceed even if a subject misses a HRQoL 
assessment. So it seems unrealistic and unreasonable to use bootstrap 
resampling methods for marginal models that can only utilise a balanced data 
set, with equally spaced QoL assessments. 
Therefore since we are interested in fitting a marginal model with an 
autoregressive structure and we are likely to have an unbalanced dataset with 
unequal observations per subject we will use a simple bootstrap case- 
resampling Algorithm (8.1) which is a modification of Algorithm 7.3. 
Algorithm 8.1 
Case (or cluster) -based resampling for a marginal regression model 
If YU represents the HRQoL response variable and x1l a row vector of length p 
of explanatory variables observed at time t#, for observation j=1,..., ni on 
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subject i= The set of repeated HRQoL outcomes for subject i are 
collected into a ni-vector, y/ = 
(YiI 
0 
Y121 
... I 
Y,,,, )with a corresponding matrix of 
explanatory variables X, = 
(Xil 
2 
X12l 
lx,,,, 
). 
We shall fit the marginal linear regression model 
YU 7' A Xy I+A Xy 2+-* + 
flp Xyp + Cil with one of several autocorrelation 
structures for the residuals. The data will consist of m blocks, say WXXI, YI) = 
(XlP YI)v V29 YA 
... i(Xint Y,, ), corresponding to the data for each subject L 
1. Case-based resampling involves drawing a bootstrap sample of size m, 
with replacement from these m blocks. The bootstrap data set is of the 
form: 
i(YI, * 
, 
X, *. 
ý (yl: 
, 
x1*2 
where il, i2,... jIn is a random sample of integers 1 through m. 
2. A GEE approach (assuming either an independent, exchangeable or 
autoregressive correlation) using Iteratively Reweighted Least Squares 
(IRLS) is then used to estimate the regression coefficients ýP*, for this 
bootstrap sample of cases. 
3. We do this repeatedly, say B times, so we now have B bootstrap 
samples and B estimates of the regression coefficients, one from each 
bootstrap sample 1,1 *I ?PI- 00) P 'gP-)2 
W, 
B 
4. The standard error of these estimated coefficients seV. ) is simply the 
standard deviation of these B estimates. As before if these estimates 
are ordered in increasing value, v VP* WPIB VP')0)tI^*)(2)2'"I 
* 
)J, a simple 
95% 
bootstrap percentile confidence interval for the coefficient would be 
from the 0.025Bth to the 0.975e largest values. 
Applying the marginal model (8.8) and both the GEE methodology and 
bootstrap resampling Algorithm 8.1 to the NAMEIT data assuming, 
exchangeable and autoregressive forms of the autoregressive matrix, gives 
the results summarised in Tables 8.10 and 8.12 respectively. For ease of 
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interpretation we only show the estimated coefficients ý6^Tj . and GP 
for the 
Time and Group covariates respectively. All analyses were carried out In 
STATA v8 (StataCorp, 2003). The bootstrap standard errors and BC3 
confidence interval estimates were based on 1000 bootstrap re-samples using 
Algorithm 8.1 and the bootstrap procedure in STATA. (See Appendix 4 for 
more details). 
Results of Marginal Model (2) - exchangeable autocorrelation 
Table 8.9 shows the estimated within subject correlation matrices for the eight 
dimensions of the SF-36 if we fit model (8.8) and assume a compound 
symmetric structure. The lower diagonal gives the observed matrix before the 
model fitting. The fitted autocorrelations ranged from 0.43 for the RE 
dimension to 0.63 for the PF and GH dimensions. On the whole, the model 
correlation estimates tend to be lower than the actual observed 
autocorrelations, for HRQoL assessments that are close together. Conversely 
the model correlation estimates tend to be larger than the observed 
correlations for HRQoL observations further apart in time. It will usually be the 
case that after model fitting the autocorrelations will appear to have been 
reduced (Fayers; and Machin, 2000). 
Table 8.10 shows the estimated regression coefficients for the group and time 
variables. There is some evidence that HRQoL increases over time for three 
dimensions of the SF-36, PF, BP and V. However, we are interested in the 
effect of treatment and comparing HRQoL over time across the Placebo and 
Neoral treated groups. Since there is no reliable evidence of a 'Group x Time' 
interaction the interpretation of the treatment group coefficient is relatively 
straightforward. The p-values for the treatment group regression coefficients 
in Table 8.10 suggest significant differences in HRQoL between the Neoral 
and Placebo groups on three dimensions of the SF-36 (RP, GH and BP). 
The bootstrap and robust standard errors for the time and group coefficients 
are different, although the bootstrap SE estimate tends to be the same size or 
somewhat smaller than its robust counterpart. However both bootstrap and 
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robust SE estimates are of a similar order of magnitude. More importantly, the 
ratios of the estimated coefficient to its standard error are of similar size. 
Table 8.9 Observed and estimated within-patient auto-correlation 
matrices (exchangeable model) from RA patients In the NAMEIT study. 
The lower diagonal gives the observed matrix before model fiffing whilst 
the upper gives the exchangeable form after model-fitting' 
a) Physical Function e) Vitality 
Week 8 U 24 32 40 48 Week 8 16 24 32 40 48 
8 1.00 0.63 0.63 0.63 0.63 0.63 8 1.00 0.54 0.54 0.54 0.54 0.54 
16 0.74 1.00 0.63 0.63 0.63 0.63 16 0.58 1.00 0.54 0.54 0.54 0.54 
24 0.69 0.75 1.00 0.63 0.63 0.63 24 0.54 0.71 1.00 0.54 0.54 0.54 
32 0.68 0.80 0.79 1.00 0.63 0.63 32 0.59 0.68 0.71 1.00 0.54 0.54 
40 0.67 0.77 0.81 0.86 1.00 0.63 40 0.49 0.67 0.68 0.77 1.00 0.54 
48 0.64 0.74 0.81 0.81 0.85 1.00 48 0.53 0.66 0.72 0.72 0.76 1.00 
b) Role Physical Q Social Function 
Week a 16 24 32 40 48 Week 8 16 24 32 40 48 
8 1.00 0.48 0.48 0.48 0.48 0.48 8 1.00 0.53 0.53 0.53 0.53 0.53 
16 0.53 1.00 0.48 0.48 0.48 0.48 16 0.53 1.00 0.53 0.53 0.53 0.53 
24 0.39 0.57 1.00 0.48 0.48 0.48 24 0.65 0.63 1.00 0.53 0.53 0.53 
32 0.30 0.56 0.67 1.00 0.48 0.48 32 0.46 0.63 0.70 1.00 0.53 0.53 
40 0.42 0.52 0.60 0.61 1.00 0.48 40 0.51 0.58 0.64 0.71 1.00 0.53 
48 0.40 0.59 0.67 0.64 0.71 1.00 48 0.45 0.58 0.64 0.71 0.71 1.00 
c) Bodily Pain g) Role Emotional 
Week 8 16 24 32 40 48 Week 8 16 24 32 40 48 
8 1.00 0.48 0.48 0.48 0.48 0.48 a 1.00 0.43 0.43 0.43 0.43 0.43 
16 0.55 1.00 0.48 0.48 0.48 0.48 16 0.47 1.00 0.43 0.43 0.43 0.43 
24 0.47 0.61 1.00 0.48 0.48 0.48 24 0.40 0.59 1.00 0.43 0.43 0.43 
32 0.46 0.51 0.68 1.00 0.48 0.48 32 0.32 0.56 0.62 1.00 0.43 0.43 
40 0.42 0.57 0.60 0.69 1.00 0.48 40 0.46 0.53 0.56 0.54 1.00 0.43 
48 0.46 0.59 0.63 0.68 0.76 1.00 48 0.37 0.49 0.58 0.54 0.69 1.00 
d) General Health h) Mental Health 
Week 8 Is 24 32 40 48 Week 8 16 24 32 40 48 
8 1.00 0.63 0.63 0.63 0.63 0.63 8 1.00 0.52 O. J2 0.52 0.52 0.52 
16 0.68 1.00 0.63 0.63 0.63 0.63 Is 0.62 1.00 0.52 0.52 0.52 O. S2 
24 0.67 0.80 1.00 0.63 0.63 0.63 24 0.59 0.72 1.00 0.52 0.52 0.52 
32 0.67 0.77 0.83 1.00 0.63 0.63 32 0.55 0.65 0.69 1.00 0.52 0.52 
40 0.65 0.72 0.79 0.84 1.00 0.63 40 0.54 0.70 0.70 0.74 1.00 0.52 
48 0.65 0.75 0.84 0.82 0.85 1.00 48 0.55 0.68 0.72 0.73 0.77 1.00 
a) All models contain age, gencter, time, baseline HRQoL and group as covatiates. 
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Table 8.10: Comparison of robust and bootstrap SE's and Ci's from the 
NAMEIT data with a Marginal Model and exchangeable autocorrelation 
Dependent Coefficients 95% Cl Interval 
Variable SE 
ýISE 
P Lower Upper Length Shape 
_ 
Physical time 0.11 0.03 3.63 0.001 0.05 0.18 0.12 1.00 
Function 0.03 3.72 0.05 0.18 0.12 0.97 
(n=222) group 2.82 2.25 1.25 0.211 -1.60 7.24 8.84 1.00 
1 1.72 1.64 -0.51 6.13 6.64 0.99 
Role time -0.06 0.07 -0.90 0.366 -0.19 0.07 0.26 1.00 
Physical 0.07 -0.94 -0.19 0.06 0.25 0.91 
(n=221) group 9.49 3.93 2.42 0.016 1.79 17.19 15.40 1.00 
3.22 2.95 3.63 16.62 12.99 1.22 
Bodily time 0.16 0.03 4.69 0.001 0.10 0.23 0.14 1.00 
Pain 0.03 4.88 0.10 0.23 0.13 1.05 
(n=222) group 4.23 1.97 2.14 0.032 0.36 8.10 7.74 1.00 
1.50 2.82 1.44 7.25 5.81 1.08 
General time 0.04 0.03 1.67 0.095 -0.01 0.09 0.10 1.00 
Health 0.03 1.68 -0.01 0.09 0.10 0.95 
(n=221) group -4.61 1.96 -2.35 0.019 -8.46 -0.76 7.69 1.00 
1 1.51 -3.04 -7.36 -1.28 6.07 1.21 
Vitality time 0.09 0.03 3.09 0.002 0.03 0.14 0.11 1.00 
(n=220) 0.03 3.05 0.04 0.15 0.11 1.24 
group 2.67 1.80 1.48 0.14 -0.87 6.20 7.07 1.00 
1.41 1.89 -0.19 5.42 5.61 0.96 
Social time 0.03 0.03 0.77 0.442 -0.04 0.09 0.13 1.00 
Function 0.03 0.79 -0.04 0.09 0.13 0.97 
(n=222) group 2.40 2.11 1.14 0.255 -1.73 6.54 8.27 1.00 
1.65 1.46 -0.72 5.88 6.61 1.11 
Role time -0.02 0.07 -0.32 0.752 -0.17 0.12 0.29 1.00 
Emotional 0.08 -0.31 -0.18 0.12 0.30 0.93 
(n=221) group 4.14 3.91 1.06 0.29 -3.52 11.81 15.33 1.00 
2.93 1.41 -1.54 10.11 11.64 1.05 
Mental time 0.02 0.03 0.69 0.489 -0.03 0.07 0.10 1.00 
Health 0.03 0.68 -0.03 0.07 0.10 1.15 
(n=221) group 1.53 1.67 0.92 0.359 -1.74 4.79 6.53 1.00 
1 1.34 1.14 1 -0.93 4.421 5.35 1.181 
Note: The bootstrap estimates orw: ancf tfus Confidence lnterVajS are shown in italics below 
the model based estimates. 
A crude test of statistical significance is to examine this ratio, if it is bigger 
than 2.0 then the estimated regression coefficient is likely to be significantly 
different from zero. Table 8.10 shows that for all the models where the original 
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(group or time) regression estimates are significant (i. e. ratios of estimate/SE 
2) then so too is the ratio of the estimate to its bootstrap standard error. 
When we compare the bootstrap BCa confidence intervals with the model- 
based estimates in Table 8.10 then the length of the bootstrap intervals tend 
to be the same size or slightly narrower than its robust counterpart. As before 
the bootstrap estimates are not constrained to be symmetric about the point- 
estimate of the regression coefficient. Qualitatively both the bootstrap and 
model based intervals include zero when the estimated regression coefficient 
is non-significant and exclude zero when the estimated coefficient is 
significant. Therefore, the actual practical interpretation of the confidence 
interval estimates is the same. That is for the RP, BP, and GH dimensions 
there is some evidence that the Neoral group has a better HRQoL than the 
Placebo group patients over time, after allowing for baseline HRQoL, age and 
gender. 
The observed deviations between the fitted model and observed 
autocorrelations are not too great, suggesting that the assumption of 
compound symmetry is not unreasonable (Table 8.9). However, the 
compound symmetry structure for the correlations implied by exchangeable 
autocorrelation may not be acceptable on theoretical grounds since it is more 
likely that correlations between pairs of HRQoL observations widely separated 
in time will be lower than for observations closer together. 
Results of Marginal Model (3) - autoregressive autocorrelation 
To allow for a more complex pattern of correlations among the repeated 
HRQoL observations, we can move to an autoregressive structure. For first 
order auto-regression specification the correlation between time point's j and k 
is assumed to be pIV - kI (8.4). This model implies the correlation between a 
pair of HRQoL assessments on the same patient declines towards zero as the 
time separation between the assessments increases. The rate of decay is 
faster for larger values of 0. 
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Table 8.11 Observed and estimated within-patient auto-correlation 
matrices (exchangeable model) from RA patients in the NAMEIT study. 
The lower diagonal gives the observed matrix before model fitting whilst 
the upper gives the autoregressive form after model-fitting' 
a) Physical Function e) Vitality 
Week a 16 24 32 40 48 Week 8 16 24 32 40 48 
8 1.00 0.69 0.48 0.33 0.23 0.16 8 1.00 0.62 0.38 0.24 am 0.09 
16 0.74 1.00 a6g 0.48 a33 0.23 Is 0.58 1.00 0.62 a38 a24 am 
24 0.69 0.75 1.00 0.69 a48 a33 24 0.54 0.71 1.00 0.62 a38 0.24 
32 0.68 0.80 0.79 1.00 0.69 0.48 32 0.59 0.68 0.71 1.00 0.62 0.38 
40 0.67 0.77 0.81 0.86 1.00 0.69 40 0.49 0.67 0.68 0.77 1.00 a62 
48 0.64 0.74 0.81 0.81 0.85 1.00 48 0.53 0.66 0.72 0.72 0.76 1.00 
b) Role Physical Q Social Function 
Week 8 16 24 32 40 48 Week 8 16 24 32 40 48 
8 1.00 a57 a33 0.19 aij 0.06 8 1.00 0.60 a36 0.22 0.13 aos 
16 0.53 1.00 0.57 0.33 0.19 0.11 16 0.53 1.00 0.60 a36 a22 am 
24 0.39 0.57 1.00 a57 0.33 aig 24 0.55 0.63 1.00 a60 a36 a22 
32 0.30 0.56 0.67 1.00 0.57 a33 32 0.46 0.63 0.70 1.00 0.60 a36 
40 0.42 0.52 0.60 0.61 1.00 0.57 40 0.51 0.58 0.64 0.71 1.00 a6O 
48 0.40 0.59 0.67 0.64 0.71 1.00 48 0.45 0.58 0.64 0.71 0.71 1.00 
c) Bodily Pain g) Role Emotional 
Week 8 16 24 32 40 48 Week 8 16 24 32 40 48 
8 1.00 0.58 0.34 0.19 0.11 0.07 8 1.00 0.51 0.27 a14 0.07 0.04 
16 0.55 1.00 0.58 0.34 0.19 0.11 16 0.47 1.00 0.51 0.27 0.14 0.07 
24 0.47 0.61 1.00 0.58 0.34 0.19 24 0.40 0.59 1.00 0.51 0.27 0.14 
32 0.46 0.51 0.68 1.00 0.58 0.34 32 0.32 0.56 0.62 1.00 0.51 0.27 
40 0.42 0.57 0.60 0.69 1.00 0.58 40 0.46 0.53 0.56 0.54 1.00 0.51 
48 0.46 0.59 0.63 0.68 0.76 1.00 48 0.37 0.49 0.58 0.54 0.69 1.00 
d) General Health h) Mental Health 
Week 8 16 24 32 40 48 Week 8 16 24 32 40 48 
8 1.00 0.70 0.49 0.35 0.24 0.17 8 1.00 0.59 0.35 0.21 0.12 0.07 
16 0.68 1.00 0.70 0.49 0.35 0.24 16 0.62 1.00 0.59 0.35 0.21 0.12 
24 0.67 0.80 1.00 0.70 0.49 0.35 24 0.59 0.72 1.00 0.59 0.35 0.21 
32 0.67 0.77 0.83 1.00 0.70 0.49 32 0.55 0.65 0.69 1.00 a5g 0.35 
40 0.65 0.72 0.79 0.84 1.00 0.70 40 0.54 0.70 0.70 0.74 1.00 0.59 
48 0.65 0.75 0.84 0.82 0.85 1.00 48 0.55 0.68 0.72 0.73 0.77 1.00 
a) All models contain age, gender, time, baseline HRQoL and group as covariates. 
Table 8.11 shows the estimated within subject matrix correlation for the eight 
dimensions of the SF-36 if we fit model (8.8) and assume an autoregressive 
symmetry structure. The lower diagonal gives the observed matrix before the 
model fitting. The estimated with-subject correlation matrix (upper diagonal) 
after model fitting has the expected pattern in which the correlations decrease 
substantially as the separation between the observations increases. 
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On the whole, the model correlation estimates tend to be lower than the actual 
observed autocorrelations, particularly for HRQoL assessments that are 
further apart in time. For example (Table 8.11a), the observed correlation 
between the 8 and 16 week PF assessment was 0.74 compared to a model 
autocorrelation estimate of 0.69. Conversely the model correlation estimates 
tend to be smaller than the observed correlations for HRQoL observations 
further apart in time (the observed correlation between the 8 and 48 week PF 
scores was 0.64 compared to a model fitted estimate of 0.16). Thus the 
autoregressive model seems to substantially overestimate the decay towards 
zero in the correlation between pairs of measurements as the time separation 
between HRQoL assessments increases. 
The autoregressive model estimates of the regression coefficients (and their 
standard errors) shown in Table 8.12 have changed but not substantially from 
the estimates in Table 8.10. There is some evidence that HRQoL increases 
over time for four dimensions of the SF-36, PF, BP, V and GH. The GH 
dimension now has a significant time effect (p = 0.028) compared to that 
obtained with the exchangeable correlation model (p = 0.095). However, we 
are interested in the effect of treatment and comparing HRQoL over time 
across the Placebo and Neoral treated groups. The p-values for the treatment 
group regression coefficients in Table 8.12 suggest significant differences in 
HRQoL between the Neoral and Placebo groups on two dimensions of the 
SF-36 (RP and GH) using a cut-off of p<0.05 for statistical significance. The 
p-value for the group effect for the BP dimension is now marginally non- 
significant (p = 0.074) compared to a p-value of 0.032 for the exchangeable 
model. 
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Table 8.12: Comparison of robust and bootstrap SE's and Ci's from the 
NAMEIT data with a Marginal Model and autoregressive autocorrelation 
Dependent Coefficients 95% Cl Interval 
Variable SE 
ýISE 
P Lower Upper Length Shape 
Physical Time 0.13 0.03 3.65 0.001 0.06 0.20 0.14 1.00 
Function 0.04 2.91 0.04 0.21 0.17 0.96 
(n=219) group 3.10 2.24 1.39 0.165 -1.28 7.48 8.76 1.00 
3.04 1.02 -2.66 9.34 12.00 1.08 
Role Time -0.06 0.93 -0.83 0.408 -0.20 0.08 0.28 1.00 
Physical 0.10 -0.61 -0.25 0.14 0.39 1.01 
(n=214) group 10.11 3.96 2.55 0.011 2.35 17.87 15.52 1.00 
5.52 1.83 -0.57 20.86 21.42 1.01 
Bodily Time 0.18 0.04 5.12 0.001 0.11 0.25 0.14 1.00 
Pain 0.05 3.95 0.09 0.28 0.18 0.99 
(n=219) group 3.54 1.99 1.78 0.074 -0.35 7.44 7.79 1.00 
2.65 1.34 -1.74 8.58 10.32 0.95 
General Time 0.06 0.03 2.19 0.028 0.01 0.12 0.11 1.00 
Health 0.04 1.72 -0.01 0.13 0.15 0.98 
(n=213) group -4.49 1.95 -2.30 0.022 -8.32 -0.66 7.66 1.00 
1 2.67 -1.68 -10.07 0.45 10.52 0.89 
Vitality Time 0.11 0.03 3.51 0.001 0.05 0.17 0.12 1.00 
(n=217) 0.04 270 0.03 0.19 0.16 1.07 
group 2.59 1.79 1.45 0.148 -0.92 6.11 7.03 1.00 
1 2.48 1.05 -2.12 7.21 9.33 0.98 
Social Time 0.03 0.04 0.80 0.426 -0.04 0.10 0.14 1.00 
Function 0.05 0.61 -0.06 0.11 0.18 0.93 
(n=219) group 2.52 2.10 1.20 0.23 -1.59 6.63 8.22 1.00 
1 2.74 0.92 -2.65 7.91 10.56 1.04 
Role Time 0.02 0.08 0.21 0.832 -0.14 0.17 0.30 1.00 
Emotional 0.10 0.16 -0.18 0.22 0.40 1.05 
(n=212) group 4.87 3.96 1.23 0.219 -2.89 12.63 15.52 1.00 
5.52 0.88 -6.63 15.10 21.73 0.89 
Mental Time 0.02 0.03 0.64 0.522 -0.04 0.07 0.11 1.00 
Health 0.04 0.48 -0.05 0.10 0.15 1.08 
(n=219) group 1.24 1.65 0.75 0.454 -2.00 4.48 6.48 1.00 
1 1 2.31 0.54 1 -3.66 5.60 1 9.26 0.8L 
Note: The bootstrap estimates or ZSL: and Ls(;,, uonticfence intervals are ShoWn in italics below 
the model based estimates. 
The bootstrap and robust standard errors for the time and group coefficients 
are different. This time the bootstrap estimates tend to be the same size or 
somewhat larger than its robust counterpart. This is turn affects the ratios of 
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AI 
the regression coefficient to its standard error PISEV). Using the bootstrap 
estimate of SE, none of the ratios are bigger than 2.0 implying that none of 
estimated regression coefficients are likely to be significantly different from 
zero. 
When we compare the bootstrap BCa confidence intervals with the model- 
based estimates in Table 8.12 then the length of the bootstrap intervals tend 
to be the somewhat longer than its robust counterpart. This in turn effects the 
interpretation of the treatment group regression coefficients since all the 
bootstrap based intervals include zero suggesting no evidence of treatment 
effect. This contrasts with model based robust confidence intervals which 
suggest that for the RP outcome there is some evidence that the Neoral group 
has a better HRQoL than the Placebo group patients over time, after allowing 
for baseline HRQoL, age and gender. Similarly, for the GH outcome, the 
model based robust confidence intervals suggest that for the GH that the 
Neoral group has a worse HRQoL than the Placebo group patients over time, 
after allowing for the covariates. It should be noted that the values for the 
lower and upper limits for the bootstrap estimates for the RP and GP 
dimensions respectively are close to zero, implying a treatment group effect is 
not completely unlikely with the data. 
Table 8.11 shows that the observed deviations between the fitted model and 
observed autocorrelations are quite large, particularly for the HRQoL 
observations further apart in time. This suggests that the assumption of an 
autoregressive correlation structure is probably unreasonable for this dataset. 
Thus, on empirical grounds the compound symmetry structure for the 
correlations implied by exchangeable autocorrelation may be more suitable for 
the NAMEIT data. (Although this may not be acceptable on theoretical 
grounds since it is more likely that correlations between pairs of HRQoL 
observations widely separated in time will be lower than for observations 
closer together). 
In practice it is often difficult to choose whether an exchangeable or 
autoregressive autocorrelation structure is appropriate (Fayers and Machin, 
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2000). We have seen that by examining the initial and subsequent (after 
model fitting) correlation matrices, (Tables 8.9 and 8.11) that an exchangeable 
matrix appears to be more likely, although this is not clear cut. The robustness 
of the inferences about 8 can be checked by fitting a final model using 
different covariance assumptions and comparing the two sets of estimates 
and their robust standard errors. If they differ substantially, a more careful 
treatment of the covariance model may be necessary (Diggle et al 2002). 
We have developed models using each of the alternative autocorrelations. 
The two models are broadly similar with respect to the size of corresponding 
regression coefficients and their robust standard errors. The empirical 
evidence seems to suggest that the simpler exchangeable autocorrelation 
model is a reasonable approximation for the underlying covariance structure. 
The interpretation of the bootstrap estimates of SE and Cl for the regression 
coefficients from the exchangeable correlation model are in agreement with 
the interpretation of their robust counterparts. Conversely, the bootstrap SE 
and Cl estimates for the autoregressive model appear to reflect the greater 
uncertainty in this model (and perhaps the poorer fitting autocorrelation 
matrix) than the robust estimates. 
Summary 
In this chapter we have shown how the bootstrap can be used in the analysis 
of longitudinal HRQoL data collected at three or more time points. The 
simplest way to analyse repeated HRQoL assessments on individual patients 
is to reduce the observations to a single summary measure such as the AUC. 
In the Leg Ulcer and NAMEIT datasets, hypothesis testing with the bootstrap 
comparing AUC between the two groups appears to offer no advantage over 
conventional significance tests such as the Mest and MIN test. The bootstrap 
also produces Cl estimates for the mean difference in AUC between groups 
that are very similar to their Normal theory (Mest) counterparts. 
A second response feature analysis involved a multiple regression (or 
ANCOVA) of average follow-up HRQoL as the dependent variable with 
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treatment group and baseline HRQoL as covariates. In the two datasets 
studied, both the case and model based bootstrap re-sampling methods for 
estimating SEs and Cis for linear regression models gave estimates almost 
identical to the conventional values estimated by OLS. Therefore in the 
example datasets there appears to be little advantage in using bootstrap case 
or model based re-sampling to estimate standard errors and confidence 
intervals compared to conventional methods of confidence interval estimation 
from the OLS multiple regression model. 
Finally in lieu of reducing the repeated HRQoL responses to a summary 
statistic we used a marginal model approach to analyse the seven individual 
HRQoL assessments in the NAMEIT dataset simultaneously. We compared 
the robust SE and Cl estimated from the marginal model with their bootstrap 
counterparts. Depending on the assumed underlying autocorrelation structure 
the bootstrap and robust SEs and Cls estimates differed slightly. 
If we assume an exchangeable autocorrelation structure for the repeated QoL 
assessments of the NAMEIT data then bootstrap and robust standard errors 
for the regression coefficients are different, although the bootstrap estimates 
tend to be the same size or somewhat smaller than its robust counterpart. 
Similarly, the length of the bootstrap intervals tended to be the same size or 
somewhat narrower than its robust counterpart. Despite these subtle 
differences the practical interpretation of the regression coefficients was the 
same. 
Alternatively, if we assume an autoregressive autocorrelation for the NAMEIT 
data then again the bootstrap and robust standard errors for the regression 
coefficients are different, although this time the bootstrap SE estimates tend to 
be larger than its robust counterpart. Similarly, the length of the bootstrap 
intervals tended to be the somewhat larger than its robust counterpart. These 
variations may lead to different practical interpretations of the regression 
coefficients from the model. The bootstrap SE and Cl estimates for the 
autoregressive model appear to reflect the greater uncertainty in this model 
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(and perhaps the poorer fitting autocorrelation matrix) than the robust 
estimates. 
Conclusion 
The use of the bootstrap to estimate SEs and Cis for marginal longitudinal 
models appears to offer little advantage (in the NAMEIT data) compared to 
the conventional robust estimates. The only advantage the bootstrap may 
have is if there is considerable uncertainty about the autocorrelation structure 
then the bootstrap may produce larger SE and wider Cis than its robust 
counterpart and hence lead to a more conservative interpretation of the 
regression coefficients from the model. As Campbell (2001) notes, "When the 
standard and the bootstrap methods agree, we can be more confident about 
the inference we are making and this is an important use of the bootstrap. 
When they disagree more caution is needed, but the relatively simple 
assumptions required by the bootstrap method for validity mean that in 
general it is to be preferred., " 
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Chapter 9: Discussion 
Introduction 
In the introduction to this thesis we started out with the aim of comparing 
bootstrap computer simulation methods with standard methods of sample size 
determination and analysis of HRQoL measures (particularly the SF-36). 
We have assumed that there exists an underlying latent continuous HRQoL 
variable, although most HRQoL measures actually generate data that has 
bounded, discrete and non-standard distributions. Therefore standard 
methods of analysis that assume Normality and constant variance may not be 
appropriate. Computer intensive methods such as the bootstrap that make no 
distributional assumptions may therefore be more appropriate for estimating 
sample sizes and analysing HRQoL data. 
If we use a hypothesis-testing framework then our null hypothesis (HO) was 
that bootstrap methods are not more appropriate for analysing HRQoL 
outcomes (determining sample size and calculating SEs and Cls) than 
conventional methods (see Table 9.1). 
In the datasets and outcomes studied we have shown that use of the 
bootstrap does not lead to different sample size estimates or different SE and 
Cl estimates compared to conventional methods. Thus, we cannot effectively 
reject the null hypothesis and accept the alternative i. e. that in the datasets 
and outcomes studied the use of the bootstrap for sample size determination 
and SE and Cl estimation is more appropriate than conventional methods. 
Table 9.1: potential null and alternative hypotheses 
Hypothesis 
HO Bootstrap methods are not more appropriate for analysing HRQoL outcomes 
than standard methods. 
Bootstrap methods are more appropriate for analysing HRQoL outcomes than 
standard methods. 
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There are several limitations or caveats to this rather simple conclusion, which 
I will discuss further in the rest of this chapter. 
Two group comparisons 
My analysis has concentrated on using the bootstrap in clinical trials or for two 
group comparisons. We have focused on a number of measures of statistical 
accuracy: standard errors, biases, and confidence intervals. All of these are 
measures of accuracy for parameters (such as the treatment group 
coefficient, 
8G ) of a regression model. 
Sometimes we are interested in predicting the HRQoL of an individual given 
various explanatory or prognostic variables. The bootstrap can be used to see 
how well a model predicts the HRQoL response value of a future observation 
i. e. to assess prediction error. Efron and Tibshirani (1993, Chapter 17) discuss 
the use of the bootstrap for cross-validation and prediction error. However, all 
the predictive models still use the regression coefficients from the original 
model (estimated by OLS in the linear regression case). So rightly or wrongly 
we have decided to concentrate on the use of the bootstrap in assessing the 
statistical accuracy of an estimated parameter, via its SE or Cl. 
Generallisability 
The generalisability of the results of this thesis could be called into question 
as the results only apply to the limited number of datasets studied (five) and 
the SF-36 outcome. This means we have only considered selected 
distributions for the SF-36 outcomes and covariates and assumed an 
underlying latent continuous HRQoL variable for each of the eight dimensions 
of the SF-36. 
The SF-36 outcome is the most widely used generic HRQoL measure in the 
world today, so that is one obvious reason to use it (Kaplan, 1998). Secondly, 
I had easy access to a variety of datasets that had previously used the SF-36 
outcome. The five studies (General Population, CPSW, OA Knee, Leg Ulcer 
and NAMEIT), and datasets were well known to me. They illustrate the use of 
HRQoL outcomes across a variety of studies including cross-sectional 
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surveys, RCTs, non-randomised before and after studies and longitudinal 
designs. So on practical and pragmatic grounds, I felt it was appropriate to 
use such datasets; because of their familiar nature and the analysis was easy 
to understand and interpret. 
The SF-36 is a multi-dimensional outcome with eight dimensions. As 
described in the Introduction the eight dimensions have a variety of different 
distributions. I believe these distributions are not atypical of other generic 
HRQoL measures such as the NHP and EORTC QLQ-C30. The distributions 
we considered were chosen based on our experiences with HRQoL data in a 
variety of settings. So I believe that my results about the bootstrap may have 
general isability to other HRQoL outcomes (besides the SF-36) used in other 
studies and populations. Although strictly speaking our results only apply to 
the SF-36 outcome and the observed datasets, since we have considered 
only a few distributions for the HRQoL outcomes (and covariates) and 
therefore we cannot make sweeping generalisations about the impact of the 
bootstrap on other HRQoL outcomes, used in other studies. Therefore these 
results need to be replicated with other HRQoL measures on other datasets 
and populations. 
Missing values 
I have assumed that any missing HRQoL values in the datasets are Missing 
Completely at Random (MCAR). This means that the probability of the HRQoL 
response being missing is independent of the scores on the previous 
observed questionnaires and independent of the current and future scores 
had they been observed. 
I have assumed that the reduced dataset represents a randomly drawn sub- 
sample of the full dataset and the inferences drawn can be considered 
reasonable. This is a strong assumption and needs to be checked. However, 
there is an extensive literature on the issue of missing values and HRQoL 
outcomes. The imputation of missing HRQoL scores and the analysis of 
HRQoL data with missing values is discussed in several papers (Curran et al 
1998; Fayers et al 1998; Troxel et al 1998) and book chapters (Fayers and 
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Machin, 2000 Chapter 11; Fairclough, 2002 Chapters 4 to 8). As the subject of 
this thesis is the use of the bootstrap I have played down the issue of missing 
data, although this is an important issue particularly with longitudinal studies. 
Sample sizes of datasets used in the thesis 
The various datasets used in this study all had a sample size in excess of 100 
patients. Some caution should be used in applying my results to smaller 
sample sizes. However the robustness of the conventional two-sample Mest 
and ANCOVA, for three-, four- and five point ordinal scale data using 
assigned scores has been demonstrated for sample sizes as small as 20 
(Heeren and D'Agostino, 1987; Sullivan and D'Agostino, 2003). 
As the various empirical "effect size" estimates calculated in Chapter 5 show, 
large dramatic differences in HRQoL (using the SF-36 outcome) between 
groups are unlikely and inconsistent with the observed data. Therefore 
reasonably large sample sizes will be required to detect significant differences 
in HRQoL between groups (whatever method of sample-size estimation is 
used). So it would not seem unreasonable to use studies with sample sizes in 
excess of 100 patients, as well designed studies (in my opinion) should have 
at least this number of patients, to detect clinically meaningful and practically 
important differences in HRQoL between groups. 
As an alternative we could try using the bootstrap with smaller sample sizes 
and then compare its performance with conventional methods. However, this 
may be slightly unrealistic, as we have already demonstrated that well 
designed quality of life studies should have reasonably large sample sizes. 
Simple bootstrapping may not be very successful in small samples (say <9 
observations), since the observations themselves are less likely to be 
representative of the study population. As Campbell (2001) states, "In very 
small samples even a badly fitting parametric analysis may outperform a non- 
parametric analysis, by providing less variable results at the expense of a 
tolerable amount of bias. " 
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Also we have not compared the bootstrap with alternative models that assume 
a parametric model distribution for the HRQoL outcome. Again this is a slightly 
unrealistic scenario as the figures in Chapter 2 show. None of the eight 
dimensions of the SF-36 appears to follow a Normal distribution and only one, 
the Vitality dimension, seems to have a symmetrical distribution. 
Multi-dimensionality and multiple endpoints 
The SF-36 is an example of a profile measure of HRQoL with eight different 
dimensions. This is a common feature of many other HRQoL outcomes such 
as the NHP and EORTC QLQ-C30 that can have a number of dimensions. 
When several HRQoL outcomes are collected on the same people, it is 
always possible to test each variable separately. 
Fairclough (Chapter 11,2002) extensively discusses the issue of multiple 
comparisons in clinical trials assessing HRQoL. Multiple comparisons arise 
from three main sources: 
(1) Multiple HRQoL measures (scales or subscales); 
(2) Repeated post randomisation assessments; 
(3) Multiple (three or more) treatment arms. 
Indeed throughout this thesis we have taken a simpler "univariate" approach 
where each individual HRQoL dimension is analysed separately. (Although in 
some cases the test statistic is derived from a multiple-variable longitudinal 
marginal analysis). For example, if two groups are compared using the SF-36 
then a difference between the means for the two groups can be tested 
separately for each of the eight dimensions of the SF-36. Unfortunately, there 
is a drawback to this approach because of the repeated use of significance 
tests means the probability of falsely finding at least one significant difference 
accumulates with the number of tests carried out. That is univariate tests of 
each HRQoL domain and time point can seriously inflate the Type I (false- 
positive) a error rate for the overall trial such that the analyst is unable to 
distinguish between true and false positive differences. 
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Fairclough (2002) mentions three typical strategies to reduce the problem of 
multiple comparisons and multiple endpoints: 
(1) A priori specification of a limited number of confirmatory tests: 
(2) The use of summary measures or statistics (e. g. AUC); 
(3) Multiple comparison procedures including a adjustments (e. g. 
Bonferroni). 
In practice, Fairclough believes a combination of all three strategies, that is, 
focussed hypotheses, summary measures, and multiple comparison 
procedures are necessary. 
Limiting the number of confirmatoty tests 
One recommended solution (Fayers; and Machin, 2000) to the multiple 
comparison problem are to specify a limited number (.: 5 3) of a priori endpoints 
in the design of the trial. While theoretically improving the overall Type I error 
rate for a study, in practice investigators are reluctant to ignore the remaining 
data and still present Cl and even formal hypothesis test results for the 
remaining scales/end points. A more important critique of this approach is an 
ethical question about the collection of data that will not be used in the primary 
analysis (Fairclough, 2002). 
Summary measures and statistics 
Well chosen summary measures or statistics often have a greater power to 
detect patterns of consistent HRQoL differences across time or measures 
(Fairclough, 2002). The use of summary measures such as the ALIC (as 
described in Chapter 8) is a good strategy that both simplifies the presentation 
of the results and reduces the multiplicity of the repeated assessments over 
time. For example the use of summary measures such as the AUC in the 
NAMEIT study can reduce the number of hypothesis tests from six (the 
number of follow-up HRQoL assessments) to one for each dimension of the 
SF-36. 
Global tests and multiple comparison procedures 
Although as we have mentioned above there are ways of adjusting 
significance levels in order to allow for multiple testing a single global 
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multivariate test that uses the information from all variables together may be 
preferable. A global test generates a single statistic for testing the overall 
treatment effect and results in the acceptance or rejection of a set of K 
hypotheses Ho: Ho(j), Ho(2),..., HO(K). For example, the vector of all eight mean 
HRQoL dimension scores of the SF-36 in the Intervention group is the same 
as the vector for all eight mean scores for the Control group. One solution for 
the global test is to use a multivariate statistic such as Hotelling's T2 test for 
the two-group situation or MANOVA (Multivariate Analysis of Variance) for 
more than two groups (Manly, 1994). The problem with such multivariate 
methods is that they test very general hypotheses (e. g. does one group differ 
in some non-specified way in their HRQoL from another) and so consequently 
have very poor power to detect any real difference. Thus, more often than not 
they will give a non-significant result (Walters et al 2001a). When the overall 
test of Ho has been rejected, the question still remains, "Which of the 
individual hypotheses can be rejected? " A global test does not allow 
inferences to be made about individual endpoints and a series of univarlate 
tests must be performed for these comparisons (Fairclough, 2002). 
Tandon (1990) suggested a parametric method that was more specific. For 
example to compare two groups, calculate Mests for each dimension and then 
find 
(jS-lj)1/2 (9.1) 
where X= 1), S is the estimated correlation matrix and t is the vector 
of t-statistics from the separate univariate Mests. The test statistic z has an 
asymptotic standard Normal distribution. The main drawback of this method is 
that it does not give an estimate of the treatment effect; it just provides a test 
statistic (9.1). 
Pragmatically, one does not like to use multivariate global hypothesis tests, 
since the interpretation of the results of such tests is difficult. So I have tended 
to use univariate methods and analyse each dimension of the SF-36 
separately, one at a time. Indeed, Fairclough (2002) advocates the use of 
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multiple comparison procedures using a set of univariate, test statistics rather 
than those using a single multivariate statistic. 
Alpha adjustments for K univariate tests 
Fairclough (2002) comprehensively describes a number of procedures that 
can be used to control the Type I error rate for K multiple comparisons using 
the following notation. If Hop), Hop),..., Ho(K) denotes the K null hypotheses that 
are to be tested and Top), TO(2),... 'TO(K) denotes the corresponding K test 
statistics. The observed p-value, p(k), denotes the unadjusted probability of 
observing the test statistic, T(k), or a more extreme value if the null hypothesis 
HO(k) is true. The K ordered p-values from smallest to largest can be written as 
P[1]: 5 P[2] 5 ... :5 PJK1- 
Most of the alpha adjustments for K univariate tests described in Fairclough 
(2002) are a variation of the simple Bonferroni correction described in Chapter 
4. The Bonferroni correction adjusts the test statistics on K endpoints. The 
global test is based on the smallest p-value, pp, for the K HRQoL endpoints. 
The global null hypothesis Ho: HO(I), HO(2),..., Ho(K) is rejected when 
p,, ]: 5 alK. (9.2) 
For individual HRQoL endpoints the Bonferroni procedure is to accept as 
statistically significant only those tests with p-values that are less than cc/K. 
The Bonferroni procedure controls the experiment wise error rate well but is 
well known to be quite conservative. (The experiment wise error rate is the 
probability of incorrectly rejecting at least one true null hypothesis, regardless 
of which (if any) null hypotheses are true). If the K outcomes are uncorrelated 
(the tests are independent) and the null hypotheses are all true, then the 
probability of rejecting at least one of the K hypotheses is approximately' ccK 
when a is small. The Bonferroni approach focuses on the detection of large 
differences in one or more endpoints and is insensitive to a pattern of smaller 
differences that are all in the same direction. 
I prob[min(p-value): 5 a] =I-0. CC)K = aK 
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Resampling tec niques 
The major limitation of all the global tests is that they were developed to 
control the Type I error rate under the most conservative condition, K 
independent tests. However, in most studies of HRQoL, the K endpoints are 
moderately correlated. As a result, these procedures are very conservative 
and the power to detect meaningful differences is severely reduced. 
Fairclough describes a bootstrap algorithm for global hypothesis tests 
(Fairclough, Chapter 11, p 254; 2002) to address this problem. 
The general idea is to obtain an estimate of the distribution of the cut-off test 
statistic (TcoT) for the multiple comparison procedure for endpoints with 
unknown correlation structure. For example the simple Bonferroni cut-off test 
statistic and its associated p-value is T11] and p[j] respectively (the largest test 
statistic or the corresponding smallest p-value from the K univariate tests). 
The bootstrap procedure was first proposed by Westfall and Young (1989) 
and adapted by Reitmeir and Wasser (1999) for multiple comparisons of K 
endpoints between two treatment groups. 
The procedure is shown in detail in Algorithm 9.1 taken from Fairclough 
(2002). The procedure is basically a modification of Algorithm 7.1, although 
this time the data is a matrix of responses X rather than a simple vector x. 
Suppose we have two groups of subjects Z= (Z1, Z2,..., Zn) and Y= (Y1, Y2, 
.... 
Ym), where the ZI (and YI) consists of a row vector of K HRQoL responses 
for subject i that is ZI = (zii, zi2,..., ziK). If we let the combined sample of 
HRQoL responses for Z and Y be denoted by X then: 
Algorithm 9.1 
ComQutation of the bootstrap global test statistic for K endpoints for a two 
gLQu 2 studLy 
1. Identify the statistic for the global test TCOT or PCOT and calculate it from 
the observed data. For example the simple Bonferron! cut-off test 
statistic and its associated p-value is T[j, and plij respectively (the 
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largest test statistic or the corresponding smallest p-value from the K 
univariate tests). 
2. Draw a random sample of subjects with replacement (bootstrap 
sample) from the pooled sample X of the same size as the original 
sample, call the first n observations Z* and the remaining m 
observations Y*. 
3. Evaluate the global test T, *,, or p, *,, statistic from the data associated 
with the subjects drawn from the bootstrap sample. 
4. Repeat the previous two steps B times, B= 10,000 is recommended 
(Reitmeir and Wassmer, 1999). We now have a bootstrap distribution 
of B values of TIIT and pýOT respectively i. e. 
(, 
r*l 2010 *B 
k2coT, TýOT,..., Tý0', 
) and 
WOT, 
PCOT, -, PCOT), (9.3) 
5. Since the bootstrap statistics were calculated under the null hypothesis 
by generating the bootstrap samples from the pooled sample, X, the 
distribution of the global test statistic is approximated by the distribution 
of the p" COT 
6. The p-value for the global test is the proportion of the B bootstrap 
statistics that are equal to or more extreme than the observed data 
statistic. 
# fp*b <p# 
IT; b T 
ASLboot COT or 
kLboo, OT 
ýý 
COT) (9.4) 
BB 
7. If this proportion is less than (x, the global test is rejected. 
I have not used Algorithm 9.1, since there is no general consensus on what 
procedure to adopt allow for multiple comparisons (Altman et al 2000). 1 
believe in following Altman's recommendation of reporting unadjusted p- 
values (to three decimal places/significant figures) and confidence limits with a 
suitable note of caution with respect to interpretation. As Perneger (1998) 
concludes: "Simply describing what tests of significance have been 
performed, and why, is generally the best way of dealing with multiple 
comparisons. 11 
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Pragmatically, one does not like to use multivariate global hypothesis tests, 
since the interpretation of the results of such tests is difficult. I prefer using a 
set of univariate test statistics since they are much easier to implement and 
report. Throughout this thesis, I have favoured a combination of Fayers and 
Machin's (2001) and Altman et al (2000) approaches to multiple 
comparisons/end points, although as I mention above other alternatives are 
available. My favoured approach is to identify the main study HRQoL 
endpoints in advance, limit the number of confirmatory hypothesis tests to 
these outcomes, and report unadjusted p-values and confidence limits with a 
suitable note of caution with respect to interpretation. 
Ordinality of HRQoL outcomes 
One of the fundamental assumptions we have made throughout this thesis is 
that there exists an underlying continuous latent variable that measures 
HRQoL, and that the actual measured outcomes are ordered categories that 
reflect contiguous intervals along this continuum. If the goal of the analysis is 
to assess the magnitude of the treatment effect on the ordered outcome, then 
an appealing approach is to assign numeric scores to the ordered categories 
and to use a more familiar linear regression method for analysis. Most HRQoL 
measures such as the SF-36 actually do assign numeric scores to the ordered 
categories. It is then common practice in medical studies to compare means 
between groups using conventional linear regression methods. Indeed the 
comprehensive textbooks on HRQoL analysis by Fairclough (2002) and 
Fayers and Machin (2000) use this approach. Following on from this we have 
assumed that our main interest lies in comparing location between treatments 
i. e. comparing means. 
If interest lies elsewhere, for example in comparing the relative frequencies of 
cumulative probabilities in the ordered categories between treatments, then 
other techniques such as the proportional odds model would be more 
appropriate, (described in Chapter 7; Lall et a/ 2001; Walters et al 2001a). A 
limitation of these approaches is in the interpretation of the models. 
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Heeren and DAgostino (1987) have demonstrated the robustness of the two 
independent samples Mest when applied to three-, four- and five point ordinal 
scaled data using assigned scores, in sample sizes as small as 20 subjects 
per group. Sullivan and D'Agostino (2003) have expanded this work to 
account for a covariate when the outcome is ordinal in nature. They again 
assign numeric scores to the distinct response categories and compare 
means between treatment groups adjusting for a covariate reflecting a 
baseline assessment measured on the same scale. Their simulation study 
shows that in the presence of three-, four- and five point ordinal data and 
small sample sizes (as low as 20 per group) that both ANCOVA and the two 
independent sample Mest on difference scores are robust and produce actual 
significance levels close to the nominal significance levels. 
The bootstrap 
Number of bootstrap replications B 
How large should we take B, the number of bootstrap replications to evaluate 
the bootstrap estimate of the standard error SeB,, t and estimate 
BC, 
confidence intervals? The ideal bootstrap estimate takes B= 00. This Is 
obviously not possible so the number of bootstrap replications B depends 
mainly how long it takes the computer to evaluate the function d= s(x). 
Time constraints may dictate a smaller value of B (e. g. 1000) if d= s(x) is a 
very complex function of x, as in the marginal model examples of Chapter 8. 
We used between 1000 and 5000 bootstrap samples to estimate SE and BC. 
Cls. We used more (B = 10,000) for the simpler sample size algorithm (6.1). 
Efron and Tibshirani (1993), describe two rules of thumb based on their 
experiences for estimating bootstrap SEs. 
(1) Even a small number of bootstrap replications, say B =25, is usually 
1-1 informative. B= 50 is often enough to give a good estimate of sekO)- 
(2) Very seldom are more than B= 200 replications needed for estimating 
a standard error. (Much bigger values of B are required for bootstrap 
confidence intervals. Efron and Tibshirani (1993) and Davison and 
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Hinckley (1997) tend to use between 1000 and 2000 replications In the 
examples throughout their books, for estimating percentile based Cis). 
Bootstrap case resampling vs. model based resampling 
The results of Chapters 7 and 8 show that there is little to choose from 
between the case and model based resampling algorithms (7.3 and 7.4) for 
the multiple linear regression model for estimating SEs and Cls. Table 7.5 
provides a summary of the issues involved. Since there was very little 
difference in the SE and Cl estimates from the datasets used, for simplicity 
one would tend to favour a case based resampling approach. Indeed this was 
the resampling method for the longitudinal marginal model in Chapter 8. 
Bootstrap model based resampling for marginal model 
In Chapter 8, for simplicity we described only a simple case based resampling 
Algorithm (8.1) for the marginal model. In Algorithm 8.1 we effectively carried 
out a stratified random resampling with replacement. That is we sampled with 
replacement blocks or clusters of each patients' repeated HRQoL responses. 
In theory one should be able to adapt the linear regression model based 
resampling Algorithm 7.4 to the marginal model. The resampling algorithm 
would be rather complex particularly for autoregressive autocorrelation 
structures and for unbalanced datasets, with HRQoL assessments at 
unequally spaced time points. One would have to take into account that the 
residuals were not independent and uncorrelated, and for the autoregressive 
correlation structure, that the correlation between residuals within a patient 
declined over time. This is a very interesting avenue and requires further 
exploration with other longitudinal datasets. 
Bootstrap observed value of the test statistic 
The bootstrap is mainly used as a method for assessing statistical accuracy 
i. e. SE, biases and Cls. Throughout this thesis I have always used the 
observed value of the test statistic t(x) or parameter estimate ý as our best 
guess at the true value of the unknown parameter 0 or statistic. For example if 
we are interested in estimating the population mean p (from a random 
sample) it may seem that the best estimator of the mean of the population is 
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the mean of the B bootstrap estimates. This is turns out not to be the case as 
the mean of the bootstrap means is biased. The original observed sample 
mean, Y from the original data, is always the best estimate of the population 
mean. The same result applies for other statistics such as the median and 
regression coefficients. 
Use of the Bootstrap for estimating sample size 
In Chapter 6 we described and used a bootstrap resampling method 
(Algorithm 6.1) for estimating power and sample size. A limitation of this 
chapter was that it only dealt with statistical power (i. e. Type 11 error). 
Therefore one could legitimately argue that the issue of Type I error and false 
positive results has not been adequately addressed. 
The bootstrap methodology provides an ideal opportunity to consider Type I 
error. Resampling Algorithm 6.1 can easily be adapted for this. It simply 
involves modification of step 1 and not adding 8 to the second simulated 
sample of patients. Under the true null hypothesis of no difference in 
distributions, the actual Type I error rate can be computed by determining the 
proportion of simulated cases which had significance levels at or below its 
nominal value. For a nominal Type I error rate of a=0.05, (i. e. using a cut-off 
of p :50.05 for statistical significance) we would expect 5% of the bootstrap 
samples to give a (false-positive) significant result under the true null 
hypothesis of no difference in distributions. The robustness of each test can 
then be determining by comparing the actual Type I error rates to the nominal 
Type I error rates. 
However, I believe the issue of Type I error is of less importance for sample 
size estimation, than Type 11 errors. The Type I error rate can easily be 
controlled for after the data have been collected by reducing the P-value cut- 
off for statistical significance. Conversely, the Type 11 error (and power) can 
only be controlled for at the design stage. Therefore I felt that it was more 
important to concentrate on the issue of power rather than significance, in 
Chapter 6, as we were interested in sample size estimation at the study 
design stage. 
220 
Chapter 9: Discussion 
For presentational purposes this thesis has separated the methods of data 
analysis (Chapters 7 and 8) from sample size determination (Chapter 6), 
although most practitioners would recommend basing sample size directly on 
the likely method of analysis. For example, if a two independent samples Mest 
is proposed for analysis, then sample size should be based on the Mest. 
Although frequently statisticians will base the sample size calculation on the t- 
test, using Equations (4.3 and 4.4), but actually use multiple regression 
methods to analyse the data and adjust the outcome variable for other 
covariates besides the treatment group. 
Whitehead's (1993) method for sample determination is derived from the 
proportional odds model (and the Mann-Whitney test). We did not evaluate 
the proportional odds model as part of the bootstrap. This was because 
ordinal regression is equivalent to the MW test when there is only a 0/1 
variable in the regression (Campbell, 2001). The advantage of the 
proportional odds model is that it allows the estimation of confidence intervals 
for the treatment group effect and for the adjustment of the HRQoL outcome 
for other covariates. Also the odds ratio effect size (ORordinai) is more readily 
interpretable than the PNoether effect size, although as we have noted before 
both are not as easily understandable as a difference in mean HRQoL. 
We have demonstrated that the effect size pN,, th., or Pr(Y > X) is difficult to 
estimate for non-Normally distributed data. This effect size is also rather 
difficult to interpret, although we have demonstrated in Chapter 5 that all effect 
sizes can be reduced to a common metric using the A and 0 statistics. If we 
use Whitehead's (1993) method to determine sample size (and either a MW 
test or a proportional odds model to analyse the data), then the advantage of 
Whitehead's method is that we do not need to know the full distribution of the 
HRQoL outcome variable. Knowledge of the proportions of responses in 
around five ordered categories for the HRQoL outcome is usually sufficient to 
estimate the required sample size (given the OROrdinal effect size). 
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Specification of the alternative hypothesis. 
Throughout Chapters 5 and 6 we only considered the situation where a single 
dimension of HRQoL is used at a single endpoint. We have assumed a rather 
simple form of the alternative hypothesis that the new treatment/intervention 
would improve HRQoL compared to the control/standard therapy. This form of 
hypothesis (superiority vs. equivalence) may be more complicated than 
actually presented. For example, superiority may be due to an improvement In 
HRQoL in the Intervention group, or due to the one therapy causing a decline 
due to an adverse experience. Alternatively, the HRQoL superiority for one 
group may be due to a treatment preventing an adverse clinical event. This 
may have an important impact for HRQoL outcome distributions that are not 
symmetrical, especially if they are bounded. All of these considerations are 
needed for determining study hypotheses and sample sizes. However, the 
assumption of a simple form of the alternative hypothesis that new 
treatment/intervention would improve HRQoL compared to the 
controllstandard therapy, is not an unrealistic scenario for most superiority 
trials and is frequently used for other clinical outcomes. 
Clinically meaningful change and the Minimum Important Difference 
There is an extensive literature on the important issue of clinically meaningful 
change and the minimum important difference (MID) for HRQoL outcomes. As 
the subject of this thesis is the use of computer intensive methods such as the 
bootstrap we have played down the issue of the MID. Again for brevity and 
practical purposes of sample size estimation this thesis has assumed the MID 
for the SF-36 outcome is around five points for each dimension. This is an 
important issue in sample size estimation. The interested reader is referred to 
a series of papers from the in the Mayo Clinic Proceedings for more detailed 
discussion (Celia et al 2002; Frost et al 2002; Guyatt et al 2002; Sloan et al 
2002; Sprangers, et al 2002 and Symonds et al 2002) and Norman et al 2003. 
SF-36 Version 2.0 
We have based our analysis on the original UK version of the SF-36 version 
1.0 (a copy of which is Appendix 1). A revised second version of SF-36 has 
been developed called the SF-36 v2 (Jenkinson, 1999; Ware et al 2000). This 
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has expanded the range of possible responses to the two Role Limitations 
questions 4 and 5 (see Appendix 1) from two-point (Yes/No) scale to a five- 
point ordinal scale (ranging from "all of the time" to "none of the time"). This 
will have the effect of increasing the number of possible discrete scores for 
the RE and RP dimensions from four (0,33.3,66.7,100) and five (0,25,50, 
75,100) values to 13 (0,8.3,16.7,..., 91.7,100) and 17 (0,6.25, 
12.5,..., 93.75,100) values respectively. 
These changes to the SF-36 will obviously expand the discrete responses for 
the RP and RE dimensions and perhaps make them have similar distributions 
to the other SF-36 dimensions such as PF and V. One of the likely 
consequences of this is that with all eight dimensions of the SF-36 now 
consisting of seven or more discrete response categories then we can treat 
these scores as continuous and use statistical methods for comparing means 
(such as Mests and multiple regression). This does of course rely on the 
fundamental assumption (as stated in Chapter 1) that there exists an 
underlying continuous latent variable that measures HRQoL (for each 
dimension) and that the actual measured outcomes are ordered categories 
that reflect contiguous intervals along this continuum. 
Are the results surprising or unexpected? 
Finally are the results of this thesis all that surprising or unexpected? We have 
shown that the use of bootstrap methods (Algorithm 6.1) for sample size 
estimation appears to offer little advantage compared to four standard 
methods in the datasets studied. Pessimistically, it is hard to see how sample 
size calculations based on bootstrap methods would have general appeal, as 
they would need to be based on a sample distribution from the population of 
interest, something we rarely have. However, with a reliable pilot population 
dataset, bootstrap sample size methods may be used to check the sensitivity 
of various assumptions and assumed forms of treatment effects. 
Firstly, if we are prepared to assume that there exists an underlying 
continuous latent variable that quantifies the HRQoL response of interest and 
that the actual measured HRQoL is on an ordered category that reflects 
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contiguous intervals along this interval. Secondly, if the goal of the analysis is 
to assess the magnitude of a treatment effect on the (ordered) HRQoL 
outcome, then an appealing approach is to assign numeric scores to the 
ordered categories and to compare means between groups. Statistical theory 
says that if the distribution of x is Normal, so will be the distribution of Y. Much 
more importantly, even if the distribution of x is not Normal, that of the sample 
mean 3F will become closer to the Normal distribution with mean P and 
variance c-'In as n gets larger. This is a consequence of the CLT (Hogg and 
Tanis, 1988). 
The Normal distribution is strictly only the limiting form of the sampling 
distribution as n increases to infinity, but it provides a remarkable good 
approximation to the sampling distribution even when n is small and the 
distribution of x is far from Normal (Armitage et al 2002). This implies that the 
distribution of the sample means for the SF-36 HRQoL data shown in Figure 
2.1 is approximately N(u, 0-21n) when n is sufficiently large and P and (72 are 
the mean and variance of the underlying HRQoL distribution from which the 
sample came. 
If the sample size is "sufficiently large" the CLT guarantees that the sample 
means will be approximately Normally distributed (Hogg and Tanis, 1998). 
Thus, if the investigator is planning a large study and the sample mean is an 
appropriate summary measure of the HRQoL outcome, then pragmatically 
there is no need to worry about the distribution of the HRQoL outcome and we 
can use equation (4.4) and the effect size ANOrmaj (4.3) to estimate sample 
sizes (Walters et al 2001a; 2001b). Furthermore, Chapter 5 has shown that 
the empirical ANomal effect sizes were mainly in the "small" to "moderate" (0.30 
to 0.50) range for the SF-36 HRQoL outcome using Cohen's (1988) 
classification. Therefore dramatic effects are unlikely in HRQoL studies using 
the SF-36 as an outcome and so large samples sizes are likely to be required. 
So perhaps unsurprisingly, the results of Chapter 6 reflect the robustness of 
conventional methods with large sample sizes and the application of the CLT 
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to sample means even for HRQoL data with such bounded, discrete and 
skewed distributions as shown in Figure 2.1. 
Generally, if n is greater than 25, these approximations to Normality for 
sample means will be good. The work of Heeren and D'Agostino (1987) and 
Sullivan and D'Agostino (2003) described previously certainly supports the 
robustness of the two independent samples Mest and ANCOVA when applied 
to three-, four- and five point ordinal scaled data using assigned scores, in 
sample sizes as small as 20 subjects per group. However, if the underlying 
distribution is symmetric, unimodal and continuous, a value of n as small as 
four can yield a very adequate approximation (Hogg and Tanis, 1998). 
The CLT for modelling the sample mean may also apply to the regression 
techniques in Chapters 7 and 8. This may explain why with "sufficiently large" 
sample sizes (> 100 in the five datasets studied) the bootstrap estimates of 
SEs and Cls are very similar to the conventional estimates despite the non- 
Normal distribution and non-constant variance of the residuals. 
So my research using the SF-36 HRQoL outcome and the five datasets has 
shown that bootstrap methods appear to produce sample size estimates, SE 
and Cls similar to conventional methods. When the standard and the 
bootstrap methods agree, we can be more confident about the inference we 
are making and this is an important use of the bootstrap, (Campbell, 2001). 
When they disagree more caution is needed, but the relatively simple 
assumptions required by the bootstrap method for validity mean that in 
general it is to be preferred. Thus, there appears to be little advantage in 
using the bootstrap for the analysis of SF-36 data particularly if one is 
interested in comparing mean HRQoL between treatment groups. 
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In Chapters 1 and 2 we described HRQoL outcomes such as the SF-36, 
which is one of the most widely used generic multi-dimensional HRQoL 
outcome measures in the world today. HRQoL outcomes like the SF-36 are 
usual measured on an ordinal scale. Although most investigators (myself 
included) assume that there exists an underlying continuous latent variable 
that measures HRQoL, and that the actual measured outcomes (the ordered 
categories), reflect contiguous intervals along this continuum. 
We demonstrated how this ordinal scaling of HRQoL measures may lead to 
several problems in estimating sample size and analysing the data. Data from 
HRQoL outcomes tends to have discrete, bounded and skewed distributions. 
For this reason non-parametric methods are often used to analyse HRQoL 
data. The bootstrap (described in Chapter 3) is one such non-parametric 
method for estimating sample sizes and analysing HRQoL data. The 
bootstrap is a computer intensive method that involves repeatedly drawing 
random samples with replacement from the data and repeatedly estimating 
the statistic of interest. 
From an extensive review of the literature (Chapter 4) we found five methods 
of estimating sample sizes for simple two-group cross-sectional comparisons 
of HRQoL outcomes. (The fifth method of estimation involved the use of the 
bootstrap and some of the test statistics involved in the calculation of the 
sample sizes for the four preceding methods. ) All five methods (amongst other 
factors) require the specification of a minimum clinically important difference 
(MCID) worth detecting and an effect size, both of which vary according to the 
method of sample size estimation. 
These effect sizes include: a simple mean difference 8 and its standardised 
counterpart, ANormal; a simple absolute difference in proportions 8Binarys for 
dichotomised outcomes; various odds ratios (OR) for either binary ORBinally, or 
ordinal (0Rordjn,, j) outcomes; and a probability, PNoether (the probability of a 
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randomly chosen outcome from one group being larger than a randomly 
chosen outcome from the second group). 
Chapter 5 calculated the six observed effect sizes for the eight dimensions of 
the SF-36 for various simple two group cross-sectional comparisons across 
five datasets. In this chapter we also demonstrated how the four seemingly 
different effect sizes ANormal, ORBinary, OROrdinal and pNo. th.,. which are all 
numerical expressions of treatment efficacy can be combined into a common 
scale of metric using the A (Axy = Pr(X > Y) and Ayx = Pr(Y > X)), X and 0 
statistics. 
We showed that for ordinal and continuous outcomes A. - Ayx =A and 
AxylAyx =0 are equivalent to the Absolute Risk Reduction (ARR) and OR for 
binary outcomes (i. e. 813inary and ORBinaly). Since the Number-Needed-to-Treat 
(NNT) is the reciprocal of the ARR, the NNT and OR statistics can be 
generalised to all data types (binary, ordinal and continuous). 
The empirical effect sizes calculated in Chapter 5 suggested that large 
differences in HRQoL (as measured by the SF-36) between groups are 
unlikely, particularly from the RCT comparisons. Most of the observed effect 
sizes are mainly in the 'small' to 'moderate' range (0.2 to 0.5) using Cohen's 
(1988) criteria. Therefore dramatic differences in HRQoL between groups are 
unlikely using the SF-36 and larger sample sizes may be required to have a 
reasonable chance of detecting statistically significant differences between 
groups. We went on to use some of these estimates of effect size as our 
MCID in the calculation of sample sizes in the next chapter. 
Chapter 6 compared the power of various methods of sample size estimation 
described in Chapter 4 for simple two-group cross-sectional study designs via 
bootstrap simulation. This chapter showed how under the location shift 
alternative hypothesis conventional methods (1 to 4) of sample size estimation 
performed well, particularly Whitehead's (1993) Method (4). Whitehead's 
method is recommended if the HRQoL outcome has a limited number of 
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discrete values (or is expected to generate data with a limited number of 
values) and/or the expected proportion of cases at either of the bounds is 
high. 
If a pilot dataset is readily available (to estimate the shape of the distribution) 
then bootstrap simulation (Method 5) may provide a more accurate and 
reliable estimate, than Methods 1 to 4. In the absence of reliable pilot data set, 
which is frequently the case at the study design stage, bootstrapping is not 
appropriate and conventional Methods (I to 4) of sample size estimation or 
parametric simulation models will need to be used. 
The final two results Chapters (7 and 8) describe how the bootstrap can be 
used for hypothesis testing and the estimation of SEs and Cls for parameters. 
In both chapters we concentrated on comparing and contrasting the bootstrap 
with standard methods of analysing HRQoL outcomes as described in Fayers 
and Machin (2000). 
In Chapter 7 we looked at analysing simple cross-sectional HRQoL data or 
HRQoL data with a baseline and single follow-up assessment. We described 
two simple resampling algorithms for performing bootstrap hypothesis tests for 
comparing groups (Algorithms 7.1 and 7.2). In the example dataset studied 
we show that there appears to be little advantage in using bootstrap 
hypothesis test compared to conventional non-parametric hypothesis tests 
such as the MlYtest. 
A major limitation of non-parametric hypothesis tests are they do not allow for 
the estimation of Cl for parameters, which is regarded as good statistical 
practice (Altman et al 2000). Nor do they allow for the adjustment of 
confounding variables such as baseline covariates. Fortunately, the bootstrap 
is able to estimate SEs and Cls for parameters from a variety of multiple 
regression models. 
Chapter 7 also describes two more bootstrap algorithms for estimating SEs 
and Cis for regression coefficients from fitting the OLS multiple regression 
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model, - case and model (residual) based resampling (Algorithms 7.3 and 7.4 
respectively). In the datasets studied, both the case and model based 
bootstrap resampling methods for estimating SEs and Cls for linear 
regression models gave estimates almost identical to the conventional values 
estimated using OLS. 
In the final results chapter (Chapter 8) we looked at methods of analysing 
HRQoL data collected at three or more time points, including the simple 
analysis of summary measures such as the AUC, and the more complex 
modelling of longitudinal HRQoL data via marginal models and GEE. In the 
datasets studied, we used the AUC to summarise the repeated HRQoL 
assessments into one observation for each subject and then compared mean 
ALIC between treatment groups. The p-values from the two independent 
samples Mest and the ASL from the bootstrap hypothesis test for comparing 
mean ALIC between the groups were very similar. As were the Normal-theory 
based Cl estimates from the Mest compared with their bootstrap BCa 
counterparts for comparing the mean difference in ALIC between groups. 
We also used ANCOVA to regress the mean of the follow-up HRQoL 
assessments against treatment group and baseline HRQoL. Again, in the 
datasets studied, both the case and model based bootstrap resampling 
methods for estimating SEs and Cls for linear regression models gave 
estimates almost identical to the conventional values estimated using OLS. 
Finally, in lieu of reducing the repeated HRQoL responses to a summary 
statistic we used a marginal model to analyse the individual assessments 
simultaneously. We used a simple case-based resampling bootstrap algorithm 
for estimating SEs and Cls for regression coefficients from the marginal model 
(Algorithm 8.1). We then compared the robust SE and CI estimated from the 
marginal model (using IRLS) with their bootstrap counterparts. Depending on 
the assumed underlying autocorrelation the bootstrap SEs and Cls; differed 
slightly. So some caution was needed in interpreting the regression 
coefficients. When the standard and the bootstrap methods agree, we can be 
more confident about the inference we are making. However the relatively 
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simple assumptions required by the bootstrap method for validity mean that in 
general it is to be preferred (Campbell, 2001) 
HRQoL outcome measures frequently generate data with discrete, bounded 
and skewed distributions. Therefore standard methods of analysis such as the 
two sample Mest and OLS multiple regression which assume Normality and 
constant variance may not be appropriate. Hence HRQoL outcomes appear to 
be ideal candidates for the application of non-parametric statistical methods. 
The bootstrap is one such method and therefore theoretically may be more 
appropriate for estimating sample sizes and analysing HRQoL outcomes than 
standard methods. 
Overall, in the datasets studied with the SF-36 outcome, the use of the 
bootstrap for estimating sample sizes and analysing (hypothesis testing, SE 
and Cl estimation) HRQoL data appears to produce results similar to 
conventional statistical methods. Therefore, the results of this thesis suggest 
that bootstrap methods are not more appropriate for analysing HRQoL 
outcome data than standard methods. This result requires replication with 
other HRQoL outcome measures, interventions and populations. 
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HEALTH STATUS QUESTIONNAIRE (SF-36) 
The following questions ask you about your healthý how'y6u foil and how well you are 
4; a'616"'to` do your usual ac'iMtlei. j i 
If you are unsure how to a'nswer, a question, please give the best answer you can.! j 
1 Ok iI 'I 
1. In general, would you say your health is: 
Excellent ........................................ 0 Very good ...................................... 0 Good .............................................. 0 Fair ................................................. 0 Poor ............................................... 0 
2. Compared to one year ago, how would you rate your health In general now? 
Much better than one year ago ................................................ 0 Somewhat better than one year ago ......... ............................... 0 About the same ......................................... ................................ 0 Somewhat worse now than one year ago ................................ 0 Much worse now than one year ago ......... .............................. 0 
H EALTH AN D DAI LY ACTIVITI ES 
3. The following questions are about activities that you might do during a typical 
day. Does your health limit you In these activities? If so, how much? 
Yes, Yes, No, not 
ACTIVITIES limited a limited a limited at 
lot little all 
a. Vigorous activities, such as running, lifting heavy 1 2 3 
objects, participating in strenuous sports 
b. Moderate activities, such as moving a table, 1 2 3 
pushing a vacuum cleaner, bowling or playing golf 
C. Lifting or carrying groceries 
1 2 3 
d. Climbing several flights of stairs 
1 2 3 
e. Climbing one flight of stairs 
1 2 3 
f. Bending, kneeling or stooping 1 2 3 
g. Walking more than a mile 
1 2 3 
h. Walking half a mile 1 2 
3 
i. Walking 100 yards 2 
3 
j. Bathing and dressing yourself 2 
3 
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4. During the past 4 weeks, have you had any of the following problems with your 
work or other regular daily activities as a result of your physical health? 
YES NO 
a. Cut down on the amount of time you spent on work or 
other activities 
2 
b. Accomplished less than you would like 2 
c. Were limited in the kind of work or other activities 2 
d. Had difficulty in performing the work or other activities 
(e. g. it took extra effort) 
2 
5. During the past 4 weeks, have you had any of the following problems with your 
work or other regular daily activities as a result of any emotional Problems (such 
as feeling depressed or anxious)? 
YES NO 
a. Cut down on the amount of time you spent on work or 
other activities 
2 
b. Accomplished less than you would like 2 
C. Didn't do work or other activities as carefully as usual 2 
6. During the past 4 weeks, to what extent have your physical health or emotional 
problems Interfered with your normal social activities with family, friends, 
neighbours or groups? 
Not at all ......................................... 1 Slightly ............................................ 2 Moderately ...................................... 3 Quite a bit ....................................... 4 Extremely ........................................ 5 
7. How much bodil pain have you had during the past 4 weeks? 
None ............................................... I Very mild ......................................... 2 Mild ................................................. 3 Moderate ........................................ 4 Severe ............................................ 5 Very severe ..................................... 6 
8. During the past 4 weeks, how much did pain Interfere with your normal work 
(including work both outside the home and housework)? 
Not at all ......................................... 
1 
A little bit ......................................... 2 Moderately ...................................... 3 Quite a bit ....................................... 4 Extremely 
........................................ 5 
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YOUR FEELINGS 
9. These questions are about how you feel and how things have been with you 
during the past 4 weeks. For each question, please Indicate the one answer that 
comes closest to the way you have been feeling. 
All of Most of A good Some A little None of 
How much of the time during the the the bit of the of the of the the 
past 4 weeks: time time time time time time 
a. Did you feel full of life? 
1 2 3 4 5 6 
b. Have you been a very nervous 
person? 1 2 3 4 5 6 
C. Have you felt so down in the 
dumps that nothing could cheer 1 2 3 4 5 6 
you up? 
d. Have you felt calm and 
peaceful? 1 2 3 4 5 6 
e. Did you have a lot of energy? 1 2 3 4 5 6 
f. Have you felt down-hearted and 1 2 3 4 5 6 
low? 
g. Did you feel worn-out? 1 2 3 4 5 6 
h. Have you been a happy person? 1 2 3 4 5 6 
i. Did you feel tired? 1 2 3 4 5 6 
j. Has your health limited your 1 2 3 4 5 6 
social activities (like visiting 
friends or close relatives) 
HEALTH IN GENERAL 
10. Please choose the answer that best describes how true or false each of the 
following statements is for you. 
Definitely Mostly Not sure Mostly Definitely 
true true false false 
a. I seem to get ill more 
easily than other people 1 2 3 4 5 
b. I am as healthy as 
anybody I know 1 2 3 4 5 
C. I expect my health to 
get worse 1 2 3 4 5 
rd 
My health is excellent 
1 2 3 4 5 
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If we let 
d(Ab, 
I from now on simplified to 0.,, be the estimated observed value of 
the statistic 0, that is the value of the statistic calculated using the original observed 
clataset, x= (X1, X2,..., xn). Let b=1,2,..., B denote the bootstrap samples, and let 
be the estimated values of the statistic computed using each of these B samples. We 
now have B bootstrap samples x*,, X*2, ... Y-*B, and 
B estimates of the statistic, one 
from each bootstrap sample The bootstrap standard error of 0, Is 
estimated as: 
B 
Se 
)2 11/2 
, where boot 0 
Ob 
. (A2.1) B-1 b-I Bb-I 
Algorithm A2.1 (derived from Efron and Tibshirani, 1993) Is a more explicit 
description of the bootstrap procedure for estimating the standard error of ý= s(x) 
from the observed data x. 
Algorithm A2.1 
The bootstrap al-gorithm for estimating standard errors 
1. Select B independent bootstrap samples x*,, X*2, ... x*j3, each consisting of n 
data values drawn with replacement from x. [For estimating a standard error, 
the number B will ordinarily be in the range 25-200. ) 
2. Evaluate 0= s(. ) on each bootstrap sample, 
obo 
= S(Xb*) b=1,2,..., B. (A2.2) 
3. Estimate the standard error of 0, seF(ý) by the sample standard deviation of 
the B bootstrap replications of the statistic 0= s(x). 
IB41.,, 11 1/ 2 Flb-I [ýb* 
-0 
SeBoot 
(B 1) 
(A2.3) 
B 
where U* = I: 
d. is the mean of the B bootstrap replications of 
b-I 
The bias is estimated as 
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bi., =0 (A2.4) 
Confidence intervals With nominal coverage rates 1-a are calculated according to 
the following formula. 
The Standard Nonnal-approximation method yields the confidence intervals: 
jo. 
bs -(ZI-a/2 *SeBoot 
(0)ý 
Oobt + 
(ZI-a 
/2* SeB., (A2.5) 
where zj-, 12 is the (1 -cc/2) quantile of the standard Normal distribution (ZO. 975 = 1.96). 
If B estimates of the statistic, one from each bootstrap sample are 
ordered in increasing value, 
(0(*, 
), 
0 
), 
* 0ý2 ... I OýB)), a bootstrap 95% confidence Interval 
for the statistic would be from the 0.025Bth to the 0.97513th largest values. This yields 
the percentile method confidence interval. For a 100(l - cc)% percentile Interval the 
limits would the (cc/2)Bh and (1 - a/2)Bth ordered largest values. Le. 
0 ^*-a12ý(B) (A2.6) i. 1, 
where Oý P) 
is the e quantile (the 100e percentile) of the ordered bootstrap 
distribution 
Although the percentile method is an obvious choice, it is not the best method for 
bootstrapping confidence intervals, because it can have a bias, which one can 
estimate and correct for. 
If we let 
I .. io = (D-'ýýOj' -< 
0,, b$)IBI, (A2.7) 
where # is a count of the number of elements of the bootstrap distribution 
that are less than or equal to the observed statistic O. b. 
0: 
1 
02 OB 
and (D is the 
standard cumulative Normal distribution function e. g. V'(0.95) =1.645. Then io is 
known as the median bias of d,, b,. We obtain io =0 if exactly half of the 
ý* s are less 
than or equal to d. b. ' 
Let 
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(oo - o(l) (A2.8) 
where O(i) are the leave-one-out jackknife estimates of 0, and 0(l) /n, Is the 
mean of the n jackknife estimates. Then 5 is known as the jackknife estimate of the 
acceleration for db,. The quantity 6 is called the acceleration because it refers to 
the rate of change of the standard error of 0 with respect to the true parameter 0. 
The standard Normal approximation 0- N(O, se(O)') assumes that the standard 
error of 0 is the same for all 0. However, this is often unrealistic and the acceleration 
constant 5 corrects for this (Efron & Tibshirani, 1993). Let 
p, = ID io + 
'0 
- ZI-a 12 (A2.9) 
1- b('O - ZI-a/2 
)I 
and 
P2 ZO + 
'0 +ZI-a/2 
(A2.1 0) 
I- 44 + ZI-a/2 )II 
where Zl-, /2 is the (1 - a/2)th quantile of the standard Normal distribution (e. g. ZO. 975'ý 
1.96 and (D(1.96) = 0.975). The bias-coffected and accelerated (BC. ) method yields 
confidence intervals: 
kP04po I- (A2.1 1) 
where OýP) is the e quantile (the 100pth percentile) of the ordered bootstrap 
(0(*1 
0 
_* A* 
distribution )q ý2),..., Oý, 
j 
as defined previously. The bias-corrected (but not 
accelerated) method is a special case of BC. with ii = 0. If both the bias and the 
acceleration are zero then p, = ct/2 and P2 =I- oJ2 and the BCa method reduces to 
the percentile method. 
Efron and Tibshirani (1993) suggest that very seldom more than B= 200 replications 
are needed for estimating a standard error using Algorithm A2.1. Much bigger values 
of B (of the order 1000 to 5000) are needed for estimating percentile and BC. 
bootstrap confidence intervals. 
Efron and Tibshirani (1993) show that the BC, method has two important theoretical 
advantages. First of all, it is transformation respecting. This means that the BCa 
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endpoints transform correctly if we change the parameter of Interest from 0 to some 
function of 0 For example, the confidence intervals for ý-var(A) = 4-0 are obtained 
by taking the square roots of BC. endpoints for 0= var(A) . 
The second advantage of the BC,, method concerns its accuracy. A central 1- (X/2 
confidence interval 
(ý,, O^. j is supposed to have probability a of not covering the 
true value of 0 from above or below, 
ProbjO "cc 0,,, 
I=al2 
and ProbjO>ý. 
J=a/2. (A2.12) 
Approximate confidence intervals can be graded on how accurately they match 
A2.12. The BCa intervals can be shown to be second-order accurate. This means that 
its errors in matching (A2.12) go to zero at rate 11n In terms of the sample size n, 
ProblO < a12 +ýI-- and ProbfO > a12 + 
ý'-'P, (A2.13) 
nn 
for two constants clo and c,, p. (Note we use --* to mean "is approximately equal to". ) 
The standard and percentile methods are only first-order accurato, meaning that the 
errors in matching A2.6 are an order of magnitude larger, 
P rob 
10< ý,,, I --*a/ 2+-El-- and P rob 
10> kp I--* aI 2+. 
S'-"' 
, (A2.14) Vn Vn 
the constants c/o and c,, p being possibly different from those above. The difference 
between first and second order accuracy is not just a theoretical nicety. It leads to 
much better approximations of exact endpoints when exact endpoints exist (Efron & 
Tibshirani, 1993). 
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Copies of: 
Walters, S. J., Campbell, M. J., Lall, R. (2001a) Design and Analysis of Trials 
with Quality of Life as an Outcome: a practical guide. Joumal of 
Biopharmaceutical Statistics, 11 (3), 155-176. 
Walters, S. J., Campbell, M. J., Paisley, S. (2001b) Methods for determining 
sample sizes for studies involving health-related quality of life measures: a 
tutorial. Health Services & Outcomes Research Methodology, 2,83-99. 
Lall, R., Campbell, M. J., Walters, S. J., Morgan, K., MRC CFAS. (2002) A 
review of ordinal regression models applied on Health related Quality of Life 
Assessments. Statistical Methods in Medical Research, 11 (1), 49-67. 
Walters, S. J. and Brazier, J. E. (2003b) Sample Sizes for the SF-61D 
Preference Based Measure of Health from the SF-36: A Comparison of Two 
Methods. Health Services & Outcomes Research Methodology, 4,35-47. 
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Appendix 4: Bootstrap Programs 
Appendix 4: Bootstrap Programs 
Examples of Resampling Stats code for Implementing Algorithm 6.1 
West 
I-------------------------------------------------------- 
'Bootstrap simulation for estimating power for comparing two means 
via a 2-sample t-test 
Taking into account the bounded nature of the outcome 
i. e. recodes values above 100 to 100 
Under the location shift alternative hypothesis 
Author: Stephen Walters 
Date: 17 April 2001 
-------------------------------------------------------- 
MAXSIZE default 10000 
READ FILE "C: \Documents and Settings \stephen walter \my 
Documents\ PhD\Boot strap data\other datafiles\females. dat" id age sex 
phys social rlp rlm mental energy pain ghp pcs mcs sf6d 
'Remember to enter the following parameters 
LET samsize =0 'Sets initial sample size to samsize 
LET step = 50 'Defines the sample size increment 
LET t= 1.98 'Defines critical value for Test Statistic 
LET delta =5 
LET testdata = ghp 'Defines testdata as the data vector to be 
bootstrap 
LET boot =10000 'Defines the number of BOOTSTRAP repetitions 
LET loop = 12 'Defines the number of LOOPs starting at 
ISAMPSIZE and increasing by STEP 
t alpha 0.05 8 df - 2.306 38 df - 2.024 80 df - 1.99 
18 df = 2.101 48 df = 2.011 100 df - 1.984 
28 df = 2.048 58 df = 2.002 150 df - 1.976 
Calculates means and standard deviations for observed control data 
MEAN testdata mn_cont 
STDEV testdata sd_cont 
PRINT mn_cont sd_cont 
LET n1 = samsize 
LET n2 - samsize 
LET n= n1 + n2 
REPEAT loop 
adds STEP to starting sample size and repeats LOOP times 
ADD step nl nl 
ADD step n2 n2 
REPEAT boot 
'Draws a random sample of size n with replacement 
SAMPLE n2 testdata treat$ 
SAMPLE n1 testdata cont$ 
'Adds the treatment effect delta to one sample 
ADD treat$ delta treat-dl 
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I Recodes values above 100 to 100 
RECODE treat di between 101 200 100 treat d2 
RECODE treat_d2 between -100 00 treat-d 
MEAN cont$ mean 
-c MEAN treat_d mean_t 
VARIANCE cont$ var_c 
VARIANCE treat d var t 
STDEV treat d sd t 
STDEV cont$ sd7c 
LET S2-((nl-l)*var 
- 
c) + ((n2-1)*var_t) 
LET denom = n1 + n2 -2 
DIVIDE s2 denom s3 
LET sp-s3AO. 5 
LET se-sp*((l/nl) + (1/n2))AO. 5 'Calculates SE 
SUBTRACT mean 
-t 
mean_c diff 
DIVIDE diff se z 'Calculates Test Statistic z 
LET z-abs = abs(z) 
'Stores Test Statistic, 
SCORE z abs scrboard 
SCORE mean 
-c 
cmean-sc 
SCORE mean_t tmean 
- 
sc 
SCORE diff diff sc 
SCORE sd t sdt sc 
SCORE sd c sdc_sc 
END 
means & mean difference 
'Counts the number of significant tests 
COUNT scrboard >= tk 
MEAN cmean sc bt cmean 
MEAN tmean sc bt tmean 
MEAN diff_sc bt_diff 
MEAN sdt sc bt sdtrt 
MEAN sdc sc bt sdcon 
DIVIDE ý boot power 
PRINT nl n2 power bt-cmean 
CLEAR scrboard 
CLEAR cmean-sc 
CLEAR tmean-sc 
CLEAR diff sc 
CLEAR sdt sc 
CLEAR sdc-sc 
END 
MWtest 
'Calculates the power 
bt-sdcon bt-tmean bt-sdtrt bt-diff 
-------------------------------------------------------------------- 
Bootstrap simulation for estimating power for comparing two means 
via a Mann-Whitney U test 
Adjusted for ties 
And corrected for the bounded outcome 
I. e. scores of 100 or more are set to 100 
Assumming a location shift alternative hypothesis 
Author: Stephen Walters 
Date: 17 April 2001 
-------------------------------------------------------------------- 
MAXSIZE default 10000 
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READ FILE 11C: \Documents and Settings \stephen walter \my 
Documents\PhD\Boots trap data\other datafiles\females. dat" id age sex 
phys social rlp rlm mental energy pain ghp pcs mcs sf6d 
'Remember to enter the following parameters .............. 
LET samsize =0 'Sets initial sample size to samsize 
LET t=1.96 'Defines critical value for Test Statistic 
LET delta =5 'Defines treatment effect 
LET testdata = mental 'Defines testdata as the data vector to be 
bootstrap 
LET boot = 10000 'Defines the number of bootstrap resamples 
LET loop = 12 'Defines the number of LOOPS 
LET step = 50 'Defines the increments 
I Calculates means and standard deviations for observed control data 
MEAN testdata mn cont 
STDEV testdata sa cont 
PRINT mn_cont sd_cont 
LET nl= samsize 
LET n2 -samsize 
LET n= n1 + n2 
COPY samsize n3 
REPEAT loop 
'adds STEP to starting sample size and repeats LOOP times 
ADD step n1 n1 
ADD step n2 n2 
REPEAT boot 
'Draws a random sample of size ni with replacement 
SAMPLE nl testdata treat$ 
'Draws a random sample of size n2 with replacement 
SAMPLE n2 testdata cont$ 
'Adds the treatment effect delta to one sample 
ADD treat$ delta treat-dl 
I Recodes values above 100 to 100 
RECODE treat 
- 
dl between 101 200 100 treat-d 
MEAN cont$ mean-c 
MEAN treat d mean t 
STDEV contý sd cont 
STDEV treat d sd trt 
SUBTRACT mean_t mean_c diff 
'Combines the two datasets into one vector 
CONCAT treat-d cont$ c 
'Calculates ranks for the combined dataset 
RANKS c rnk 
'Calculates an indicator variable with ni zeros and n2 ones 
URN n1#1 n2#0 ind_01 
MULTIPLY rnk ind 
- 
01 rk_prod 
SUM rk_prod rkl - SUM LET rnk 2= rnkT2 
SUM rnký2 rk 2 SUM 
LET U= rkl_sum - (nl*(nl+l))/2 
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END 
LET eu (nl* n2)/2 
LET varl (nl*n2)/((nl+n2)*(nl+n2-1)) 
LET var2 ((nl*n2)*(nl+n2+1)A2)/(4*(nl+n2-1)) 
LET var u (varl* rk 2 sum) - var2 
LET se-ýu var u^0.5 
'calculates Maýn-whitney/wilcoxon test statistic 
LET w= (u -e- u)/se -u LET w-abs=abs(w) 
'Calculates the Probability (X_cont < Y-trt) 
LET prob_xy - u/(nl*n2) 
'Stores Test Statistic, means & mean difference 
SCORE w abs scrboard 
SCORE mean_c cmean-sc 
SCORE mean t tmean sc 
SCORE sd cont sdc sc 
SCORE sd trt sdt sc 
SCORE diFf diff s-c 
SCORE probý_xy prý_xy_sc 
'Counts the number of significant tests 
COUNT scrboard >= tk 
MEAN cmean sc bt cmean 
MEAN tmeaný_sc bt_tmean 
MEAN diff-sc bt-diff 
MEAN pr_xy_sc bt_prbxy 
MEAN sdc sc bt sdcon 
MEAN sdt sc bt sdtrt 
DIVIDE )ý-boot power 'Calculates the power 
PRINT n1 n2 power bt_prbxy bt-cmean bt-sdcon bt-tmean bt-sdtrt 
bt diff 
CLEAR scrboard 
CLEAR cmean-sc 
CLEAR tmean-sc 
CLEAR diff_sc 
CLEAR pr_xy-sc 
CLEAR sdc-sc 
CLEAR sdt-sc 
END 
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Example of SPSS syntax code for Implementing Algorithm 7.1 
SPSS F= G 
" TITLE: BOOTSTRAP TEST STATISTIC FOR TESTING F=G. 
" Bootstrap testing F=G. sps 
" AUTHOR: S. J. Walters. 
" DATE: 30/7/2003. 
" COMMENTS% 
------ - -- - ------ - --- - 
SPSS Syntax for generating bootstrap random samples AND 
COMPUTATION OF BOOTSTRAP TEST STATISTIC FOR TESTING F=G. 
Le. equality of distributions (means and variances). 
nsamples = no of random samples (1000-2000) to estimate Cis. 
ncases = no of cases. 
GET 
FILE='C: \Documents and Settings\stephen walter\My Documents\PhD\Bootstrap'+ 
data\SPSS datafiles\cmsw summary data n=495. sav'. 
calculates the plug-in estimates from the empirical distribution. 
T-TEST 
GROUPS=group(O 1) 
/MISS ING=ANALYS IS 
NARIABLES=tmental 
/CRITERIA=CIN(. 95). 
SORT CASES BY group. 
SPLIT FILE 
BY group . 
SPLIT FILE 
OFF. 
COMPUTE ID=$CASENUM. 
SAVE OUTFILE'CADocuments and Settings\stephen walter\My Documents\PhD\Bootstrap 
data\SPSS datafiles\O RIG DATA. SAV` . 
* REMEMBER to alter ncases EVERY TIME you change variables. 
INPUT PROGRAM. 
*ncases=495 number of valid cases. 
LOOP SAMP=1 to 5000. 
LOOP V= 1 to 495. 
COMPUTE ID=TRUNC(UNIFORM(495))+ 1. 
END CASE. 
LEAVE SAMP. 
END LOOP. 
END LOOP. 
END FILE. 
END INPUT PROGRAM. 
SORT CASES BY ID. 
" Calls the first n observations Group I and the remaining m observations 2. 
"V> 241 ie number in first group. 
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COMPUTE GROUP=l. 
DO IF (V > 241). 
COMPUTE GROUP=2. 
END IF. 
SAVE OUTFILEC: \Documents and Settings\stephen walter\My Documents\PhD\Bootstrap'+ 
' data\SPSS datafiles\BOOTSAM. SAV'. 
MATCH FILES /FILE * /TABLE 'C: \Documents and Settings\stephen walter\My 
Documents\PhD\Bootstrap'+ 
'data\SPSS datafiles\ORIGDATA. SA\P/BY ID. 
SORT CASES BY SAMP. 
SAVE OUTFILE'C: \Documents and Settings\stephen walter\My Documents\PhD\Bootstrap'+ 
'data\SPSS datafiles\BOOTDATA. SA\/'. 
Creates bootstrap mean and bootstrap standard deviation. 
Remember to alter tmental to name of outcome variable. 
* selects the FIRST group. 
SELECT IF (GROUP = 1). 
AGGREGATE 
/OUTFILE='C: \Documents and Settings\stephen walter\My Documents\PhD\Bootstrap+ 
'data\SPSS datafiles\BOOTAGGI. SAV' 
/BREAK=samp 
/btmeani 'Mean of Bootstrap Replications'= MEAN(tmental) 
/btsdl 'SD of bootstrap replications' = SD(tmental). 
selects the SECOND group. 
GET FILE 'C-. \Documents and Settings\stephen walter\My Documents\PhD\Bootstrap+ 
' data\SPSS datafiles\BOOTDATA. SA\I'. 
SELECT IF (GROUP = 2). 
AGGREGATE 
/OUTFILE='C: \Documents and Settings\stephen walter\My Documents\PhD\Bootstrap'+ 
data\SPSS datafiles\BOOTAGG2. SAV' 
/BREAK=samp 
1btmean2'Mean of Bootstrap Replications'= MEAN(tmental) 
/btsd2'SD of bootstrap replications'= SD(tmental). 
GET FILE='C: \Documents and Settings\stephen walter\My Documents\PhD\Bootstrap'+ 
' data\SPSS datafiles\BOOTAGG1. SA\, r. 
MATCH FILES /FILE * ITABLE'C: \Documents and Settings\stephen walter\My 
Documents\PhD\Bootstrap'+ 
data\SPSS datafiles\BOOTAGG2. SA\r 
BY SAMP. 
SORT CASES BY SAMP. 
SAVE OUTFILE'C: \Documents and Settings\stephen walter\My Documents\PhD\Bootstrap'+ 
' data\SPSS datafiles\GROUP. SAV. 
" number in each group. 
" No of cases in GROUP 1. 
COMPUTE n= 241. 
* No of cases in GROUP 2. 
COMPUTE m= 254. 
* Computes variances. 
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COMPUTE btvarl = btsd 1 **2. 
COMPUTE btvar2= btsd2**2. 
* Computes test statistics. 
COMPUTE txboot=btmeanl-btmean2. 
COMPUTE sigma = sqrt(((n-l)*btvarl + (m-l)*btvar2)/(n +m -2)). 
COMPUTE txstud =(btmeanl-btmean2)/(sigma*sqrt((l/n) + (1/m))). 
VARIABLE LABELS txboot'Difference between Means'/ 
txstud 'Stud entised Difference between Meansl 
n 'No of Cases in Group 17 
m'No of Cases in Group 27 
sigma'Pooled SD'. 
SAVE OUTFILE'CADocuments and Settings\stephen walter\My Documents\PhD\Bootstrap'+ 
I data\SPSS datafiles\GROUP. SAV'. 
* Note STANDARD DEVIATION of bootmean Is an estimate of the STANDARD ERROR of 
the statistic. 
DESCRIPTIVES 
VARIABLES txboot txstud 
/FORMAT=LABELS NOINDEX 
/STATISTICS=MEAN SUM STDDEV 
FREQUENCIES 
VARIABLES=txboot txstud. 
FREQUENCIES 
VARIABLES=txboot txstud 
/FORMAT=NOTABLE 
/PERCENTILES= 0.010.1 0.5 12.5 5 10 25 50 75 90 95 97.5 99 99.5 99.9 99.99 
/STATISTICS=STDDEV SEMEAN MEAN 
/HISTOGRAM. 
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Example of STATA commands for Implementing Algorithm 7.2 
STATA ASLb,,. t and generating BCm Cis 
" STATA program for testing equality of means 
" and calculating ASL-boot 
" based on unequal variances t-test 
use 'IC: \Documents and Settings\stephen walter\My 
Documents\PhD\Bootstrap data\STATA datafiles\cmsw summary data 
n=495-dta", clear 
log using 'IC: \Documents and Settings\stephen walter\My 
Documents\PhD\Bootstrap output\Stata output\CmSW pf analysis 
log. log", replace 
ttest tphys, by(group) unequal 
scalar tobs=r(t) 
summarize tphys, mean 
scalar omean r(mean) 
summarize tphyB if group. -O, mean 
replace tphys - tphys - r(mean) + scalar(omean) if group -wO 
summarize tphys if group. -1, mean 
replace tphys = tphys - r(mean) + scalar(omean) if group --1 
sort group 
by group: summarize tphys 
log close 
keep tphys group 
bootstrap 'Ittest tphys, by(group) unequal" t-r(t), rep(5000) 
strata(group) notable replace saving(bsauto2) nowarn 
use 'IC: \Documents and Settings\stephen walter\My 
Documents\bsauto2. dta", clear 
generate indicator =abs(t) >-abs(scalar(tobs)) 
summarize indicator, mean 
display "ASLboot = "r(mean) 
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Example of S-PLUS commands for Implementing Algorithm 7.3 and 7.4 
S-PLUS -Regression Case and Model Resampling 
########################################4##4################################ 
# OA Knee study surgery vs rheumatology patients 
PHYSICAL FUNCTION DIMENSION 
GROUP coded as 0- rheumatology clinic I= surgery 
SEX coded as 0- female I- male 
# Bootstrap regression stratified by GROUP 
# strata option 
############################################################################ 
library(boot) 
attach(OA-Knee. pf. data) 
case resampling (Algorithm 7.3) 
tphys-lm <- glm(FTPHYS-TPHYS+AGE+SEX+GROUP, data-OA. Knee. pf. data) 
summary(tphys-1m) 
tphys. diag <-glm. diag. plots(tphys. 1m, ret=T) 
tphys. fit <-function(data) coef(glm(data$FTPHYS-data$TPHYS + data$AGE + 
data$SEX + data$GROUP)) 
tphys. case <- function(data, i) tphys. fit(datati, l) 
tphys. bootl <-boot(OA. Knee. pf. data, tphys. case, 
strata=OA. Knee. pf. data$GROUP, R-4999) 
tphys. bootl 
# regression coefficients from original data 
tphys. bootl$tO 
# calculating bootstrap 95 CIs for regression coefficient estimates 
tphys. bootlcil <- boot. ci(tphys. bootl, conf-0.95, 
type=c(nnormu, "basic", "perc", "bca"), index=l) 
tphys. bootlcil 
tphys. bootlci2 <- boot. ci(tphys. bootl, conf=0.95, 
type=c(Ilnorm", "basic", "perc", "bcall), index=2) 
tphys. bootlci2 
tphys. bootlci3 <- boot. ci(tphys. bootl, conf=0.95, 
type=c(Ilnormll, "basic", "perc", "bcall), index-3) 
tphys. bootlci3 
tphys. bootlci4 < - boot. ci(tphys. bootl, conf=0.95, 
type=c(Ilnormll, "basic", "perc", "bca"), index-4) 
tphys. bootlci4 
tphys. bootlci5 < - boot. ci(tphys. bootl, conf=0.95, 
type=c(unorm", "basic", "perc", "bca"), index=5) 
tphys. bootlciS 
###############4##4#################################44###################### 
# Model (residual) based resampling stratified by GROUP (Algorithm 7.4) 
# Note: you need to perform the case-based resampling first to get values 
# for the tphys. 1m, tphys. diag & tphys. fit functions 
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calculating modified residuals 
tphys. res <- tphys. diag$res*tphys. diag$sd 
tphys. res <- tphys. res - mean(tphys. res) 
tphys. df <- data. frame(OA. Knee. pf. data, res-tphys. res, fit-fitted(tphys. 1m)) 
tphys. model <- function(data, i) 
(d <- data 
d$FTPHYS <- d$fit + d$res(i] 
tphys. fit(d)) 
tphys. boot2 <- boot(tphys. df, tphys. model, strata=OA. Knee. pf. data$GROUP, 
R-4999) 
tphys. boot2 
# regression coefficients from original data 
tphys. boot2$tO 
# calculating bootstrap 95 CIs for regression coefficient estimates 
tphys. boot2cil <- boot. ci(tphys. boot2, conf-0.95, 
type=c(Ilnorm", "basic", "perc", "bca"), index-1) 
tphys. boot2cil 
tphys. boot2ci2 <- boot. ci(tphys. boot2, conf=0.95, 
type-c(Ilnorm", "basic", "perc", "bca"), index-2) 
tphys. boot2ci2 
tphys. boot2ci3 <- boot. ci(tphys. boot2, conf-0.95, 
type=c(Ilnormll, "basic", "perc", "bca"), index-3) 
tphys. boot2ci3 
tphys. boot2ci4 <- boot. ci(tphys. boot2, conf=0.95, 
type=c(Ilnormll, "basic", "perc", "bcall), index=4) 
tphys. boot2ci4 
tphys. boot2ci5 <- boot. ci(tphys. boot2, conf-0.95, 
type=c("normn, "basic", "perc", "bca"), index-5) 
tphys. boot2ci5 
##########################################################4################ 
Example of STATA commands for GEE case resampling Algorithm 8.1 
. xtgee pf base age sex time group, i(id) t(time) corr(exc) 
link(iden) fam(gauss) robust 
. bootstrap llxtgee pf base age sex time group, i(id) t(time) 
corr(exc) link(iden) fam(gauss) 11 - 
b, reps(1000) bca nobc nonormal 
nopercentile cluster(id) strata(group) 
. xtgee pf 
base age sex time group, i(id) t(time) corr(arl) 
link(iden) fam(gauss)robust 
. bootstrap llxtgee pf 
base age sex time group, i(id) t(time) 
corr(arl) link(iden) fam(gauss) 11 _b, reps(1000) 
bca nobc nonormal 
nopercentile cluster(id) strata(group) 
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Appendix 5: Statistical Background 
1. The area under the curve (AUC) 
The AUC is a useful way of summarising the information from a series of 
measurements on one individual (Matthews et al 1990). The AUC can also be used 
to summarize repeated HRQoL scores over time into a single measure of health for 
each patient. 
Figure A5.1: Summary measure of HRQoL: the ALIC 
1.0 
("full health 
Utility 
("death") 0.0 
Cakulating the AUC 
The area (see Figure A5.1 above) can be split into a series of shapes called 
trapeziums. The areas of the separate individual trapeziums are calculated and then 
summed for each patient. The mean AUC in each group can then be calculated. 
If Y, represents the HRQoL response variable observed at time tij, for observation j= 
1, ... ni on subject i=1, ..., m. The set of repeated HRQoL outcomes for subject i are 
collected into a ni-vector, Y1 (YiIIYi2P*-, Yi,,, ),. The AUC is for the Jh subject is 
calculated by 
A UCj (A5.1 -ý 
(tm 
- ti 
xYJ + YJ+I 
2 j., 
The units of AUC are the product of the units used for Yjj and tij, and may not be easy 
to understand, since HRQoL outcomes have no natural units. So it may be useful to 
divide the ALIC by the total time to get a weighted average level over the time period. 
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We can calculate AUC even when there are missing data, except when the first and 
final observations are missing. 
The AUCs calculated from the Leg Ulcer study and NAMEIT studies were based on 
12 months and 48 week follow-up respectively (i. e. approximately one year follow- 
ups). If the time t# for each HRQoL assessment is represented as a fraction of a year 
then the AUCs represent the weighted average level of HRQoL over the year. An 
AUC of 100, corresponds to "good health" over the year, conversely an AUC of 0, 
corresponds to "poor health" over the period. 
2. Likelihood, Generallsed Linear models, and robust standard errors 
Likelihood inference 
Likelihood inference is based on a specification of the probability or probability 
density of the observed data, y. This expression, f (y; 0), is indexed by a vector of 
unknown parameter(s) 0 Once the data are observed, the only quantities in f (. ) that 
are unknown to the investigators are 0 Then, the likelihood function for 0 is the 
function 
L(O I y) = f(y; 0). (A5.2) 
The likelihood is interpreted as a function of 0, with y held fixed at its observed value. 
The maximum likelihood estimate of 0 is the value, d, which maximises the 
likelihood function or equivalently, its logarithm. That is, for any value of 0, 
L(O I y):! ý L(ý I y) (A5.3) 
According to the likelihood principle, 0 is then regarded as the value of 0 which is 
most strongly supported by the observed data. In practice, ý is obtained by the 
direct maximisation of log L, or by solving the set of equations 
S(o) =0 
log L=0. (A5.4) 
ao 
The function S(O) is known as the score function for 0 Very often, numerical 
methods are required to evaluate the maximum likelihood estimate (A5.4). 
The asymptotic variance matrix of 0 is given by the expression 
V= -E( ao, 
)j-, 
(A5.5) 
The matrix V1 is also known as the Fisher information matrix for 0 
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Generalized linear models 
Regression models for independent (binary, discrete and continuous) responses 
have been unified under the class of generalized linear models, or GLMs (McCullagh 
and Nelder, 1989), thus providing a common body of statistical methodology for 
different types of response. 
Linear, logistic and Poisson regression models are all special cases of GLMs, which 
share the following features. First, the mean response, p, = E(Y, ), is assumed to be 
related to a vector of covariates, x, through 
hýtj = x, 'P. (A5.6) 
For linear regression, h(u, ) =, u,; for logistic regression h(, u, ) = log I 
Pp'i 1; 
and for 
Poisson regression h(p, ) = log(p, ). The function h(-) is called the link function. 
Second, the variance of Yj is a special function of its mean, gi namely, 
Var(Y, ) = v, = Ov(pl). (A5.7) 
In this expression, the known function v(. ) is referred to as the variance function; the 
scaling factor 0 is a known constant for some members of the GLM, whereas in 
others it is an additional parameter to be estimated. For the linear model 0 
whereas for the Poisson model 0=1. 
Third, each class of GLMs corresponds to member of the exponential family of 
distributions, with a likelihood function of the form 
(yi 
9 01,0) = exp[ 
ly, 0,0 v/ (of» 
+ C(Yi 9 0)] - (A5.8) 
The parameter Oi is known as the natural parameter, and is related to a, through 
Pi = aq, . 
For example, the Normal distribution is a special case of the 
exponential family, with 
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Ayisoi, o)= exp - 
(YI 
-, Ui 
)2 
2a' 
2 )J2 lfy, 2 2 exp 
fy'pl 
- 
(lj' 
+ log(2; ra 
I 
cr 22 La" 
)II 
2 10= 
C2. 0, =P1, V(O, )=Li - C(Yito)=- 
Y, + log(2; ro and (A5.9) 220 
11 
Similarly, the Poisson distribution is another example from the exponential family, 
with 
01 = logp,, V/(O, ) = exp(Ol), c(yio) = -log(y,! 
) and 0=1. (A5.1 0) 
In any GLM the regression coefficients, p, can be estimated by solving the same 
estimating equation, 
S(P)= E(ap')TVar(Yj)-'fYj 0- (A5.1 1) 
i-I afl 
S(8) is the derivative of the logarithm of the likelihood function. The solution 
which is the maximum likelihood estimate, can be obtained by iteratively reweighted 
least squares (IRLS) as described in McCullagh and Nelder (1989). 
Finally, in large samples 0 follows a Normal distribution with mean P and variance 
V 
P, 
)T aA 
Var(Y, )-' (A5.12) 
m 
This variance can be estimated by V which is obtained by fl replacing with in the 
expression (A5.12). 
Quasi-likelihood 
One important property of the GLM family is that the score function, S(P) depends 
only on the mean and variance of the Yi. Wedderburn (1974) was the first to point out 
that the estimating equation (A5.1 1) can be used to estimate the regression 
coefficients for any choices of link and variance functions, whether or not they 
correspond to a particular form of the exponential family. The name quasi-score 
function was coined for S(P) in (A5.1 1) since it's integral with respect to P can be 
thought of as a 'q uasi-likeli hood' even if it does not constitute a proper likelihood 
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function. This suggests an approach to statistical modelling in which we make 
assumptions about the link and variance functions without attempting to specify the 
entire distribution of Yj or its likelihood. This is desirable, since we often do not 
understand the precise details of the probabilistic mechanism by which the data were 
A generated (Diggle et al 2002). McCullagh (1983) showed that the solution, P, of the 
quasi-score function has a sampling distribution which, in large samples, Is 
approximately Normal with mean P and variance given by equation (A5.12). 
Generalised estimating equations (GEEs) for longitudinal data (adapted from 
Zeger and Liang, 1986) 
Consider the observations (Y11, x1l) for times t#, J=1,..., ni and subjects i= 
Here Yi, is the outcome variable and xy is apx1 vector of covariates. Let Y, be the n, 
x1 vector 
(Y,,, Y12 
9***Yi., Y and xi be the ni xp matrix (X,, I X12) "' 11 X,,, 
Yfor the I' subject. 
Quasi-likelihood has previously been applied in the regression context (A5.1 1) where 
nj =I for all L Hence in discussing the results in this section, we drop the subscriptj 
and treat each subject's data as a scalar. 
Define /4 to be the expectation of Y, and suppose that 
pi =h (x,, 6) (A5.1 3) 
where a is apx1 vector of parameters. The inverse of h is referred to as the link 
function (McCullagh and Nelder, 1989). In q uasi-likeli hood, the variance, 14 of YJ is 
expressed as a known function, g, of the expectation, /4, i. e., 
V1 = 9(PJ/O (A5.14) 
where 0 is a scale parameter. The focus of q uasi-li keli hood is on methods for 
inference about fl. Hence, 0 is treated as a nuisance parameter. 
The q uasi-li keli hood estimator is the solution of the score-like equation system 
= 
±(_ý 
TV 
fli 
_, fy Sk (fl) 2: 
1-0, k=1,... P. (A5.15) 
i-I aflk 
Equation (A5.15) is in fact the score equation (A5.1 1) for, 8when Y, has a distribution 
from the exponential family. 
To apply the quasi-likelihood approach to the analysis of longitudinal data we must 
consider the mean and covariance of the vector of responses, Y1, for the Ih subject. 
In addition let RAa) be the ni x ni "working" correlation matrix for each Y1. Note that 
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the observation times and the correlation matrix can differ from subject to subject. 
Rga), however, is assumed to be fully specified by the sx1 vector of unknown 
parameters, a, which is the same for all subjects. Then following the quasi-likelihood 
approach, the working covariance matrix for Y, is given by 
All /2 Ri (a)A 11/2/0, (A5.16) 
where & is an ni x ni diagonal matrix with g(fl. ) as the Ih diagonal element. We 
refer to RAa) as a "working" correlation matrix because we do not expect it to be 
correctly specified. We would like estimators that are consistent and have consistent 
variance estimates even when RAa) is incorrect. (A5.16 will be equal to cov(YI) if is 
indeed Rja) the true correlation matrix for the Yj's. ) Our extension of equation 
(A5.15) to the longitudinal case is given by 
Ui 
)T 
(A5.17) S, 6 
(fl, 
a) Var(Y, ) -'IY 0 
i-I ap 
Or simplified to 
2: D TVýISI = 0, (A5.18) 
where S, = Y, - pl, p, = (Al,..., pi, ý and D, = c1pi 16P . 
Equations (A5.18) reduce to the q uasi-likel i hood estimating equations (A5.15) when 
n, =1 for all L More generally U, (fl, a)= DTjVj-'Sj is equivalent to the estimating 
function suggested by Wedderburn (1974) except that the Vis here are functions of a 
as well as P. 
While the estimating equations (A5.18) now depend on a as well as fl, they can be 
re-expressed as a function of fl alone by first replacing a in equations (A5.16) and 
(A5.18) by a m112-consistent estimator, et(Y, fl, O), then replacing 0 in 6 by a m'12- 
consistent estimator, O(Y,, 6). Consequently, for any given RAa), the estimate ft., , of 
fl is defined as the solution of the "generalized estimating equation" (GEE) 
ý")TV_, (L 
U, a) (aXY, -, u, ) = 0, or simplified to aj6 
M (A5.19) 
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Under mild regularity conditions, Liang and Zeger (1986) show that as m -+ oo, 
ft,, Is 
a consistent estimator of fl and that MI/2 
V,, 
-, 0) is asymptotically multivariate 
Normal with covariance matrixVRgiven by 
'n 
VR = "MMED, TV, -'D, 
)-'[I: 
D, TV, -' cov(r, )V, -'D, 
(±DTV, 
-'D, 
M-+00 
IW 
V "M ln(VýIV, wl 
M-*00 
(A5.20) 
where the covariance of Y, is the actual rather than the assumed covariance. VR can 
be estimated consistently without evaluating cov(YI) directly. This is achieved by 
simply replacing cov(Yi) by SiSr and a, 6 and ý by their estimates in (A5.20). 
To solve the GEE for 6,, we iteratively solve for the regression coefficients and the 
correlation and scale parameters, a and 0. Given an estimate of RAct) and of 0, we 
can calculate an updated estimate of jO by 
I RLS. Given an estimate of 6, we calculate 
standardised residuals, r. =(Y, -jjj/#77ý, which are used to consistently #Y 
estimate a and ý. These two steps are iterated until convergence. Details on 
computing 8,, and are provided by Liang and Zeger (1986). As in many quasi- 
likelihood problems, it is often possible to estimate 8 without estimating ý directly. We 
require only that the elements of R be multiples of the parameters, (x. 
Robust standard errors 
We estimate, 8 by using IRLS to solve the GEE (A5.19). A robust variance estimate is 
given by (A5.20) which can be simplified to (Zeger et al 1988): 
v 
Pit -molmimoll 
(A5.21) 
m 
where mo E -, aftR 
T 
ýU, 
T 
and m 
"A' 
P, -' (Yi -A, 
XY, 
- OR 
(A5.21) is also consistent even when cov(Yi) * Vf. The marginal regression models 
were fitted in sTATA v8 (StataCorp, 2003) using the xtgee command with an 
identity link function (link (iden) ) and the robust standard errors option. 
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